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ABSTRACT 
 
 
Improving swine feed efficiency (FE) by selection for low residual feed intake (RFI) 
is of practical interest. However, whether selection for low RFI compromises a pig‟s immune 
response is not clear. In addition, current RFI-based selection for improving feed efficiency 
was expensive and time-consuming. Seeking alternative tools to facilitate selection, such as 
predictive biomarkers for RFI, is of great interest. The objectives of this thesis are as follows: 
(1) to investigate whether selection for low RFI compromise a pig‟s immune response; (2) to 
develop candidate biomarkers applicable at early growth stage for predicting RFI at late 
growth stage; (3) to improve the annotation of the porcine blood transcriptome. 
In Chapter 2, pigs of two lines divergently selected for RFI were injected with 
lipopolysaccharide (LPS). Transcriptomes of peripheral blood at baseline and multi-time 
points post injection were profiled by RNA-seq. LPS injection induced systemic 
inflammatory response in both RFI lines. However, no significant differences were detected 
in dynamics of body temperature, blood cell count and cytokine levels during the time 
course. Only a very small number of differentially expressed genes (DEGs) were detected 
between the lines over all time points, though ~ 50% of blood genes were differentially 
expressed post LPS injection compared to baseline for each line. The two lines were largely 
similar in most biological pathways and processes studied. Minor differences included a 
slightly lower level of inflammatory response in the low- versus high-RFI animals. Cross-
species comparison showed that humans and pigs responded to LPS stimulation similarly at 
both the gene and pathway levels, though pigs are more tolerant to LPS than humans. 
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In Chapter 3, post-weaning blood transcriptomic differences between the two lines 
were studied by RNA-seq. DEGs between the lines significantly overlapped gene sets 
associated with human diseases, such as eating disorders, hyperphagia and mitochondrial 
disease. Genes functioning in the mitochondrion and proteasome, and signaling had lower 
and higher expression in the low-RFI group relative to the high-RFI group, respectively. 
Expression levels of five differentially expressed genes between the two groups were 
significantly associated with individual animal‟s RFI values. These five genes were candidate 
biomarkers for predicting RFI. 
Given limitations of current annotation of the porcine reference genome, a high-
quality annotated transcriptome of porcine peripheral blood was built in the last study via a 
hybrid assembly strategy with a large amount of blood RNA-seq data from studies mentioned 
above and public databases. 
Taken together, this work provides evidence that selection for low RFI did not 
significantly compromise pigs‟ immune response to systemic inflammation, offers a few 
candidate biomarkers for predicting RFI to facilitate RFI-based selection, and significantly 
advances the structural and functional annotation of porcine blood transcriptome. 
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CHAPTER 1. INTRODUCTION 
 
 
Current Status of the Pig Reference Genome and Its Annotation 
The domestic pig is one of the most economically important livestock species. Globally, 
pork accounts for more than 40 percent of total meat consumed by humans and rank as the top 
one meat source (2015). The pig has also been recognized as an emerging biomedical model for 
human physiology and many diseases, because genomic, physiological and anatomic similarities 
of the pig to human are greater than those of classic animal models to human [1, 2]. For example, 
mini-pigs have played a valuable role in biomedical research. Besides naturally occurring 
mutants and pigs with artificially induced diseases, genetically modified pigs have also been 
used as biomedical models over the last two decades. 
Deep understanding of the pig genome has been essential to improving pig genetics for 
better performance and developing useful models for human diseases. The pig genome is 
composed of 18 autosomes (SSC1-18) and two sex chromosomes (SSCX and SSCY), with a 
total size of 2.7 ~2.9 gigabases (Gb). The draft sequence of the pig genome was first released in 
2009 by the Swine Genome Sequencing Consortium (SGSC), which was mainly based on BAC-
by-BAC Sanger sequencing and low coverage of Illumina whole genome shotgun sequencing of 
DNA from 3 individuals of different genetic backgrounds [3]. The draft assembly was further 
refined and the current version of the draft assembly is Sscrofa10.2 [4]. This reference genome 
assembly includes 2.60 Gb placed onto 20 chromosomes consisting of 5,343 scaffolds and 212 
megabases (Mb) unplaced sequences distributed among 4,562 scaffolds. Because of the sequence 
depth was not high enough, the draft assembly was still very fragmented, with contig N50 = 
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80,720 base pairs (bp) and scaffold N50 =637,332 bp. In the most recent release (Release 87) [5], 
21,630 coding and 3,124 noncoding genes have been annotated. The non-coding genes include 
2,804 small non-coding genes, 135 long non-coding genes and 185 miscellaneous non-coding 
genes. In addition, 568 psudogenes were also identified. Surprisingly, only 30,585 transcripts 
were annotated.  
The draft reference genome has been shown to facilitate genetic improvement of pig for 
better performance [6-8]. The availability of the draft reference genome and its structural and 
functional annotation, and the development of genetic manipulation tools, such as somatic cell 
nuclear cloning, transgenesis and genome editing techniques especially the recent developed 
CRISPR/cas9 system, have been accelerating the use of genetically modified pigs as biomedical 
models for specific human diseases and a potential source of organ xenotransplantation [9-12]. 
However, further study showed that the current version of reference genome is neither 
well-assembled nor well-annotated [13]. For example, only 43% of the 25,510 transcripts of the 
21,630 coding genes have both a 5‟ and 3‟ UTRs defined. On average, less than 1.2 isoforms per 
protein-coding gene and only 3,124 non-coding genes have been identified in SSC10.2. More 
recently, Warr et al. [14]  reported that more than 33% of SSC10.2 is not correctly assembled or 
is otherwise unreliable. In addition, many known genes are missing from the reference genome 
[15, 16]. Therefore, improvement of the pig reference genome assembly is necessary. With the 
advent of PacBio long read sequencing technology,  recently two groups, at the Roslin Institute, 
Edinburg University, and the Meat Animal Research Center, USDA-ARS have independently 
reassembled the pig reference genome by using this new sequencing technology [15, 17]. The 
new assemblies show great improvement over Sscrofa10.2, especially the assembly by the Roslin 
Institute, which has been released to NCBI GenBank as Sscrofa11.0, and is comprised of 19 
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chromosomes (SSC1-18, and SSCX), with DNA from the single female Duroc animal that was 
used for the Sscrofa10.2 assembly. There are only 122 contigs and less than 600 unplaced 
scaffolds in this version, with contig N50 = 58.5 Mbp and scaffold N50 = 107.6 Mbp. And the 
estimated base accuracy is 99.999%, meeting the gold standards of a finished genome. Further 
efforts are being taken to fill the remaining gaps by targeted sequencing. Compared to the Roslin 
assembly, the US-MARC assembly is less contiguous. The US-MARC assembly was based on a 
single castrated crossbred male (5/8 Yorkshire × 1/4 Landrace × 1/8 Duroc). Further work is 
needed to improve this assembly. These two new assemblies are to be annotated soon using ab 
initio algorithms, existing evidence, such as EST, cDNA, RNA-seq data and IsoSeq data (T. 
Smith and H. Liu et al., unpublished). RNA-seq short reads-based genome-guided and de novo 
transcriptome assemblies, such as the high-quality annotated blood transcriptome assembly 
presented in Chapter 4 will be useful in annotation of these reference genomes. These high-
quality genome assemblies will further promote application of pigs in agriculture and 
biomedicine. 
Porcine Transcriptomics: Tools and Their Applications 
Transcripts derived from a genome are intermediate or end products of gene expression. 
Broadly speaking, all transcripts encoded by a genome as a whole are called the transcriptome 
(broad-sense transcriptome), including protein-coding mRNAs and non-protein-coding RNAs, 
such as microRNAs (miRNAs), small RNAs, and long non-coding RNAs (lncRNA). A narrow-
sense transcriptome is the collection of RNA expressed in a specific cell or tissue type in a given 
condition at a given time. Hereafter, I will focus on the narrow-sense transcriptome because it is 
a building block of the broad-sense transcriptome. Transcriptomes are very dynamic, depending 
on various factors, including developmental stages and external conditions. For an organism, the 
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transcriptome plays important roles in controlling genetic information flowing from the genome 
to the phenome, by acting as messengers between genes and their protein products, components 
of translation machinery, regulators of gene expression, intercellular signal carriers and so on. 
The ultimate goal of transcriptomics is to determine the identity, abundance and function of each 
transcript in each cell or tissue type under a given condition, how they respond to internal and/or 
external changes and the biological effects of transcriptomic changes. Though the estimated 
correlation between the transcriptome and proteome is only moderate (reviewed by [18]), it is 
important to comprehensively study the transcriptome to better understand the genome. First, 
because the transcriptome can at least partially reflect the current and the immediately following 
states of a cell or tissue and can reveal molecular mechanisms underlying biological phenomena, 
especially by comparing transcriptomes under different conditions. Another reason that 
transcriptomes are extensively investigated is because many convenient, cost-effective, high-
throughput tools are available or are being developed for transcriptomics. Over the last two 
decades, the technologies used for gene discovery, genome annotation and transcriptome 
profiling have evolved quickly from large scale EST sequencing to most recent RNA-seq and 
PacBio IsoSeq. 
Sanger method-based EST and full-length cDNA sequencing 
Large-scale EST sequencing came into being in the early 1990s [19]. It is a cost effective 
alternative to whole genome sequencing, with focus on the transcribed portion of a genome. 
Usually, by one-pass sequencing, reads of 200 to 800 bases are generated from randomly 
selected cDNA clones. These reads are useful for gene discovery, alternative splice isoform 
discovery, verifying predicted gene models, phylogenetics, transcriptome profiling, providing 
training data for ab initio genome annotation, expression evidence for microarray probe design, 
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and facilitating protein discovery by proteomics approaches [20]. However, due to the high 
sequencing cost and limited throughput of the technology, expression analysis by EST 
sequencing was limited to shallow depth, and was thus considered as an only semi-quantitative 
approach. If the relative abundance of genes is not the main concern, using normalized or 
subtracted cDNA libraries can further boost the efficiency of gene discovery [21]. 
In pigs, the first EST sequencing effort was reported in 1994 [22], which determined the 
sequence of 14 pig skeletal muscle cDNAs. Since then, large scale EST sequencing for many 
various porcine tissues have been conducted, such as small intestine, anterior pituitary, backfat, 
brain, liver, reproductive tissues and so on [23-29]. By January, 2017, 1,676,489 EST sequences 
had been deposited to ESTdb (https://www.ncbi.nlm.nih.gov/nucest). The large number of ESTs 
has been further clustered to generate UniGenes. Based on the most recent statistics 
(https://www.ncbi.nlm.nih.gov/UniGene/UGOrg.cgi?TAXID=9823, Jun 19, 2012), 1,294,785 
EST sequences are clustered into 50,106 UniGene clusters in the UniGene Build 42. ESTs from 
more than 40 categories of tissues have been sequenced. All the efforts of EST sequencing have 
greatly improved the discovery of pig genes, marker development, and genome annotation. 
Full-length cDNA sequences are more valuable than fragmented ESTs to fully 
understand the fine structures, transcript diversity in pig transcriptome, and for functional 
studies. Full-length cDNA enriched libraries were constructed by using oligo-capping [30], 
vector-capping [31], SMART [32, 33] or more recently-developed TeloPrime [34] methods. To 
date, full-length cDNA sequences are available for 28 tissues [29]. 
A high throughput variant of EST sequencing is serial analysis of gene expression 
(SAGE) [35], which has been used to estimate relative gene expression abundance, determine 
differential expressed genes between different treatment conditions, and profile gene expression 
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patterns over development stages [36, 37]. Compared to the original EST sequencing, no cDNA 
clones or library construction is involved in SAGE. After synthesis of double-stranded cDNA, 
the cDNA is digested with enzymes, adaptors are ligated to both ends, and resulting fragments 
are concatenated and sequenced to get enough tags of 10 to 20 bp. The relative gene expression 
abundance is estimated based the count of tags after mapping the tags to the cDNA sequence of a 
gene. 
Gene expression microarray 
Large-scale EST sequencing and full-length cDNA sequencing for a broad range of 
tissues provided enormous amount of transcript sequences for design of cDNA-based 
microarrays and oligo probesets-based microarrays [38, 39]. This DNA microarray technology 
emerged in the middle of 1990s, which can simultaneously quantify the relative abundance of 
thousands of transcripts/genes by hybridizing labeled targets derived from transcripts to 
addressable probes that are fixed on a solid surface and imaging and quantifying the abundance 
of targets by fluorescence-based methods [38, 39]. This technology supplanted the EST 
sequencing and SAGE methods in many applications because it was more cost effective and 
higher throughput. The application of these platforms significantly sped up genome-wide gene 
expression profiling, identification of gene function and gene regulation, and understanding 
biological mechanisms that underlay a given biological phenomenon. Over the years, arrays of 
different profiling capacity from targeted to genome-wide were created based on the interest of 
researchers and the availability of knowledge about the porcine transcriptome, such as the 
Agilent-037880/INRA Sus scrofa 60K v1 Array, which was enriched with genes expressing in 
the immune system, muscle and adipose tissues, Affymetrix Porcine Genome Array based on 
UniGene Build 28 (2004), the Affymetrix PorGene-1_0-st-v1 and the Affymetrix Porcine 
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Snowball arrays (2010), both of which were designed based on Genome build 9, with the latter 
including nearly twice as many probes as the former, as well as probesets for noncoding RNAs, 
and the Agilent porcine gene expression microarray v1 and v2 (For more details, see review [40] 
). Using the Snowball platform, gene expression patterns of 65 tissues/cell types were profiled 
[41]. In addition, these platforms have been used to study differential gene expression of animals 
of different physiological states, health conditions, development stages, and genetic 
backgrounds. From July 21, 2006, to November 28, 2016, 355 transcription profiling data sets 
were deposited to ArrayExpress [42] (https://www.ebi.ac.uk/arrayexpress, EMBL EBI) using 
custom or commercial porcine microarrays with foci on different transcriptome targets, and 
profiling experiments using cross-species arrays excluded. However, microarrays are closed 
platforms. Probe design of microarrays depends on known knowledge about gene sequences and 
gene structural annotation, and, thus, it is only possible to study known genes using microarrays. 
In addition, this technology suffered from issues such as limited dynamics, cross-hybridization 
and noisy background [43]. 
Semi-high throughput real time-PCR and Nanostring nCounter 
Real time PCR is usually considered as the gold standard for quantifying gene expression 
due to its sensitivity and accuracy and is often used to validate discoveries from high throughput 
assays, such as microarrays and RNA-seq (see below), due to its limited throughput and high 
cost. However, recent developments of the real time PCR platforms make it a useful and 
convenient technique for profiling a specific set of genes of interests (up to several hundred) in a 
large number of samples. Currently, several semi-high throughput real time PCR platforms are 
available, using 96-well, 384-well, and 1536-well plate formats. For example, the LightCycler® 
1536 Real-Time PCR System (Roche Applied Science, Germany) can detect gene expression in 
 8 
1536 reactions simultaneously [44].  The Microfluid Dynamic Arrays in different formats (Flex 
Six
TM
, 48.48, 96.96 and 192.24 Dynamic Arrays12.765 and 48.770 Digital Arrays) 
(https://www.fluidigm.com/products/biomark-hd-system) provide very flexible choices for 
different high-throughput real time PCR [45-47]. The microchamber-based reaction significantly 
reduces the cost of consumables and the amount of biological materials needed. Single-cell high-
throughput real time PCR assays using the Fluidigm arrays have been reported [48]. Fluidigm 
real time PCR has been applied to simultaneously detect host and pathogen gene expression, as 
well as miRNA and mRNA expression in pigs infected with bacteria and viruses [49, 50]. 
Another semi-high throughput platform for gene expression profiling is the NanoString 
nCounter system (http://www.nanostring.com). To detect the abundance of multiple transcripts, 
this system uses multiplexed probesets with two target-specific probes for each target of interest: 
a color-coded reporter probe for visualizing the target and a capture probe to immobilize the 
target-probe complex for counting [51]. Up to 800 targets, including miRNA, mRNA or 
lncRNA, can be detected in a single tube without enzymatic reaction or bias. The NanoString 
nCounter platform provides a digital readout for target abundance and its sensitivity is higher 
than that of microarrays and equivalent to that of real time PCR [51]. It can even handle samples 
of bad RNA quality, such as RNA extracted from formalin-fixed, paraffin-embedded (FFPE) 
tissues, and direct cell lysate, such whole blood lysate [52]. Assays (nCounter Plex
2
) for 
multiplexed single cell gene expression profiling, and for profiling hundreds of genes in multiple 
samples in a single tube are also available. To date, no application of Nanostring nCounter to 
gene expression analysis in pigs has been reported. 
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RNA sequencing 
RNA sequencing (RNA-seq) is a more recently developed revolutionary, high-
throughput, cost effective method for transcriptomics, based on next generation sequencing 
(NGS) technology. In one run, millions of short reads of length between 50 to 300 bases can be 
generated, so RNA-seq can be considered as a much higher throughput EST sequencing 
successor, providing nucleotide-level resolution but at much lower cost due to high throughput 
and multiplexing. RNA-seq suffers much less from background noise, provides a much greater 
dynamic range of detection of gene expression and higher reproducibility than microarray-based 
methods [53] and is not constrained by a priori knowledge of the genome or transcriptome of 
interest. So it can be applied to any organism with or without reference genome. The applications 
of this technology have been quickly expanded since its first use in profiling gene expression of 
yeast in 2008 [54]. Today, it has been used to determine differentially expressed genes between 
conditions, allele-specific expression, known and novel transcripts, novel RNA species, 
transcription starting sites (TSS), polyadenylation sites (PAS), alternative splicing, RNA editing, 
expressing variant, gene fusion, and pathways and gene networks involved in a specific 
biological processes [55-57]. In addition, RNA-seq has also been used to determine single-cell 
transcriptomes [58-60], RNA structure [61], and RNA interactions with other molecules [62-64]. 
Currently, RNA-seq can be implemented by using three mainstream NGS technologies: 
the SOLiD sequencing and Ion Torrent sequencing technologies (ThermoFisher), and the 
Illumina sequencing technology, with the first using a “sequencing-by-ligation” method and the 
other two using two different “sequencing-by-synthesis” methods (reviewed by [65]). Due to its 
high throughput, cost effectiveness, high accuracy and many open-source analysis tools, Illumina 
sequencing technology is currently the most popular for RNA-seq. A yearly updated comparison 
of NGS technologies and platforms is available at http://www.molecularecologist.com/2016 
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/03/2016-ngs-field-guide-preview/ [66]. Hereafter, I will mainly focus on the Illumin RNA-seq 
technology and its applications. Depending on the species, the biological question of interest and 
the scale of projects, different Illumina platforms with different throughputs are available, from 
MiniSeq to Hiseq X (https://www.illumina.com/systems.html). Currently, the maximal read 
length is 300 bases on MiSeq series platforms. For more detailed information about all Illumina 
platforms, see the Illumina website (https://www.illumina.com/systems.html). 
Illumina sequencing platforms can also be used to sequence miRNAs and other small 
RNAs, circular RNA and other long RNAs by adopting different strategies of library 
construction [67, 68]. Many variants of library construction methods have been developed [69-
73]. Each strategy has its own advantages and disadvantages [74]. A typical procedure is as 
follows. First, mRNA is enriched by poly (A) capture or rRNA is selectively depleted from the 
total RNA before library construction for long RNA-seq. Then long RNA molecules are sheared 
into pieces of an average size between 100 and 600 bases by heat hydrolysis, with the actual 
optimal size range depending on the sequencing strategy. After that, the RNA fragments undergo 
reverse transcription by using random primers to obtain double stranded cDNA fragments. 
Subsequently, sequencing adaptors with or without barcodes are ligated to both ends and the 
resulting products are further linearly amplified by PCR. PCR products are size selected and 
purified to get sequencing-ready libraries. The libraries are loaded onto a flow cell to generate 
clusters for each fragment. Finally, each cluster is sequenced by using the cylic reversible 
termination approach-based “sequencing-by-synthesis”. 
However, RNA-seq technology is not unbiased in terms of read coverage along a given 
transcript or between transcripts. For long RNA-seq, the main biases include transcript length 
bias, GC content bias and dinucleuotide frequency bias [75, 76]. For small RNA-seq, the main 
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bias is introduced by adaptor ligation due the sequence preference of RNA ligases [77].  
Different library construction methods can bring different biases [78]. To reduce the biases 
introduced during library construction, several optimizations have been suggested [67, 75, 77-
80]. 
Similar to the RNA-seq technology itself, the analysis tools and methods for RNA-seq 
data are still quickly evolving. Discovery of differentially expressed genes (DEG) between 
conditions is usually of interest to many researchers. In this paragraph, I will focus on this type 
of analysis. For RNA-seq-based DEG analysis, consensus on methods for count normalization 
and DEG discovery has not been reached yet. The actual analysis pipeline might have to be 
established case by case in a data-driven way [81]. However, several guideline papers on RNA-
seq data analysis are worth mentioning [81-88]. A currently recommended practice for DEG 
analysis is as follows. First, quality of RNA-seq raw reads is checked. If necessary, sequencing 
adaptors and bases of low quality are trimmed. For species with a good-quality reference 
genome, RNA-seq reads are generally mapped to the reference genome using some splice-aware 
aligner, such as STAR [89], GSNAP [90], Novoalign (http://www.novocraft.com/products/ 
novoalign/), CLC (http://www.qiagenbioinformatics.com/products/clc-genomics-workbench/), 
HPG aligner [88], and HISAT2 [91],. Gene- or exon-level count summary is generated by using 
featureCounts [92] or HTSeq [93], with the former more efficient and accurate than the latter. 
For species without a good-quality reference genome, it is necessary to perform de novo 
transcriptome assembly to get a rough reference transcriptome first. Then the RNA-seq reads are 
aligned to the de novo transcriptome using an aligner for DNA alignment, such as Bowtie2 [94] 
and HPG aligner [95]. Abundance per transcript is estimated by using expectation-maximization 
(EM) algorithm-based methods, such as RSEM [96], eXpress [97] and Mix
2
 [98]. Gene-level 
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expression abundance can be obtained by summing the per-transcript abundance if the gene-
transcript relationship is available, which is usually the case. After the read count summary at a 
feature (gene, transcript, or exon) level is available, the widely used R packages, such as edgeR 
[99], DESeq2 [100] and QuasiSeq [101], are used for a statistical analysis to identify 
differentially expressed genes. When the RNA-seq data includes some hidden variations that are 
not accounted for by known covariates, removing the hidden variations is recommended by using 
tools, such as svaseq [102] or RUVSeq [103]. 
To reconstruct full-length transcripts from RNA-seq short reads, de novo or genome-
guided transcriptome assembly is essential [104]. All de novo assembly methods are based on the 
de Bruijn graph theory [105], although the detailed implementations are more or less different. 
While most methods, such as SOAPdenovo-trans [106], allow multiple k-mers for assembly, 
Trinity uses only 25-mers for assembly [107]. However, different theories have been adopted for 
genome-guided transcriptome assembly. The two most widely used assemblers are Cufflinks and 
StringTie [108, 109]. The former builds overlap graphs and determine the parsimony transcript 
isoforms that can explain the aligned reads, while the latter builds splice graphs and uses the 
network flow algorithm to determine the most likely transcript isoforms [108, 109]. Two 
genome-guided assembler which have been more recently developed but not yet widely used, 
which the authors claimed to be better performers are Bayesembler [110] and TransComb [111]. 
Florea and Salzberg [112] reviewed the details of different genome-guided transcriptome 
assembly approaches. Which transcriptome assembly strategy should be taken depends on the 
actual situation, because each has its own advantages and disadvantages [105]. Because de novo 
assembly is reference genome-independent, it is not misled by misassembled genome regions. 
However, it tends to assemble fragmented transcript pieces. On the other hand, genome-guided 
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assembly can take advantage of the well-assembled genome regions to assemble contiguous 
transcripts, but can also suffer from wrongly assembled genomic regions to report wrong 
transcripts. Both de novo and genome-guided transcriptome assembly strategies have difficulties 
in correctly assembling transcripts derived from very similar paralogs. If a high-quality reference 
genome is available, genome-guided assembly is usually proposed, otherwise de novo 
transcriptome assembly is the preferred choice or a hybrid assembly method that integrates de 
novo and genome-guided assemblies can be adopted if a decent reference genome is available 
[104, 113]. Some best practices for de novo transcriptome assembly have been suggested [114-
117]. Because de novo assembly usually results in an unexpectedly large number of putative 
transcripts (PT), also known as “transfrags”, a significant portion of which are “transcriptional 
noise”, redundant PTs, and assembly artifacts. The redundancy, noise and artifacts can be filtered 
out based on following the following steps: (1) clustering and collapsing by using tools such as 
cd-hit-est [118] and EasyCluster2 [119]; (2) removing intronic unspliced PTs after aligning them 
to the reference genome, if possible; (3) removing sequences that are significantly similar to 
those of distantly related species in the NCBI NT database; (4) filtering sequences that are poorly 
supported by RNA-seq reads (Liu H. unpublished). Quality of the resulting transcriptomes can 
be evaluated in reference-free and reference-dependent ways [105, 120]. Subsequently, the large 
number of PTs should be functionally annotated by using tools such as BLAST2GO [121], 
TRAPID [122], Trinotate (https://trinotate. github.io/) and Annocript [123]. The assembled 
transcriptome can be used for genome annotation, gene expression analysis, expressed variant 
discovery, marker development, and phylogenetics and so on. 
For pigs, data of 72 RNA-seq experiments on different tissue types of different breeds 
under different conditions have been collected in ArrayExpress [42] since 2009. These data are a 
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big asset for swine transcriptomics, which is still under-investigated, although the number of 
tissue types used for RNA-seq is still very limited. The original interest of most of these 
experiments was to identify differentially expressed genes between conditions. So far, very little 
effort has been put to assemble these RNA-seq data [117, 124-128]. These studies all focused on 
discovery of long noncoding RNA (lncRNA) based on genome-guided transcriptome assembly. 
Given that the current pig reference genome Sscrofa10.2 is not well annotated yet and the newly 
released Sscrofa11.1 is much better assembled than Sscrofa10.2, making use of these RNA-seq 
data with and without assembly will be very helpful to annotate the emerging porcine reference 
genome. 
IsoSeq: full-length cDNA isoform sequencing 
Due to the read length limitation of most next generation sequencing technologies except 
Pacific Biosciences (PacBio) SMRT and Oxford NanoPore long read sequencing, determining 
the full-length sequences of most transcripts (> 1kb) without assembly is impossible. With the 
latest chemistry P6-C4, PacBio IsoSeq technology on RS II sequencing platform can sequence 
full-length cDNAs more than 10kb in length with size fractionation [129]. The newly released 
Sequel system from PacBio can generate nearly as 7 fold reads as the RS II platform per run at 
half the cost of RS II, due to the use of the redesigned SMRT cell of 1 M zero-mode 
waveguide (ZMW) wells. With modification to the solution for loading templates by adding 
some additive, no size fraction is needed. Multiplexing samples for IsoSeq run on the Sequel 
system resulted in no significant length bias of the output circular consensus sequences. The new 
system will speed up transcriptome sequencing and reduce costs. The read length from the 
Sequel system is currently shorter than that of the RS II, with an average polymerase-read-length 
of 10 kb and a maximal subread length of 35 kb. Therefore, the Sequel system is good for IsoSeq 
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because most transcripts are shorter than 10 kb. However, due to the high error rate (~15%) of 
PacBio reads, error correction is necessary before the reads can be reliably mapped to the 
reference genome, and used for similarity search and functional annotation. Currently, two types 
of error correction approaches exist: (1) self-correction by using redundant PacBio long reads, 
and (2) hybrid correction by using Illumina RNA-seq reads. 
The average length of reads generated on a MinION platform is ~ 10 kb, but reads more 
than 150 kb have been reported [130]. Direct RNA sequencing on a MinION platform using 
Oxford Nanopore technology has recently been reported [131]. By the technology, biases 
introduced by reverse transcription and PCR amplification are avoided; full-length, strand-
specific reads are generated; and it is even possible to detect nucleotide analogues [131]. 
However, the error rate of reads generated by the Nanopore technology is still very high, ranging 
from 5 to 40% [130, 132, 133]. So far, only two studies using the Nanopore technology to 
determine transcript splicing isoforms of limited genes have been reported [134, 135]. With the 
maturation of the Nanopore technology, it is promising that in the near future the whole 
transcriptome of a complex organism could be directly sequenced without biases. 
Feed Efficiency in Pigs 
Feed efficiency (FE) is one of the important traits directly related to profitability, 
productivity, and sustainability in the pork industry [136, 137]. An increasingly popular measure 
of FE is residual feed intake (RFI), which is the difference between the actual and expected feed 
intake of an animal for given production parameters and maintenance [138]. While many non-
genetic strategies have been developed to improve feed efficiency of pigs [139], improving feed 
efficiency by genetic selection could be a sustainable alternative, because RFI is moderately 
heritable and responds well to genetic selection in pigs [140, 141]. 
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Over the last decade, significant efforts have been made to understand the molecular, 
genetic and physiological basis of RFI in pigs. Researchers have found many interesting 
differences between pigs with divergent RFI phenotypes [142, 143]. For example, compared to 
high RFI pigs (less efficient), low RFI pigs (more efficient) have altered feeding behaviors [144], 
slightly lower growth rate [145], less back fat [141, 146, 147], lower protein turnover rate in 
muscle [148], altered mitochondrial protein profiles [149, 150], less mitochondrial reactive 
oxygen species (ROS) production [151], and lower levels of leptin [152, 153] and juvenile IGF-1 
in circulating blood [145]. To explore the genetic basis of RFI in pigs, several genome-wide 
association studies (GWAS) have been conducted [154-157]. Some chromosomal regions tagged 
by single nucleotide polymorphisms (SNPs) have been found to be associated with RFI, but 
these associations were not consistent across studies and explained only small portions of the 
genetic variance for RFI [154-157]. The wide range of differences between lines of pigs with 
divergent RFI and the lack of SNPs with major effects on RFI suggest that RFI is a highly 
polygenic, quantitative trait with multiple tissues contributing to its variation. 
Global gene expression profiling technologies have also been used to explore the 
molecular basis of RFI in pigs. By profiling the transcriptomes of the adipose tissue of two lines 
of pigs divergently selected for RFI with gene expression microarrays, Lkhagvadorj et al. [158] 
found that genes involved in the lipid metabolic pathway were overrepresented among the 
differentially expressed genes (DEGs) that had lower expression in low versus high RFI pigs, 
and genes involved in carbohydrate metabolism and response to stress were overrepresented 
among the DEGs that had higher expression in low versus high RFI pigs [158]. They also 
reported that the leptin-related gene network to be different between the two lines. Recently, 
Vincent et al. [159] and Jing et al. [160] profiled the transcriptome of the longissimus dorsi (LD) 
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muscle from pigs with divergent RFI by using gene expression microarrays and RNA-seq, 
respectively. Using pigs from lines divergently selected for RFI, Vincent et al. [159] found that 
genes involved in protein synthesis and glycolysis, and genes associated with mitochondrial 
energy/oxidative metabolism had higher and lower expression, respectively, in the low versus 
high RFI lines. Using Yorkshire barrows with extreme phenotypes for RFI, Jing et al. [160] 
found that genes involved in glycolysis had lower expression in the low versus high RFI groups, 
while genes involved in muscle proliferation and differentiation had higher expression in the low 
versus high RFI groups. Surprisingly, these two studies shared no DEGs and proposed opposite 
differences in glycolytic activities in the low- versus high-RFI pigs. Therefore, in consideration 
of the complexity of RFI and the inconsistency from study to study, the molecular mechanisms 
underlying RFI in pigs are still largely unclear. 
To incorporate RFI into animal breeding programs for improving feed efficiency, feed 
intake, body weight gain and back fat depth must be recorded on individual pigs. As it is very 
expensive and time-consuming to record feed intake on individual animals [140, 141], 
convenient and predictive biomarkers (for definition, see the next section) for RFI that can be 
measured at an early age are in demand. In cattle, Chen et al. [161] successfully used 14 DEGs 
identified in the liver of Angus bulls that were divergently selected for RFI to classify Angus 
steers from the same divergent RFI lines, and Al-Husseini et al. [162] developed a RFI predictor 
using 8 of these 14 DEGs and validated it in an independent Angus population. However, these 
liver biopsies for biomarker development were collected after feed efficiency test in their late 
life. Thus, whether these biomarkers could be used at an early growth stage to predict lifetime 
feed efficiency of cattle is not sure. Furthermore, these biomarkers are not very practical even if 
they are predictive because invasive liver biopsies are needed. 
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Rationale for Developing Biomarkers for Breeding Feed Efficient Pigs 
Biomarkers are often used in both clinical research and in clinical practice for risk 
assessment, detection or screening, diagnosis, prognosis, predicting and monitoring treatment 
response and recurrence monitoring. Several definitions of biomarkers with different breadth 
have been given. A definition given by the National Institutes of Health is that a biomarker is “a 
characteristic that is objectively measured and evaluated as an indicator of normal biological 
processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention” 
[163]. In clinic studies and practices, biomarkers may but are not necessarily correlated with the 
clinical endpoints, which generally refer to reduced morbidity and mortality and promote health 
and wellbeing. In clinical trials, “well-characterized biomarkers with well-evaluated clinical 
relevance” are considered to be surrogate endpoints, which “act as surrogates for clinically 
meaningful endpoints” [163]. Before biomarkers can be used as surrogate endpoints, their 
relevance and validity should be determined. That is, how relevant is a biomarker to the 
biological process of interest clinically? How effective and reproducible is a biomarker as a 
surrogate endpoint to predict the clinical endpoint? A caution that should be taken is that 
biomarkers as surrogate endpoints should be constantly reevaluated to reduce false positives and 
false negatives [164]. Mayeux gave a good review on the potential uses and limitations of 
biomarkers [165]. Currently, biomarkers have been suggested for breast cancer across the 
continuum of care from risk assessment to recurrence monitoring (https://www. 
provistadx.com/power-of-proteins), although very few cancer biomarkers are useful for cancer 
diagnosis and monitoring [166, 167]. 
Based on the usage of biomarkers, biomarkers are classified as prognostic biomarkers, 
predictive biomarkers, pharmacodynamic markers and efficacy-response biomarkers. Based on 
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the identities of biomarkers, one type of biomarkers is molecular biomarkers, which can further 
categorized into genomic biomarkers, epigenomic biomarkers, transcriptomic biomarkers, 
proteomic biomarkers, metabolomic biomarkers, and microbiomic biomarkers [168, 169].  
Genomic biomarkers are DNA variants, which can be discovered by genome wide association 
studies (GWAS) and/or functional analysis [170]. Other types of molecular biomarkers are 
generally identified by differential analysis [171]. Based on how biomarkers are prioritized, 
biomarkers can be classified as gene biomarkers, gene set biomarkers, pathway biomarkers and 
network biomarkers. Because biological data are usually noisy, gene biomarkers are less stable 
and network biomarkers are most robust [172-175]. Based on the number of molecular types 
included, biomarkers can be classified as single-molecule-type biomarkers and multiple-
molecule-type biomarker panels, with the former type in use and the latter still in a discovery 
stage [169]. Rafai et al. gave a review on discovery and verification of protein biomarkers, which 
should also be instructive for development of other types of molecular biomarkers [176]. 
Peripheral blood is an informative tissue, not only because it carries a variety of cells that 
are directly involved in immunity and inflammation, but also because it interacts with every 
organ and tissue in the body via bioactive circulating factors, such as nutrients, metabolites, 
cytokines, hormones and exosomal cargoes, which are released from the same or different organs 
or tissues [177]. Molecular signatures in circulating blood, including gene expression profiles, 
have been shown to reflect the physiopathological status, growth stage and lifestyle of subjects 
[177-181]. Due to its easy accessibility and informativeness, peripheral blood has become a 
popular sample for disease diagnosis, prediction, prognosis, and biomarker discovery [177, 178]. 
Interestingly, the concentration of IGF-1 in serum at a young age has been shown to differ 
between animals with divergent RFI in poultry and livestock, including pigs [145, 152, 182, 
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183]. Blood cell profiles at early growth stages have also been found to be different between 
livestock with divergent RFI phenotypes, including pigs [184] and cattle [185]. In addition, the 
post-weaning abundance of three serum proteins, gesolin, vitronectin and serine protein inhibitor 
A3, are significantly higher in pigs with extremely low RFI than in pigs of extremely high RFI 
[186]. These results suggest that animals with divergent RFI phenotypes, measured later in life, 
have early physiological differences in circulating blood that may be reflected in blood gene 
expression profiles at these early stages. 
Dissertation Organization 
Genetic selection for low-RFI pigs can improve feed efficiency. However, it is not clear 
whether selection for improved feed efficiency compromises a pig‟s immune response to 
pathogens or virulent components of pathogens. Chapter 2 of this thesis reports on results of 
investigating how similarly and/or differently the two ISU RFI lines responded to systemic 
inflammation induced by intramuscular injection of lipopolysaccharide (LPS), a typical 
inflammatory stimulant mimicking bacterial infection, by using RNA-seq profiling their 
peripheral blood transcriptome at baseline and multi-time points post LPS injection. Through this 
study, I found that the two lines that were divergently selected for RFI responded to the 
inflammation in very similar ways. No significant differences in dynamics of body temperature, 
complete blood count, and blood cytokine levels were detected between the two lines at baseline 
and post LPS injection. Only a very small numbers of DEGs were detected at baseline, and at 2, 
6 and 24 hours post LPS injection (hpi) between the two lines. Powerful and sensitive gene set 
enrichment analysis suggested pigs from the low-RFI line generally had a lower level of 
inflammation response during the time course. Small differences in other pathways and 
biological processes were also identified. I further systematically compared response to LPS-
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induced systemic inflammation in pigs to that of humans. I found pigs and humans shared a core 
set of more than 1,500 orthologous genes, many of which showed similar expression patterns in 
response to LPS stimulation and mainly function in immune response and inflammatory 
response, although pigs are more tolerant to LPS than humans. 
In addition, it is very expensive and time-consuming to implement RFI-based genetic 
selection [140, 141]. As an alternative way, identifying convenient and predictive biomarkers for 
RFI that can be measured at an early age is of great interest. Thus, in this thesis, post-weaning 
blood transcriptomic differences between Yorkshire pigs from two lines that were divergently 
selected for RFI at ISU were profiled by RNA-seq. The ultimate goal was to develop practical 
biomarkers for feed efficiency based on the revealed transcriptomic differences in peripheral 
blood. Differentially expressed genes (DEGs) and gene clusters between post-weaning animal 
groups with extremely low RFI and with extremely high RFI were identified and annotated with 
gene ontology terms and pathways. These DEGs significantly overlapped expression signatures 
of human diseases, such as eating disorders, hyperphagia and mitochondrial diseases. I also 
identified five candidate DEGs whose expression level were significantly associated with RFI 
values. These five genes could be potential biomarkers for feed efficiency. This work is 
presented in Chapter 3. 
When I worked on projects presented in Chapter 2 and 3, I realized the limitations and 
issues of the assembly and annotation of the current pig reference genome, Sscrofa10.2. So I 
decided to improve the pig genome annotation by assembling a high-quality transcriptome for 
porcine peripheral blood with public RNA-seq data and RNA-seq data from studies described in 
Chapter 2 and 3. I built, validated and annotated a comprehensive porcine blood transcriptome, 
composed of more than 130,000 putative transcripts, with significant improvement over the 
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annotation of Ensembl Sscrofa10.2 and the NCBI pig RefSeq mRNA collection. This work is 
presented as Chapter 4. 
In Chapter 5, general conclusions were drawn based on the studies presented in Chapters 
2 to 4; limitations of the current methodology for whole blood transcriptome profiling were 
discussed; perspectives of single cell-based blood transcriptomics were put forward with. 
Supplementary methods, figures and tables supporting Chapters 2, 3, and 4 were 
provided as Appendices A, B and C, respectively, where appropriate. Large Excel spread sheets 
were provided as extra files hyperlinked to the texts for easy page layout. 
In summary, this dissertation provides insight into the potential molecular mechanisms 
underlying feed efficiency in pigs and identified five candidate genes for developing biomarkers 
for swine feed efficiency in the future. It also provides evidence that selection for RFI has not 
compromised the pigs‟ immune response to acute systemic inflammation. In addition, it offers 
significant advances to the structural and functional annotation of the porcine blood 
transcriptome. 
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CHAPTER 2. PIGS DIVERGENTLY SELECTED FOR RESIDUAL FEED INTAKE 
RESPOND TO SYSTEMIC INFLAMMATION TRIGGERED BY 
LIPOPOLYSACCHARIDE IN LARGELY SIMILAR WAYS AND SHARE A LARGE 
SET OF CORE INFLAMMATORY RESPONSE GENES WITH HUMANS 
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Abstract 
Background: Breeding pig for improved feed efficiency is of practical interest. 
However, it is not clear whether selection for improved feed efficiency by selection for low 
residual feed intake (RFI), a measure of feed efficiency, compromises a pig‟s immune response 
to pathogens or inflammatory stimuli. In this study, we intramuscularly injected pigs from two 
lines divergently selected for RFI with lipopolysaccharide (LPS) to investigate whether these two 
lines responded to LPS stimulation differently. And we also aimed to determine to what extent 
transcriptomic response to endotoxemia in pigs and humans are similar. 
Results: Intramuscular injection of LPS induced systemic inflammation in pigs of both 
lines (n = 4 per line), but no significant differences in dynamics of body temperature, complete 
blood count (CBC), and levels of several cytokines in plasma were detected between the lines 
during the first 24 hours post injection (hpi). Profiling peripheral blood transcriptomes at 
baseline and at 2, 6, and 24 hpi by RNA-seq revealed that LPS induced dramatic transcriptome-
wide changes, with 5,871 genes differentially expressed for at least one time point post LPS 
injection compared to baseline for the average line (|log2(FC)| ≥ log2(1.2), q < 0.05). However, 
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we detected only a very small number of genes that were differentially expressed between the 
two lines at baseline, and at 2, 6, and 24 hpi, with negligible line-by-time interaction effects on 
gene expression. Gene set enrichment analyses suggested that at the pathway level the two lines 
were largely similar in transcriptomic response to LPS stimulation, although the low RFI line 
had a slightly lower level of inflammatory response than the high RFI line at each time point post 
LPS injection. Genes involved in protein translation, defense and immune response, and 
signaling formed individual co-expression clusters. Compared to the inflammatory response 
induced by intravenous LPS infusion in humans, swine inflammatory response observed in this 
pig study was much weaker, although a much higher dosage of LPS was used in pigs than in 
humans. While hundreds of key pathways and biological processes were shared between the two 
species during LPS response, any pathways and biological processes were specifically involved 
in human response, but only a few were pig-specific. In total, 1,543 porcine genes and their 
human orthologs were differentially expressed in response to LPS stimulation in both species. 
Nearly one third of these genes shared a very similar dynamic expression pattern over the time 
course in these species. These conserved genes mainly functioned in biological processes 
including translation, RNA catabolism, signaling, apoptosis, immune response and inflammatory 
response. 
Conclusions: The pig lines divergently selected for RFI responded very similarly to 
systemic inflammation triggered by intramuscular LPS injection, though the low-RFI line had a 
lower level of inflammation response than the high-RFI line at every time point post LPS 
injection. Pigs and humans shared similarity in response to systematic inflammation triggered by 
LPS at both the gene and pathway levels, although the response to LPS in pigs was much weaker 
than previously reported in humans. But caution should be taken to interpret the differences seen 
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in humans and pigs due to differences in routes of LPS administration, dosage and sources of 
LPS, blood fractionation, expression profiling platforms, and completeness of genome 
annotation in both species. Our work indicates that selection for feed efficient pigs does not 
compromise a pig‟s ability to handle acute systemic inflammation, and also offered another line 
of evidence that pigs can be used as models for human inflammatory disease. 
 
Keywords: Sus scrofa, lipopolysaccharide, systemic inflammation, residual feed intake, RNA-
seq 
Background 
Feed efficiency in pigs is a trait of economic, environmental and societal importance. 
One increasingly accepted metric of feed efficiency is residual feed intake (RFI), the difference 
of an individual animal‟s observed and expected feed intake for growth and maintenance [138]. 
That is, pigs with low RFI are more feed efficient than those with high RFI. Pilot studies of 
divergent selection for RFI in pigs showed that RFI responds well to genetic selection [141, 187, 
188]. 
Compared to high RFI pigs, low RFI pigs have reduced feed intake, but their growth rate 
is only slightly decreased [141, 187, 188]. So they are more efficient in allocating resources for 
production and maintenance. On the other hand, immune response is an energy-demanding 
biological process and directly related to pig health. Thus, one interesting question is whether 
improving feed efficiency by selection for low RFI affects the animal‟s ability to respond to 
immune challenges. Based on the resource allocation theory [189], selection for low RFI is 
expected to compromise the animal‟s capacity to handle immune stimulation, such as infectious 
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diseases. Importantly, selection of chicken and beef cattle for increased feed efficiency indeed 
negatively affected their immune system [189]. So far, several experiments have investigated the 
potential side effects of selection for divergent RFI phenotypes on immune response in pigs. 
First, based on results from an experimental infection of porcine reproductive and respiratory 
syndrome virus (PRRSv) on pigs from the two ISU RFI lines, Dunkelberger et al. [190] reported 
that low-RFI pigs tended to have lower levels of viral load in blood, a faster humoral immune 
response to PRRSv, and a less affected growth rate than high-RFI pigs. Second, to test the 
divergent RFI lines developed at INRA, piglets from both lines were challenged with Complete 
Freund‟s Adjuvant (CFA) to induce a non-infectious pneumonia [191-194]. This work showed 
that both RFI lines handled the inflammatory challenge similarly but by adopting different 
metabolic strategies [191-194]. Finally, Vigros et al. [195] examined expression profiles of a set 
of target genes related to intestinal immunity of pigs with extremely divergent RFI phenotypes 
before and after an ex vivo LPS challenge of ileal and colonic tissue explants. No differentially 
expressed genes were found at the basal state. However, they found that the mRNA expression 
level of several cytokines (IL8, IL1, IL6, TNFα, IFNγ) and SOCS3 were lower in the low-RFI 
than the high-RFI explants following LPS challenge [195]. They proposed that low-RFI pigs 
may exert an energy saving mechanism during intestinal innate immune response to an immune 
challenge [195]. Taken together, although no significant negative side effects of a selection for 
lower RFI on immune response in pigs have been detected, little is known about the global 
transcriptomic response to acute systemic inflammation in pigs divergently selected for feed 
efficiency. 
LPS is a major component of the outer membrane of gram-negative bacteria, which has 
been widely used in vertebrates to mimic bacterial infection. LPS can bind to TLR4 and its 
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associated factor MD2 with the help of LBP and CD14. MD2 facilitates dimerization of the 
LPS/TLR4/MD2 complex, which induces the assembly of myddosomes including MyD88 and 
several IRAK kinases with mediation of TIRAP [196-199]. The myddosomes activate 
transcription factors NFκB and AP1, leading to expression of pro-inflammatory genes, such as 
IL1, IL6 and IL10, in a MyD88-dependent manner. However, cellular response to LPS is 
predominantly mediated by MyD88-independent signaling [200], where the TLR4/MD2/LPS 
complex is internalized via endocytosis with the engagement of CD14 and other cell type-
specific cofactors and then endosomal TLR4 activates IRF3-dependent production of Type I 
interferon, TNFα and co-stimulatory molecules through adaptor proteins TRAM and TRIF [201, 
202]. Binding of secreted TNFα its receptor can also activate NFκB. TLR4-independent host 
response to LPS has also been identified [203], and cytosolic LPS can activate non-canonical 
inflammatory caspases to trigger pyroptosis [204]. 
Comparative studies have revealed that TLR4 in different mammalian species differs in 
affinity and specificity to its ligands, gene structure, cellular expression patterns and tissue 
distribution [205]. TLR4 genes are highly conserved across mammalian species, with the 
intracellular TIR domain most conserved and the ligand-recognition domain most divergent, 
which, along with divergent MD2 proteins, is believed to cause the TLR4 receptors in each 
species to have different affinity and specificity to their ligands [205]. Porcine TLR4 is more 
similar to human TLR4 than is the murine counterpart at the nucleotide level, including both the 
promoter and coding regions, and as well as at the protein sequence level [206-208]. 
Further, different mammalian species differ in their sensitivity to LPS. Among the 
studied mammals, humans and chimpanzees are most sensitive to LPS, while pigs and rabbits are 
more sensitive to LPS than mice and rats [205]. Previous comparative studies of murine and 
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human transcriptomic response to in vivo LPS treatment raised an unresolved debate whether 
mice are good models for human inflammatory diseases [209-212]. Given that pigs are more 
sensitive to LPS than mice, the porcine immunome is more similar to that of humans than that of 
mice [16], and that pigs share more similar physiological and genomic similarities with human 
than mice [213], it is of interest to study the porcine transcriptomic response to systemic 
inflammation induced by LPS, using a similar experimental design as reported in a human study 
[214] and compare the results between these species. So far, dozens of in vivo LPS challenge 
experiments have been performed in pigs (see review [40, 215]), but in most cases only one time 
point was investigated. An exception is one study [216], which reported a number of gene targets 
that were evaluated by RT-qPCR rather than a broad transcriptomics study [215]. In addition, 
several in vitro LPS challenge studies have been performed on porcine macrophage or PBMCs 
using gene expression microarray, mass spectrometry, or RT-qPCR [217-221]. Limited data 
support that porcine bone-marrow macrophages are very similar to the humans in their response 
to LPS [217]. However, how similarly pigs and human respond in vivo to systemic inflammation 
induced by LPS challenge has not been studied well. 
The objectives of this study were twofold: (1) to determine whether divergent selection 
for RFI has significantly affected the pig‟s immune response to mimic bacterial infection, (2) to 
determine whether pigs and humans share similar transcriptomic response to endotoxemia. Thus, 
we investigated the swine peripheral blood transcriptomic response to acute systemic 
inflammation induced by intramuscularly injection of LPS in the two ISU lines that were 
divergently selected for RFI by using RNA-seq of a time series of samples mimicking a previous 
human study [214]. Based on clinical observation and differential expression analysis, we 
detected a few minor differences between the two RFI lines in response to LPS stimulation. 
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Differential expression analysis, gene expression clustering analysis and gene set enrichment 
analyses suggested that humans and pigs share similar transcriptomic responses to LPS challenge 
at both the gene level and the pathway level, although more biological processes and pathways 
were involved in systemic inflammation in humans than in pigs. Our work indicates that feed 
efficient pigs are resilient to an acute inflammatory challenge, and also offered another line of 
evidence that pigs can be used as models for human inflammatory disease. 
Methods 
Animals, experimental design and sample collection 
All animal-involved protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC) at Iowa State University under permit number 11-1-4996-S. All pigs were 
from Generation 8 residual feed intake selection project at ISU [141, 154, 184] and the 
experiment was conducted in the summer of 2010. 
Fourteen (n = 7 per line) gilts of initial body weight (BW) of 63 ± 4 kg from two lines of 
Yorkshire pigs divergently selected for low RFI and high RFI were randomly selected and 
utilized for either of two replicates. For each replicate, the following procedures were performed. 
All pigs were housed in individual metabolism pens, had free access to water and were fed a 
corn-soy-based diet twice daily, and feed restricted (1.5 kg/day) as previously described [222]. 
After a 9-day adaptation period pigs were randomly assigned within line to either a control (n = 
6, three pigs per line) or LPS challenge (n = 8, four pigs per line) group. Pigs in the challenge 
group were then repeatedly challenged with an intramuscular injection of 30, 36, 39, and 42 
µg/kg BW of LPS from E. coli O5:B55 (Sigma-Aldrich, St. Louis, MO) dissolved in saline 
solution at time points 0 (baseline), 48, 96, and 144 hours post initial injection (hpi). At each 
subsequent time point following the initial injection, LPS dosage was increased by 20, 30 and 
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40% from initial dose to compensate for LPS tolerance. Pigs in the control group were injected 
with an equivalent volume of saline solution at the equivalent time points. Rectal temperatures of 
individual pigs were measured immediately before the initial injection and at 2, 4, 6, and 24 hpi, 
and at 0, 4, 24 hours after each subsequent injection for all pigs. Blood samples were collected 
from the jugular vein into Tempus
TM
 Blood RNA tubes (Life Technologies, Grand Island, NY) 
for long-term storage at -80 °C, into EDTA tubes (BD, Franklin Lakes, NJ) for CBC tests and 
into serum tubes for cytokine assays at 0, 2, 6, 24 and 168 hpi. At 168 hpi, all pigs were 
euthanized by barbiturate overdose, exsanguinated and tissue samples from the longissimus dorsi 
(LD) muscle, liver, spleen, and ileum were isolated, cleaned and frozen for later use. This study 
only focused on samples and data collected for the first 24 hours after initial injection to 
investigate the acute inflammatory response. 
RNA preparation 
Total RNA was extracted from the 32 blood samples of the treatment group in Replicate 
2, collected at 0, 2, 6, and 24 hpi, by using preserved blood RNA purification kit I (Norgen 
Biotek Corp, Thorold, Ontario) per manufacturer‟s instruction. On-column DNA digestion was 
performed as described using DNase I (Qiagen, Valencia, CA). Globin transcripts (HBB and 
HBA) were depleted by following an RNase H-mediated method [223]. The quantity and 
integrity of the RNA were monitored by using Nanodrop 2000 (Thermo Scientific, Waltham, 
MA) and Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA) before and after globin 
depletion [223]. The efficiency of globin depletion of each sample was checked by conventional 
RT-qPCR with β-actin and GAPDH as the internal controls. Globin depletion efficiencies for all 
RNA samples were above 85%. Metadata, including RINs and concentration of RNA post globin 
depletion, CBC, and sequencing batches are available in Table A.1. 
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Complete blood count (CBC) test and blood cytokine analysis 
CBC tests were conducted as described [184, 224]. Eight cytokines (IFNα, IFNγ, IL1B, 
IL4, IL6, IL8, IL10 and TNFα) in the plasma sampled at 0, 2, 6, 24 and 168 hpi were assayed by 
using Aushon Ciraplex assays for cytokines (Billerica, MA) per manufacturer‟s instruction. 
Verification of transcriptional response to LPS stimulation by RT-qPCR 
To verify the LPS stimulation did induce an acute inflammatory response in the pigs, 
expression profiles of 36 candidate genes (Table A.2), which were porcine orthologs of human 
and murine genes responsive to LPS stimulation or important for Gram-negative sepsis control 
and resolution, were assessed by using Fluidigm high throughput RT-qPCR. Briefly, primers 
were designed and synthesized by Fluidigm Corporation (San Francisco, CA) such that two 
primers of each pair were separated by exon-exon boundaries and could amplify all known 
isoforms of a target gene if possible. The specificities of the primer pairs were tested by 
conventional RT-qPCR on the DNA Engine Opticon 2 system (BioRad, Hercules, California) 
and only primer pairs that gave single peaks in melting curve analyses were kept. This resulted in 
36 and 2 primer pairs for genes of interest and internal controls (RPL32 and GAPDH) meeting 
the requirement, respectively. The 32 RNA samples prepared from blood samples of the 
treatment group in Replicate 2 collected at 0, 2, 6, and 24 hpi were used for Fluidigm RT-qPCR 
without globin depletion. By following the Fluidigm user guide for Real-Time PCR analysis 
[225], real time-qPCR was done on a 48.48 dynamic array chip (Fisher Scientific, Pittsburgh, 
PA), using the Biomarker HD system (Fluidigm, San Francisco, CA). Data were analyzed with 
the Fluidigm Real-Time PCR analysis software with the default settings, to obtain raw Ct (cycle 
of threshold) values. Since the expression levels of internal controls were not very stable from 
time point to time point for individual pigs, RT-qPCR data were analyzed by using the R 
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package “MCMC.qpcr” [226]. With this method, internal reference genes are not mandatory but 
can be incorporated as Bayesian priors or as trackers of global effects when template abundances 
correlate with conditions [226]. Briefly, Ct values were converted into the copy number of 
templates by incorporating the amplification efficiencies of the primers and then analyzed by 
using generalized linear mixed models, which assumed the copy numbers of transcripts of  given 
genes follow lognormal-Poisson distributions. No line difference was detected for any time point 
post treatment compared to baseline for any selected gene, except for CXCL13. In the 
generalized linear mixed effects models, time or time and line (only for CXCL13) effects, and 
plate effects were modeled as fixed effects, and individual animal effects were treated as random 
effects, with GAPDH and RPL32 as internal controls by allowing 1.2 fold change across time 
points. The p-values associated with the line and time effects were adjusted by using the 
Benjamini-Hochberg (“BH”) method [227]. 
RNA-sequencing 
The 32 RNA samples used for RT-qPCR assays as above were used for RNA-seq. 
Library construction and sequencing were performed by Beijing Genomics Institute (BGI, 
Hongkong). Briefly, the RNA-seq libraries were constructed using the Illumina TruSeq RNA 
Sample Preparation Kit v2 (Illumina, San Diego, CA) per manufacturer‟s instructions. Individual 
libraries were diluted to 2 nM and pooled in approximately equimolar amounts with 8 libraries 
per pool. Paired-end sequencing (2 × 50 base) was run on an Illumina Hiseq2000 platform with 
one pool per lane. RNA-seq data will be available in ArrayExpress under accession number: [E-
MTAB-5606, http:// https://www.ebi.ac.uk/arrayexpress/]. 
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Quality control, preprocessing and alignment of RNA-seq reads 
Read quality was checked and filtered by BGI using their custom scripts. For a pair of 
reads, the whole pair was removed if either read met the following criteria: (1) either read had 
more than 50% of their bases aligned to the adapter sequences; (2) either read contained more 
than 10% of „N‟ bases; (3) either read had more than 40% of bases with PHRED+64 quality 
scores lower than 20. The kept reads were aligned to the pig reference genome Sscrofa 10.2 
(version 77, Ensembl) using 2-pass rna-STAR (version 2.3.0) with the default settings [228, 
229]. Read counts per gene per library were summarized by using featureCounts (version 1.4.4) 
[92] with default settings and the pig genome GTF file (version 77, Ensembl) as the genomic 
annotation reference file. Prior to differential expression analysis, hemoglobin genes (HBA and 
HBB) and genes with few reads (mean read counts per gene across all 32 samples ≤ 8 or the 
number of samples with non-zero count per gene ≤ 3) were removed from the count table, 
resulting in a final count table of 11,911 genes. This count table was used for subsequent 
differential expression analysis and clustering analysis after further transformation and 
adjustment (see below). 
Differential expression analysis of pig RNA-seq data 
Because there is no generally accepted, applicable method to analyze RNAseq data for a 
short time series experiment in which within-individual measures are generally correlated, we 
used the R/Bioconductor package DESeq2 for differential expression analysis for two reasons: 
(1) DESeq2 adopts emperical bayes shrinkage estimation for dispersions and fold changes which 
improves stability and interpretability of estimates; (2) DESeq2 allows statistical tests of 
differential expression with a specified minimum effect size, which avoids the issue that post hoc 
filtering of differentially expressed genes (DEGs) based on a fold change threshold results in a 
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false discovery rate (FDR) that is not easy to interpret [100]. Briefly, the pig RNA-seq raw count 
table was first normalized by using the default normalization method of DESeq2 and then 
rounded to get a normalized count table. Although several nuisance variables, such as RNA 
preparation batch, RIN, body weight, and complete blood cell count were recorded, it was very 
difficult to account for the treatment-unrelated variations of the complicated blood transcriptome 
by using only those nuisance variables, several of which were not accurately measured. So we 
used six surrogate variables estimated by the svaseq function of the R/Bioconductor package sva 
(v3.20.0) [102] to account for the hidden, unwanted variations. The six surrogate variables were 
estimated by using a full model, including an intercept and effects for combinations of the RFI 
lines and sampling time points, and a reduced model, including only an intercept. 
Differential expression analyses were conducted as follows. After performing 
normalization of the raw count data as above, dispersions were estimated by using a parametric 
method with maximum number of iterations of 500. log-transformed normalized count per gene 
was modelled by using a generalized linear model with the combinations of the RFI lines and 
sampling time points and the six estimated surrogate variables as covariates. The 
nbinomWaldTest function was used to estimate and test the significance of coefficients of the 
covairates with the following explicit parameter settings: betaPrior=FALSE, maxit = 5000, 
useOptim = TRUE,  useT = FALSE, useQR = TRUE. Differentially expressed genes between 
conditions were identified by testing the significance of relavent contrasts by using the results 
function with the following explicit parameters specified: alpha = 0.01, contrast = 
contrast.matrix[i,], lfcThreshold = log2(1.2), altHypothesis = "greaterAbs", that is, testing the 
absolute values of the log2 fold change between conditions were greater than log2(1.2). Thus, the 
estimates of the fold changes were shrunken by performing empirical Bayes shrinkage and their 
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significance were tested by specifying a minimum effect size, which can improve stability and 
interpretability of the estimates [100]. Multiple testing correction was performed by using the 
“BH” method [227]. Genes with absolute values of the log2 fold change greater than log2(1.2) 
and q values less than 0.05 were considered as significant DEGs. 
Statistical analysis of data for body temperature, CBC and cytokine profiles 
Rectal temperature data were analyzed by using a general linear model, with temperature 
modelled by time, treatment and  time-by-treatment interactions, and assuming an AR(1) 
correlation structure for repeated measures on the same individuals, since line and replicate 
effect were not significant (p > 0.1). Because the concentrations of some cytokines at some time 
points were zeros, a small constant was added to all concentrations of cytokines to make log-
transforming possible. After log-transformation, the transformed cytokine and CBC data were 
analyzed by using SAS PROC MIX by assuming an unstructured (UN) covariance and 
heterogeneous variance compound symmetry (CSH) covariance matrices, separately. Starting 
with full models including line, treatment, time, two-way and three-way interaction between line, 
treatment and time, plate (not included for CBC response), cohortRoom, body weight before 
initial injection, age upon initial injection, with time specified as repeated measure, backward 
model selection was performed based on the Akaike information criterion (AIC). Models of the 
smallest AIC were preferred. 
Reanalysis of microarray data for human transcriptomic response to systemic 
inflammation 
Microarray data from profiling transcriptomic response in human peripheral blood to LPS 
stimulation and its metadata [214] were downloaded from http://www.gluegrant.org/ 
pubsupport/Nature_1/. For details of the experimental design, see [214]. Briefly, eight humans 
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were assigned to two treatment groups, such that each group was assigned one female and 3 
males. The treatment group was intravenously injected with 2 ng/kg BW of LPS dissolved in 
0.9% NaCl, while the control group was injected with an equivalent volume of 0.9% NaCl 
saline. Blood samples were collected immediately before injection (called “0 hpi” for 
convenience) and at 2, 4, 6, 9 and 24 hpi. Transcriptomic responses were profiled by using 3' 
IVT expression analysis arrays (Human Genome U133 Set, Affymetrix, CA), which contains 
44,924 probesets on the two sub-arrays (Hu133A and Hu133B) arrays. The latest annotation files 
(Release 36, July, 2016) for the array platform were downloaded from Affymetrix website 
(http://www.affymetrix.com/support/technical/annotationfilesmain.affx). Microarray .CEL files 
from the two sub-arrays were separately processed with DNA-Chip Analyzer (dChip, the latest 
build on July 19, 2010) [230, 231] to get the normalized signal intensities per probeset by model-
based expression calculation with 5
th
 percentile of PM signals as background subtraction and 
quantile normalization. Probesets identified as absent by dChip [230, 231] on more than 43 
arrays were excluded from further analysis. The expression values for 100 probesets shared by 
the two sub-arrays were averaged for each sample and the original measures for these probesets 
were replaced with their averages for each sample when the normalized expression data from the 
sub-arrays were combined. Because no further metadata, such as RNA processing batch and 
array hybridization batch, were available [214], 8 surrogate variables accounting for hidden 
batch effects and other unwanted variation were identified by using the R/Bioconductor package 
sva [232] and considered in the linear models for differential expression analysis. Probesets 
showing significant differential expression with |log2(fold change)| greater than log2(1.2) (q < 
0.05) at each time point after LPS injection were identified by using the R/Bioconductor limma 
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package [233] with time 0 as reference. Multiple testing correction was performed by using the 
“BH” method as above. 
Gene ontology (GO) term overrepresentation analysis 
GO annotation for pig genes was downloaded from Ensembl BioMart (Release 87)GO 
terms for human genes were extracted from the latest annotation files for Human Genome U133 
Set provided by Affymetrix (Release 36, July, 2016). GO terms associated with less than 10 
genes were excluded. For human microarray and pig RNA-seq data, 13,734 Entrez Genes IDs 
and 11,911 Ensembl Gene IDs with detectable expression in blood were used as reference lists, 
respectively. Hypergeometric tests of overrepresentation of GO biological process (GO-BP) and 
GO cellular component (GO-CC) terms by a given gene list were performed separately by using 
the Cytoscape v3.4.0 [234] package BiNGO (v3.0.3) [235] with a q value cutoff of 0.05. GO 
annotation was visualized using REViGO [236]. 
STEM-based clustering of gene expression profiles 
Both pig RNA-seq data and human microarray data were clustered by using STEM 
(Short Time-series Expression Miner, v1.3.8) [237]. For RNA-seq data, the DESeq2 normalized 
count data were transformed to log (cpm) by using the voom function of the limma package [233, 
238] with the model used for RNA-seq DEG analysis. The transformed gene expression levels 
were then adjusted for the nuisance parameters, i.e. the six surrogate variables. The adjusted 
log(cpm) for all individuals of the two lines were altogether used for clustering with STEM, 
which is a tool specifically developed for short time-series expression data mining [237]. For 
parameter settings, see Supplementary Methods. For human microarray data, preprocessed 
probeset-level expression data used for DE analysis were adjusted for the eight surrogate 
variables. The resulting expression values were used for clustering analysis by using STEM 
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[237] using the same parameter settings as those used for clustering of the pig RNA-seq data. 
Expression profiles with more genes assigned than expected (q < 0.05) were considered as 
significant profiles. Significant expression profiles were clustered if their profile correlation 
coefficients were no less than 0.6. GO term overrepresentation analyses and visualization were 
performed for genes in each cluster of profiles with a q value cutoff of 0.05 by using BINGO 
(v3.0.3) [235] in Cytoscape (v3.4.0) [234], as above. 
Gene set enrichment analysis 
Gene set enrichment analysis for both the pig blood RNA-seq and human blood 
microarray data were performed using the R/Bioconductor (v3.3.1) GAGE package (v2.22.0), 
which implements a gene permutation-based algorithm for gene set and pathway enrichment 
analysis[239]. Expression data adjusted for surrogate variables were used as input. Hallmark 
gene sets (H), curated gene sets (C2, including CGP: chemical and genetic perturbations and CP: 
canonical pathways, with KEGG pathways excluded), transcription factor targets (C3:TFT) and 
immunologic signatures (C7) were downloaded from the Molecular Signature Database 
(MSigDB v5.2, http://software.broadinstitute.org/gsea/msigdb) [240, 241], the latest species-
specific KEGG pathways and diseases, and GO terms-associated genes from the KEGG database 
(Release 81.0) and Ensembl Biomart (Release 87). Assuming porcine and human genes that have 
the same HGNC gene symbols share the same gene functions and belong to the same gene sets, 
gene sets from the MSigDB represented by HGNC gene symbols were used for analysis of the 
pig data, except the KEGG gene sets and GO gene sets. GAGE was run in a paired-comparison 
mode when compared sample were from the same individuals, otherwise it was run in a “group 
comparison” mode. For gene sets composed of only up- or down-regulated genes, tests for either 
direction of change was conducted for gene set composed of a mixture of up- and down-
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regulated genes, tests unaware of change directions were performed. The q value cutoff of 
significant enrichment was set at 0.05. 
Other statistical methods 
Surrogate variable-adjusted expression level of differential expressed genes or probesets 
were hierarchically clustered using the Ward.2 method with 1 minus Spearman correlation 
coefficient as distance to generate heatmaps using the gplots package (v3.0.1). Multidimensional 
scaling plots showing samples relationships were made by using the plotMDS function of the 
edgeR package (v3.14.0) [242]. 3D-PCA plots were generated using the R package pca3d (v0.8) 
(Weiner J. unpublished). 
Results 
Intramuscular injection of LPS causes similar systemic inflammatory response in RFI lines 
We intramuscularly injected pigs from the two lines divergently selected for RFI with 
LPS or saline to investigate whether divergent selection for RFI for multiple generations affects 
response to systemic inflammation over a 24-hour time course. We did not detect significant line 
or replicate difference in rectal temperature profile (p > 0.1), but the effects of time, treatment, 
and time-by-treatment interactions were all significant (p < 0.0001). The average rectal 
temperatures of pigs challenged with LPS significantly increased at 2 hpi, peaked at 4 hpi, and 
then decreased and almost returned to baseline at 24 hpi. During the time course, the overall 
rectal temperature of the low-RFI animals tended to be lower than that of the high-RFI animals 
except at 24 hpi when the tendency reversed (Figure 2.1A). The maximal increase of mean rectal 
temperatures was respectively one and more than two degrees for the low- and high-RFI pigs 
treated with LPS compared to their baseline temperatures. On the other hand, the body 
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temperature of pigs in the control group only slightly fluctuated during the time course (Figure 
2.1A). Increased rectal temperature indicates that intramuscular injection of LPS induced fever in 
pigs, which was one of the typical symptoms in systemic inflammation response. 
The CBC profiles significantly changed in animals challenged with LPS during the time 
course, but no significant effects were detected for line, replicate, or line-by-time interaction (Fig 
2.1B and Table A.3). Specific CBC parameters, including red blood cell count, hemoglobin and 
hematocrit decreased from 2 to 24 hpi in the control group, but their decrease were only seen by 
24 hpi in the treatment group. The concentrations of platelets and white blood cells (WBCs) did 
not change in the control group except that of neutrophils, which slightly increased at 2hpi, then 
slightly decreased at 6 hpi and went back to baseline at 24 hpi. For the treatment group, the 
concentration of platelets and WBCs decreased at 2 hpi in response to the LPS challenge. The 
decreased concentration of neutrophils rebounded to baseline by 6 hpi and further increased at 24 
hpi. The profile of eosinophils was very similar to that of neutrophils, but concentration of 
eosinophils rebounded more slowly by 24 hpi. The profiles of lymphocytes, basophils, 
monocytes and platelets were similar to each other. They all started rebounding slowly at 6 hpi, 
and were nearly on the halfway back to baseline by 24 hpi. Summary statistics of comparing the 
concentrations of the five major types of WBCs in peripheral blood at 2 and 24 hpi to that at 
baseline in the control and treatment groups are shown in Table A.3. The dynamic profiles of 
WBCs during this time course further indicated systemic inflammation was induced by LPS in 
pigs. 
Another typical metric of inflammation is the levels of cytokines in the bloodstream. 
Response profiles of eight cytokines (IL1B, IL4, IL6, IL8, IL10, TNFα, IFNα and IFNγ) are 
shown in Figure 2.1C. Based on the measured cytokine level of high variations, no significant 
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effects were detected for line and line-by-time interaction. But animals treated with LPS tended 
to have higher cytokine levels in their blood at 2 hpi compared to their baseline level and 
compared to the control group at the equivalent time point. In the treatment group, the levels of 
IL6, IL1B and TNFα were generally still higher at 6 hpi than baseline and returned to baseline by 
at 24 hpi while the level of other cytokine almost went back to baseline by at 6 hpi. Summary 
statistics of comparing the concentrations of the eight cytokines in peripheral blood at 2 and 24 
hpi to baseline in each experimental group are shown in Table A.4. 
In addition, we assessed the changes in the transcript abundance of 36 inflammatory 
genes by RT-qPCR to verify the transcriptomic response triggered by LPS. The expression levels 
of 24 genes were significantly different from baseline levels for at least one time point after LPS 
challenge in pigs of the treatment group (q < 0.05) (Figure 2.2). Another two genes, TLR2 and 
TLR7, tended to be differentially expressed (q < 0.09) due to treatment. No line-by-time 
interaction effects were detected for any gene assayed. A line difference in gene expression was 
detected only for the CXCL13 gene (maximal log2(FC) = 1.6, p = 0.004). In summary, genes 
encoding nine cytokines/chemokines (IL1B, IL12A, IL15A, CCL20, CXCL2, CXCL8, CXCL10, 
CXCL13, and CCL20), seven receptors (TLR4, CD11B, CD14, CD97, CCR4, TNFRSF1A and 
IL1R2), and eight TLR4/NFκB signaling pathway components or effectors (IRF3, IRAKM, 
IKBNS, STAT4, S100A9, SOD2, CASP1 and IDO1) were significantly up-regulated in response 
to LPS stimulation for at least one time point (Figure 2.2). mRNA levels of proinflammatory 
cytokines and chemokines, including IL1B, IL12A, CXCL2, CXCL8, CXCL10 and CCL20, 
peaked at 2 hpi, while mRNA levels of anti-inflammatory cytokines IL1R2, TNFSF1A and IL10 
peaked at 6 hpi. mRNA levels of several genes involved in initiating innate immune response, 
including TLR4, IRAK4, IRAKM, IRF3, NFκB, RELA and STAT1, and those involved in 
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limiting the innate immune response, such as IKBNS, reached or nearly reached their zeniths by 
6 hpi. Thus, the RT-qPCR data indicated that the pigs did undergo typical inflammation response 
triggered by LPS, which progressed from an acute proinflammatory phase to an anti-
inflammatory phase towards full recovery. 
RNA-seq reveals systematic transcriptomic response to LPS stimulation in pigs but only 
small differences between RFI lines 
We profiled the peripheral blood transcriptomes of pigs from the two RFI lines (n = 4 per 
line) in the LPS treatment group at 0, 2, 6 and 24 hpi using RNA-seq. On average, more than 
19.4 ± 2.5 million (mean ± standard deviation) pairs of 2   50-base reads per library were 
obtained and more than 80.3 ± 0.5% of reads were uniquely mapped to the pig reference 
genome. After filtering genes of very low expression and hemoglobin genes (HBA and HBB), 
we had 11,911 genes whose expression level met the minimal abundance requirement for 
downstream analyses. Principal component analysis suggested that samples were well-separated 
by time, and samples of given time points were separated by line (Figure A.1). It also indicated 
that transcriptomes at 24 hpi were closer to those at baseline than those at 2 and 6 hpi, (Figure 
A.1). 
We only detected 22, 32, 55 and 173 genes differentially expressed between the two RFI 
lines at 0 and 2, 6 and 24 hpi, respectively. Overall, we identified 216 unique genes which were 
differentially expressed between the two lines for at least one time point during the time course. 
Since differential expression analysis revealed there was significant line-by-time interaction 
effect for only four genes (INSIG1, PTX3, FBP1 and ENSSSCG00000015140), we tested for the 
main effect of line and identified 255 DEGs between the two lines across all time points. A 
heatmap showing expression profiles of these 255 DEGs are displayed in Figure 2.3. Ten of the 
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DEGs between lines at baseline were persistently detected as DEGs along the time course, as 
shown by the Venn diagram (Figure 2.4A). 
By comparing within-line gene expression between time points post treatment and 
baseline, we identified many more DEGs (Figure 2.4B and 2.4C). DEGs of the two lines at a 
given time points compared to baseline largely overlapped, but DEGs at different time points 
only moderately overlapped (Figure 2.4B-G). Given the negligible line-by-time interaction 
effects, we performed average line differential expression analysis to increase the power of 
detecting DEGs at each time point post LPS treatment compared to baseline. The number of 
average line DEGs at 2, 6 and 24 hpi compared to baseline were 3,172, 4,137 and 1,239, 
respectively, and in total, 5,871 unique genes were differentially expressed at least for one time 
point post LPS stimulation relative to baseline, which included 34 of the 36 genes assayed by 
RT-qPCR as above (Figure 2.4D and Table A.5). Over the time course, the expression of many 
genes was transient, with only 508 genes persistently differentially expressed at all 3 time points 
post LPS stimulation compared to baseline (Figure 2.4D). Average line DEGs between each time 
point post LPS treatment and baseline included a large majority of DEGs for equivalent within-
line comparison plus some extra DEGs specific to the average line analysis (Figure 2.4E-G). A 
full list of within-line and average line DEGs at 2, 6, and 24 hpi compared to baseline is 
available in Table A.5. Taken together, differential expression analyses suggested that the pigs‟ 
blood transcriptomes were dramatically disturbed by LPS injection. Average line DEGs at least 
for one time point post LPS treatment compared to baseline were hierarchically clustered and are 
displayed as a heatmap (Figure 2.5). 
 44 
DEGs in response to LPS stimulation functioned in inflammatory response and beyond 
The functions of the DEGs between the two lines at each time point were annotated by 
using GO term overrepresentation analysis. No GO terms were overrepresented in the lists of 
DEGs between the two lines at 0, 2 and 6 hpi. However, one GO-BP term was overrepresented in 
the list of between-line DEGs at 24 hpi: antigen processing and presentation of peptide or 
polysaccharide antigen via MHC class II (GO:0002504). The expression levels of seven porcine 
MHC class II genes were lower in the low-RFI line compared to the high-RFI line ( q < 0.05). 
Gene set enrichment analysis based on comparison of mean expression levels of genes of the 
low-RFI line to the counterparts of the high-RFI line indicated that cytokine-cytokine receptor 
interaction (KEGG pathway ssc04060) was slightly enriched by genes of higher expression 
levels in the high-RFI line than in the low-RFI line at 0 hpi (q = 0.001) and 24 hpi (q = 0.03) 
(Table A.6). 
We also carried out gene set enrichment analysis by comparing gene expression at 2, 6 
and 24 hpi to baseline for each line separately and then compared the enrichment level of each 
set between the two lines. These analyses are believed to be more powerful than the enrichment 
analysis mentioned above because the within-individual correlation in gene expression was 
considered [239]. Hallmark gene sets, including interferon gamma and alpha response, TNFα 
signaling via NFκB, inflammatory response, P53 pathway and complement, were of higher level 
of enrichment at 2, 6 and 24 hpi in relative to baseline in the high-RFI line than in the low-RFI 
line. Gene sets of IL2/STAT5 signaling and KRAS signaling down were more enriched in the 
low-RFI line than in the high-RFI line at 2 hpi compared to baseline (Figure 2.6). This analysis 
suggests the low-RFI line had a slightly lower level of inflammatory response at 2, 6 and 24 hpi 
than the high-RFI line. Besides inflammation response, this analysis also suggests genes 
involved in reactive oxygen species (ROS) pathway, apoptosis, hypoxia, glycolysis, xenobiotic 
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metabolism, apical junction and heme metabolism were disturbed post LPS stimulation in pigs 
(Figure 2.6). 
Twenty-six KEGG signaling and metabolism pathways were significantly enriched by 
disturbed genes post LPS injection (Figure A.2), including cytokine-cytokine receptor 
interaction, neuroactive ligand-receptor interaction, hematopoietic cell lineage, TNF signaling 
pathway, NOD-like receptor signaling pathway, chemokine signaling pathway, complement and 
coagulation cascades, NFκB signaling pathway, Toll-like receptor signaling pathway, TGF-β 
signaling pathway, ribosome, and several amino acid metabolism pathways,. Several KEGG 
signaling pathways was more highly enriched among disturbed genes in the high RFI at 6 and 24 
hpi in relative to baseline, including cytokine-cytokine receptor interaction, NOD-like receptor 
signaling pathway and complement and coagulation cascades, although they were almost equally 
enriched in both lines at 2 hpi relative to their own baseline. The toll-like receptor signaling 
pathway was equally enriched by disturbed genes in both lines across all 3 time points. 
Ribosome component-encoding genes were more enriched among down-regulated gens in the 
high-RFI line than in the low-RFI line at 6 hpi. At 24 hpi, they were not enriched by disturbed 
genes in the high-RFI line but they were in the low-RFI line. KEGG gene sets of diseases were 
similarly enriched by disturbed genes at 2, 6, and 24 hpi in both lines (Figure A.3), including 
infectious diseases, autoimmune disease and cancer. 
Transcription factor targets-based gene set enrichment analysis suggested targets of 
immune response-related transcription factors were significantly enriched by disturbed genes 
post LPS stimulation (Figure A.4), including AP1, E12/E47, PU1, several interferon-regulatory 
factors (IRFs), NFAT, CEBP, ISRE, NFκB and GATAs. Targets of transcription factors 
including IRF7, IRF8 (also called ICSBP), PU1 and GATA6 were more enriched, if 
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significantly, among disturbed genes in the high-RFI line than in the low-RFI line at 2, 6 and 24 
hpi. But targets of transcription factors including AP1, NFκB, CDC5, GATA3, and CEBP were 
more enriched among disturbed genes in the low-RFI line than the high-RFI at 2 hpi, while the 
opposite was suggested for 6 and 24 hpi (Figure A.4). 
Gene set enrichment analysis based on canonical pathways without KEGG pathways 
suggested that genes involved in the extracellular matrix were more affected by LPS treatment in 
the low-RFI pigs than in the high-RFI pigs at 2 hpi, but at 6 and 24 hpi genes involved in the 
extracellular matrix were more affected by LPS treatment in the high-RFI pigs than in the low-
RFI pigs at 2 hpi (Figure A.5). In addition, enrichment analysis based on chemical and genetic 
perturbation-associated gene sets and immunological signatures suggested that genes that were 
disturbed post LPS stimulation in pigs were significantly similar to those detected in LPS- or 
cytokine-stimulation human and murine tissues or cell lines, while the high-RFI line had a 
slightly higher level of inflammatory response than the low-RFI line (data not shown). 
GO-BP and -CC terms-associated gene set enrichment analysis gave more details about 
disturbed biological processes and affected cellular components (Table A.6 and A.7). GO-BP 
gene sets-based enrichment analysis suggested that at 2 hpi, LPS had induced a defense response, 
including both an anti-virus response and an inflammatory response, with GO:0051607 (defense 
response to virus) being the most enriched gene set among up-regulated genes, and more 
enriched in the high-RFI than the low-RFI lines. This analysis again suggested the inflammatory 
response was slightly higher in the high-RFI line than in the low-RFI line. At 6 hpi, GO-BP gene 
sets of I-κB kinase/NFκB signaling, positive regulation of JUN kinase activity and negative 
regulation of MAP kinase activity were more enriched in the low-RFI line than in the high-RFI 
line. Translation, the most enriched GO biological process was more repressed in the high-RFI 
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line than the low-RFI line at 6 hpi, but the opposite was suggested at 24 hpi. Antigen processing 
and presentation of peptide or polysaccharide antigen via MHC class II were more enriched 
among down-regulated genes in the low-RFI line than in the high-RFI line at 24 hpi. Other 
significantly enriched, up-regulated GO-BP gene sets included cell inflammatory response and 
chemotaxis, which was more enriched among up-regulated genes in the high-RFI line than the 
low-RFI line at both 6 and 24 hpi. Results of these GO-CC gene sets-based enrichment analyses 
were consistent with the enriched GO-BP (Table A.7). 
Because we only detected line-by-time interaction effect for a few genes, we also 
performed average line gene set enrichment analysis. Average line differentially enriched gene 
sets between time points post LPS injection and baseline are shown in Table A.7, which were 
largely similar to those enriched gene sets in each individual line. 
Genes co-expressed in response to LPS stimulation showed enriched biological functions 
related to inflammatory response 
We then performed gene co-expression analysis using STEM to complement with the 
conventional differential expression analysis which considered each gene independently and the 
gene set enrichment analysis which considered groups of genes with known related functions or 
behaviors. Given that only few significant line-by-time interactions were detected, we performed 
an average line clustering analysis of gene expression to improve the stability of the clustered 
profiles. Thirty-one significant expression profiles were identified and were further merged into 
8 clusters based on profile similarity (Figure 2.7). GO terms overrepresented among genes in 
each cluster are in Table A.8. Overrepresented GO-BP terms among genes in Cluster 1 included 
translation, ribosome biogenesis, fatty acid oxidation, cilium assembly and small molecular 
metabolism. Defense response, inflammatory response, response to chemical and biotic stimuli 
including bacterium and virus were overrepresented among genes in Clusters 2 and 3. Genes in 
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Cluster 4 were also involved in ribosome biogenesis. Among genes in Cluster 5, signaling and 
endocytosis were enriched. Phospholipid metabolic process and receptor complex were enriched 
among genes in Clusters 7 and 8, respectively (profile 13). No significant GO-BP or -CC terms 
were enriched among genes in Cluster 6. Expression of genes in Clusters 2 and 3 peaked at 6 and 
2 hpi, respectively. Typical inflammatory genes were included in Cluster 2, including S100A8, 
S100A9, S100A12, MyD88, IRF3, JAK2, CXCL13 and CXCL16, and reactive oxygen species 
response genes including SOD2, while inflammatory and immune responsive genes were 
included in Cluster 3, including IL1B1, CXCL2, GBP4 and 5, IRF1 and 2, NFκBIB, STAT2, 
TNFSF4 and 10, and TGFβ2. 
Pigs and humans shared conserved mechanisms responsive to systemic inflammation 
induced by LPS 
We reanalyzed available microarray data for a time-series, repeated measures of 
peripheral blood transcriptomic response to LPS in human [214] to have an across-species 
comparison to the data of this study. A major modification we made was to include eight 
surrogate variables in the model for differential expression analysis to account for hidden 
variation of no interest, such as processing batch effects. MDS plots showing sample relationship 
based on gene expression abundance with and without adjusted for surrogate variables are 
displayed in Figure A.8A and A.8B. Adjusting for the hidden variation significantly improved 
the clustering of samples under the same conditions and separation of samples in different states. 
We identified 6,628 probesets (4,428 Entrez genes) that were significantly differentially 
expressed for at least one time point post LPS infusion compared to baseline, with 3,378 (2,378 
DEGs), 4,810 (3,339 DEGs), 4,604 (3,118 DEGs), 3,582 (2,478 DEGs) and 0 differentially 
expressed probesets (DEPs) at 2, 4, 6, 9 and 24 hpi relative to baseline for the LPS treatment 
group, respectively. But we did not detect any significantly DEP for the control group over the 
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time course (Table A.9). A full list of DEPs/DEGs is provided in Table A.9. Notably, 3,955 
(59.7%) of our DEPs were also detected as DEPs by Calvano et al. [214]. The number of DEGs 
as well the MDS plot suggested LPS induced systematic transcriptome changes by 2 hpi, and 
transcriptomic response at 4, 6 and 9 hpi were more similar to each other than to that at 2 hpi, 
while the blood transcriptome nearly returned to baseline at 24 hpi. 
We performed gene set enrichment analysis for transcriptomic changes at 2, 4, 6, 9 and 
24 hpi in relative to baseline. Enriched gene sets are listed in Table A.10. We then compared the 
gene set enrichment patterns in the humans to those in the pigs. Hallmark gene set enrichment in 
pigs and humans is shown in Figure 2.8. Generally, of the 39 Hallmark genes sets that were 
significantly enriched in at least one species for at least one time point, 22 were enriched in both 
species for at least one time point. This enrichment analysis suggests that pigs and human shared 
similar transcriptomic response to systemic inflammation induced by LPS, though gene sets of 
interferon α and γ response, TNFα signaling via NFκB, inflammatory response and IL2/STAT5 
signaling were much more highly enriched in LPS-stimulated humans at 2, 4, 6 and 9 hpi 
compared to baseline, than in pigs at 2 and 6 hpi compared to baseline. Another strikingly and 
specifically enriched gene set in humans was Myc targets V1. Notably, 6 and 7 Hallmark gene 
sets were only significantly enriched in pigs and humans, respectively (Figure 2.8). 
KEGG signaling and metabolism pathway enrichment analysis suggested gene sets of 19 
KEGG pathways were enriched in both species, including ribosome, chemokine signaling 
pathway and cytokine-cytokine receptor interaction (Table A.10). It also showed that the gene 
set related to ribosome was more highly enriched among down-regulated genes in humans than 
in pigs post LPS stimulation. Gene sets associated with hematopoietic cell lineage and cytokine-
cytokine receptor interaction were more highly enriched in humans and pigs, respectively, than 
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in pigs and humans in response to LPS challenge. Nineteen pathways were only significantly 
enriched in pigs post LPS stimulation, including several pathways for protein/amino acid 
metabolism and lipid/fatty acid metabolism, drug metabolism-cytochrome P450 and HIF-1 
signaling, while 13 pathways were only significantly enriched in humans, including carbon 
metabolism, TCA cycle, oxidative phosphorylation and splicesome. 
Comparison of the enriched targets of transcription factor suggested the two species 
shared many common transcription factors during LPS-induced systemic inflammation and 
resolution of inflammation, including NFκB, AP1, IRFs, STATs, CEBP, PU1, and CDC5. But it 
also suggested that species-specific transcription factors were involved in this process, such as 
Myc/MAX, USFs and E2F for humans, and ETS2 for pigs (Figure A.11). 
Comparison of enrichment of gene sets of GO-BP and -CC terms suggested that there 
were many more biological processes and cellular components involved in the LPS-induced 
systemic inflammation in humans than in pigs, although tens of GO-BP and –CC gene sets were 
enriched in both species and a small number of GO gene sets were specifically enriched in pigs 
in response to LPS stimulation (Figure A.12 and A.13). “Nuclear-transcribed mRNA catabolic 
process, nonsense-mediated decay”, SRP-dependent cotranslational protein targeting to 
membrane, translation initiation and viral transcription were specifically, persistently, and highly 
enriched in humans during the process of inflammation by 24 hpi (Figure A.12). 
We also compared the clustered gene expression profiles in response to systemic 
inflammation in both species. For better comparison, only expression data for 0, 2, 6 and 24 hpi 
were considered. Based on the expression data of LPS-challenged humans at 0, 2, 6 and 24 hpi, 
we identified seven clusters, which consisted of 27 significant gene expression profiles (Figure 
A.14). Notably, no significant profiles were detected for the control group gene expression 
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profiles. Four human clusters were comparable to four porcine clusters in both dynamic patterns 
of gene expression, and enriched biological processes and cellular components (Figure A.14). 
The commonly enriched GO biological processes and cellular components in these four similar 
clusters included cytosolic and mitochondrial translation, ribosome, mitochondrial respiratory 
chain, inflammatory response, defense response, response to LPS, cell migration and signaling 
(Figure A.14). We also found that clusters that over-representing the biological process, 
“cytosolic and mitochondrial translation”, in humans and pigs shared 396 genes, including tens 
of ribosomal protein-encoding genes and several translation initiation factor-encoding genes. 
Finally, we compared the dynamic expression profiles of porcine and human orthologs 
that showed differential expression in response to LPS in both species. Again, only expression 
data for 0, 2, 6 and 24 hpi were considered for better comparison. Figure 2.9 shows the time-
course expression patterns of 1,543 porcine genes and 2,175 human probesets (1,548 human 
Ensembl genes), both of which were differentially expressed at least for one time point post LPS 
stimulation in pigs and human compared to baseline, respectively. One third of these common 
DEGs showed very similar expression dynamics over the time course (Figure 2.9, Green box 1). 
This group of genes was generally down-regulated during LPS-induced systemic inflammation. 
Only a very small number of genes showed opposite expression patterns in the two species 
(Figure 2.9, Blue box 2). The remaining shared more or less similar expression patterns over 
only some of the time points. GO term overrepresentation analysis indicated that these conserved 
genes mainly function in biological processes including translation, RNA catabolism, signaling, 
apoptosis, immune response and inflammatory response (Figure 2.10). 
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Discussion 
Divergent selection for RFI in pigs resulted in only minor differences in response to 
systemic inflammation triggered by LPS 
In this study, we challenged pigs from two lines which had been divergently selected for 
RFI for multiple generations with LPS. Typical observations from pigs post LPS treatment 
induced a systemic inflammatory response, including fever response and dynamic changes of 
concentration of WBCs and cytokines in peripheral blood. However, no significant differences in 
these physiological traits were detected between the two lines. By transcriptome-wide profiling 
of peripheral blood, we only identified a very small number of DEGs between the two RFI lines 
at each time point. In addition, gene set enrichment analysis suggested that the toll-like receptor 
and NFκB signaling pathways, which are canonical pathways in response to LPS stimulation in 
mammals, were equally enriched by disturbed genes in both lines post LPS injection. All these 
lines of evidence support that the two lines responded to LPS-induced systematic inflammation 
in similar ways and indicated no distinguishable defect in inflammatory response in the low RFI 
line. 
It is worth noting that we did find some minor differences between the two lines in 
response to LPS stimulation by using powerful and sensitive functional annotation tools. Both 
gene set enrichment analysis and GO term overrepresentation analysis of DEGs suggested that 
the low-RFI line may slightly differ from the high-RFI line at 24 hpi in antigen processing and 
presentation via MHC class II. Expression levels of seven SLA class II genes were significantly 
lower in the low-RFI line compared to the high-RFI line. Thus, it is possible that the low-RFI 
line has lower activity in processing and presenting exogenous antigen via MHC class II than the 
high-RFI line at the end of resolving phase of systemic inflammatory response. 
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The KEGG pathway ssc04060: cytokine-cytokine receptor interaction was found to be 
slightly more enriched among genes of higher expression levels in the high-RFI line than the 
low-RFI line at all time points studied. Consistent with this, the low-RFI line tended to have 
lower expression levels for many cytokines and cytokine receptors both at baseline and post LPS 
stimulation. We also found gene sets of inflammatory response, interferons gamma and alpha 
response, TNFα signaling via NFκB, and complement were of lower levels of enrichment at 2, 6 
and 24 hpi relative to baseline in the low-RFI line than in the high-RFI line. This suggests that 
the low-RFI line had a slightly lower level of inflammatory response than the high-RFI line 
during the time course of inflammation. 
Translational inhibition is widely observed from invertebrates to mammals in response to 
pathogen infection [243]. Without exception, we found genes that encode ribosome components 
and other translational machinery were down-regulated in response to LPS stimulation, including 
translation initiation factors. Notably, gene sets for ribosome and translation were more enriched 
by down-regulated genes in the high-RFI line than in the low-RFI line at 6 hpi. At 24 hpi, they 
were not enriched in the high-RFI line, but they still were enriched in the low-RFI line. It is 
unclear whether translation inhibition was a true direct sensor of bacterial pathogens or is an 
indicator of a more general host metabolic stress response to LPS [243]. A recent study reported 
that translational inhibition plays an important role in negative feedback of the inflammatory 
response in the macrophages [244]. 
The two lines were slightly different in the activity of transcription factors related to 
inflammatory and immune responses. Targets of transcription factors-based gene set enrichment 
suggested that transcription factor AP1 may be more active at 2 hpi and less active at 6 and 24 
hpi in the low-RFI line than in the high-RFI line, while other transcription factors such as IRFs, 
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PU1 and CEBP may be more active over the time course in the high-RFI line than in the low-
RFI. These potential differences in transcriptional network might explain the slightly different 
level of inflammatory response in the two lines. 
Thus, the two lines divergent selected for RFI responded to the systemic inflammation 
triggered by LPS in similar ways, although the low RFI pigs has a slightly lower level of 
inflammatory response post LPS stimulation than the high-RFI line. A slightly lower level of 
inflammatory response might reduce the energy required for handling inflammation, which 
might be beneficial if the existing level of inflammatory response is enough for the host to 
remove the pathogen and recover from infection. Body temperature records for the 7-day time 
course indicated that the two lines responded equally to repeated LPS challenges (data not 
shown). Importantly, the gain of body weight of the two lines during the time course was not 
significant different (data not shown). Thus, it is reasonable to assume that the slightly lower 
level of inflammatory response in the low-RFI line than in the high-RFI line was not detrimental. 
It will be interesting to compare the level of inflammatory response post LPS stimulation in the 
low-RFI animals to that in a population not selected for feed efficiency in the future. 
Pigs and humans shared similar blood transcriptomic response to systemic inflammation 
induced by LPS 
Previous cross-species comparisons ended up with absolutely opposite conclusions in 
terms of similarity of inflammatory response in humans to that in mice based on different 
comparing metrics [211, 212]. The potential drawbacks in all previous comparative studies 
included, but were not limited to (1) Gene expression microarray data were generated on 
differently platforms in different labs with different experiment designs for different purposes; 
(2) Only data from single time points which were assumed to be the most comparable were 
compared, although inflammation is a very dynamic process; (3) Batch effects and other hidden 
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variations were not considered in differential gene expression analyses; (4) The same but 
arbitrary statistical stringency of cutoffs were used to determine DEGs for comparison; (5) Only 
common DEGs in both species or the union of DEGs in either species were compared. These and 
other limitations could compromise the reliability of the results of comparisons. 
To avoid or minimize some of problems mentioned above, we compared blood 
transcriptomic response to systemic inflammation triggered by LPS in pigs in this study to that in 
humans from a similarly-designed experiment [214]. These two studies had 4 common time 
points: baseline, and 2, 6, and 24 hpi. After adjustment for hidden variations in the gene 
expression data from both studies, we not only compared the DEGs common in both species but 
also gene profiles without a hard threshold for identifying DEGs based on powerful and sensitive 
gene set enrichment analysis. We identified more than 1,500 orthologous genes that were 
differentially expressed in both species. These core sets of conserved genes mainly function in 
biological processes including immune response, inflammatory response, leukocyte migration, 
toll-like receptor signaling pathway, cytokine-mediated signaling, regulation of cytokine 
production, translation, protein targeting, and mRNA catabolism. Notably, nearly one third of 
this set of genes had very similar dynamic expression patterns in response to LPS stimulation 
over the common time points in the two species. Except for a handful of genes that showed 
opposite expression patterns, the rest of the genes showed more or less similar expression 
patterns over the time points in the two species. Clustering analysis of gene expression by STEM 
also identified gene clusters with similar temporal expression patterns, shared biological 
functions and gene contents. 
More powerful gene set enrichment analysis further supported that the conclusion that 
pigs and humans shared many more biological pathways and processes than those mentioned 
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above, including those mentioned in the previous paragraph, in response to LPS-induced 
systemic inflammation. We found that most pathways and biological processes that were 
involved in porcine response to systemic inflammation were also involved in the human 
response. However, it also revealed many differences in biological processes and pathways that 
were involved in response to LPS stimulation in the two species, with many biological processes 
and pathway specifically involved in human response and only a few specifically involved in 
porcine response. This might be partly due to different level of inflammatory response triggered 
by LPS stimulation in pigs versus humans. Although 15,000-fold higher dosage of LPS was 
administered in pigs than in humans, pigs appeared to have a much lower level of inflammatory 
response than humans. This might be mainly because pigs are more tolerant to LPS than humans 
[205]. The differences in routes of LPS administration, and sources and serotypes of LPS could 
also contribute to the different levels of inflammatory response [210, 245, 246]. Differences in 
experimental procedures and platforms might also explain some of the detected differences in 
transcriptomic response to inflammatory stimulation. Total RNA extracted from whole blood and 
leukocytes were profiled in this study by RNA-seq and in the human study by gene expression 
microarray, respectively. In addition, all knowledge-based analyses for pigs were mainly based 
on functional annotation of pig orthologs of human genes. However, only nearly 7,000 of 11,911 
genes that were detected in peripheral blood in this study have been projected with HGNC gene 
symbols. Thus, the poor functional annotation of porcine genes could exaggerate, but less likely 
underestimate, the interspecies differences in response to systemic inflammation induced by 
LPS. 
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Conclusions 
Pigs from the two lines divergently selected for RFI responded to systemic inflammation 
triggered by LPS injected intramuscularly in similar ways, although the low-RFI animals had a 
slightly lower level of inflammation response than the high-RFI animals along the time points 
post LPS stimulation. Pigs and humans shared similar response to systemic inflammation 
induced by LPS at both pathway and gene levels, although many more biological processes and 
pathways were specifically involved in inflammatory response in humans and only a few were 
preferentially involved in pigs. But caution should be taken with the differences seen between 
humans and pigs, due to differences in routes of LPS administration, LPS dosage, sources and 
serotype of LPS, blood fractionation, and completeness of genome annotation in both species. 
Our work indicates that selection for feed efficient pigs did not compromise the pig‟s capability 
to handle acute systemic inflammation triggered by LPS, and also offered another line of 
evidence that pigs can be used as models for human inflammatory disease. 
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Figure 2.1. Intramuscular injection of LPS induced systemic inflammation in pigs. (A) LPS, 
but not saline induced similar febrile response in pigs. Shown are profiles of mean body 
temperature for the two lines injected with LPS or saline at each time points. Error bars show 
standard errors of the mean body temperature of each line at each time point. (B) Dynamic CBC 
profiles in response to LPS or saline treatment in pigs showed LPS injection triggered 
inflammation in pigs, while saline not. Quantity of each CBC parameter was standardized by 
normal transformation and displayed as heatmap. (C) Cytokine dynamic profiles in response to 
LPS or saline injection in pigs. Cytokine concentrations were standardized by normal 
transformation and displayed as heatmap. 
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Figure 2.2. (Legend on next page) 
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Figure 2.2. Expression profiles of inflammation-related genes during inflammatory 
response determined by Fluidigm RT-qPCR. Shown are means of log2 abundance of gene 
expression ± 95% confidence intervals. Symbols of genes differentially expressed at least at one 
time point post LPS injection compared to baseline were colored in yellow. TLR2 and TLR7 
tended to be differentially expressed at 6 hpi in relative to 0 hpi (q < 0.09). For reference, 
profiles of the two control genes, GAPDH and RPL32, are also displayed. The expression levels 
of the two control genes were not stable over the time course. 
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Figure 2.3. Heatmap showing expression profiles of 255 DEGs with line main effects. H, 
high RFI; L, low RFI; Tx, time point x hpi. 
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Figure 2.4. Venn diagrams showing between-line, within-line and average line DEGs at 
different time points. (A) Venn diagram showing 216 DEGs between lines at each time point. 
(B and C) Venn diagrams showing DEGs between time points post LPS treatment and baseline 
in the high (B) and low (C) RFI animals. (D) Venn diagram showing average line DEGs between 
time points post LPS treatment and baseline. (E-G) Venn diagrams showing relationship of 
within-line and average line DEGs at 2, 6, and 24 hpi, respectively. HRFI, high RFI; LRFI, low 
RFI. Time points without being qualified were for the averaged line. 
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Figure 2.5. Heatmap showing the expression 
profiles of 5,871 average line DEGs for at least 
one time point post LPS treatment relative to 
baseline. H, high RFI; L, low RFI; Tx, time point 
x hpi. 
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Figure 2.6. Hallmark gene sets enriched among disturbed genes in each line at time points 
post treatment compared to baseline. Shown are gene sets significantly enriched under at least 
one condition (q value < 0.01). HRFI, high RFI; LRFI, low RFI; Tx, time point x hpi. 
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Figure 2.7. Clusters of significant profiles of gene expression in response to LPS 
stimulation. Representative significantly overrepresented GO terms by each cluster are also 
displayed.  
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Figure 2.8. Hallmark gene sets enriched in disturbed genes in pigs and humans post LPS 
stimulation. Shown are gene sets significantly enriched under at least one condition (q value < 
0.01). HRFI, high RFI; LRFI, low RFI; Tx, time point x hpi.  
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Figure 2.9. Expression profiles of genes differentially expressed in both species. Groups of 
genes showed very similar expression dynamics and opposite expression dynamics were labeled 
with green and blue boxes on the right side, respectively. H, high RFI; L, low RFI; Tx, time 
point x hpi. 
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Figure 2.10. GO-BP terms overrepresented by common DEGs in response to systemic 
inflammation in humans and pigs. GO-BP terms significantly overrepresented (q < 0.05) were 
summarized and visualized by using REViGO. GO-BP terms with semantic similarity in the 
measure of SemRel no less than 0.7 were collapsed. log 10-based p-values associated with 
overrepresented GO terms were coded in a color gradient from red to blue. 
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CHAPTER 3. POST-WEANING BLOOD TRANSCRIPTOMIC DIFFERENCES 
BETWEEN YORKSHIRE PIGS DIVERGENTLY SELECTED FOR RESIDUAL FEED 
INTAKE 
 
 
Modified from a paper published in BMC Genomics 2016;17:73. 
Haibo Liu, Yet T. Nguyen, Dan Nettleton, Jack C. M. Dekkers, Christopher K. Tuggle 
Abstract 
Background: Improving feed efficiency (FE) of pigs by genetic selection is of economic 
and environmental significance. An increasingly accepted measure of feed efficiency is residual 
feed intake (RFI). Currently, the molecular mechanisms underlying RFI are largely unknown. 
Additionally, to incorporate RFI into animal breeding programs, feed intake must be recorded on 
individual pigs, which is costly and time-consuming. Thus, convenient and predictive biomarkers 
for RFI that can be measured at an early age are greatly desired. In this study, we aimed to 
explore whether differences exist in the global gene expression profiles of peripheral blood of 35 
to 42 day-old pigs with extremely low (more efficient) and high RFI (less efficient) values from 
two lines that were divergently selected for RFI during the grow-finish phase, to use such 
information to explore the potential molecular basis of RFI differences, and to initiate 
development of predictive biomarkers for RFI. 
Results: We identified 1,972 differentially expressed genes (DEGs) (q ≤ 0.15) between 
the low (n = 15) and high (n = 16) RFI groups of animals by using RNA sequencing technology. 
We validated 24 of 37 selected DEGs by reverse transcription-quantitative PCR (RT-qPCR) in a 
joint analysis of 24 (12 per line) of the 31 samples already used for RNA-seq plus 24 (12 per 
line) novel samples from the same contemporary group of pigs. Using an analysis of the 24 novel 
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samples alone, only 9 of the 37 selected DEGs were validated. Genes involved in small molecule 
biosynthetic process, antigen processing and presentation of peptide antigen via major 
histocompatibility complex (MHC) class I, and steroid biosynthetic process were 
overrepresented among DEGs that had higher expression in the low versus high RFI animals. 
Genes known to function in the proteasome complex or mitochondrion were also significantly 
enriched among genes with higher expression in the low versus high RFI animals. Alternatively, 
genes involved in signal transduction, bone mineralization and regulation of phosphorylation 
were overrepresented among DEGs with lower expression in the low versus high RFI animals. 
The DEGs significantly overlapped with genes associated with diseases, including hyperphagia, 
eating disorders and mitochondrial diseases (q < 1E-05). A weighted gene co-expression network 
analysis (WGCNA) identified four co-expression modules that were differentially expressed 
between the low and high RFI groups. Genes involved in lipid metabolism, regulation of bone 
mineralization, cellular immunity and response to stimulus were overrepresented within the two 
modules that were most significantly differentially expressed between the low and high RFI 
groups. We also found five of the DEGs and one of the co-expression modules were significantly 
associated with the RFI phenotype of individual animals (q < 0.05). 
Conclusions: The post-weaning blood transcriptome was clearly different between the 
low and high RFI groups. The identified DEGs suggested potential differences in mitochondrial 
and proteasomal activities, small molecule biosynthetic process, and signal transduction between 
the two RFI groups and provided potential new insights into the molecular basis of RFI in pigs, 
although the observed relationship between the post-weaning blood gene expression and RFI 
phenotype measured during the grow-finish phase was not strong. DEGs and representative 
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genes in co-expression modules that were associated with RFI phenotype provide a preliminary 
list for developing predictive biomarkers for RFI in pigs. 
 
Keywords: Sus scrofa, feed efficiency, residual feed intake, blood transcriptome, RNA-seq 
Background 
Feed efficiency (FE) is one of the important traits directly related to profitability, 
productivity, and sustainability in the pork industry [136, 137]. While many non-genetic 
strategies have been developed to improve feed efficiency of pigs [139], improving feed 
efficiency by genetic selection can be a sustainable alternative. An increasingly popular measure 
of FE is residual feed intake (RFI), which is the difference between the actual and expected feed 
intake of an animal for production and maintenance [138]. Importantly, RFI is moderately 
heritable and responds well to genetic selection in pigs [140, 141]. 
Over the last decade, significant efforts have been made to understand the molecular, 
genetic and physiological basis of RFI in pigs. Researchers have found many interesting 
differences between pigs with divergent RFI phenotypes [142, 143]. For example, as compared 
to high RFI pigs (less efficient), low RFI pigs (more efficient) have altered feeding behaviors 
[144], slightly lower growth rate [145], less back fat [141, 146, 147], lower protein turnover rate 
in the muscle [148], altered mitochondrial protein profiles [149, 150], less mitochondrial reactive 
oxygen species (ROS) production [151], and lower levels of leptin [152, 153] and juvenile IGF-1 
in circulating blood [145]. To explore the genetic basis of RFI in pigs, several genome-wide 
association studies (GWAS) have been conducted [154-157]. Some chromosomal regions tagged 
by single nucleotide polymorphisms (SNPs) have been found to be associated with RFI, but 
these associations were not consistent across studies and explained only small portions of the 
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genetic variance for RFI [154-157]. The wide range of differences between lines of pigs with 
divergent RFI and the lack of SNPs with major effects on RFI suggest that RFI is a highly 
polygenic, quantitative trait with multiple tissues contributing to its variation. 
Global gene expression profiling technologies have also been used to explore the 
molecular basis of RFI in pigs. By profiling the transcriptomes of the adipose tissue of two lines 
of pigs divergently selected for RFI with gene expression microarrays, Lkhagvadorj et al. [158] 
found that genes involved in the lipid metabolic pathway were overrepresented among the 
differentially expressed genes (DEGs) that had lower expression in low versus high RFI pigs, 
and genes involved in carbohydrate metabolism and response to stress were overrepresented 
among the DEGs that had higher expression in low versus high RFI pigs [158]. They also found 
the leptin-related gene network to be different between the two lines [158]. Recently, Vincent et 
al. [159] and Jing et al. [160] profiled the transcriptome of the longissimus dorsi (LD) muscle 
from pigs with divergent RFI by gene expression microarray and RNA-seq, respectively. Using 
pigs from lines divergently selected for RFI, Vincent et al. [24] found genes involved in protein 
synthesis and glycolysis, and genes associated with mitochondrial energy/oxidative metabolism 
had higher and lower expression, respectively, in the low versus high RFI line. Using Yorkshire 
barrows with extreme phenotypes for RFI, Jing et al. [160] found that genes involved in 
glycolysis had lower expression in the low versus high RFI group, while genes involved in 
muscle proliferation and differentiation had higher expression in the low versus high RFI group. 
Surprisingly, these two studies shared no DEGs and proposed opposite differences in glycolytic 
activities in the low versus high RFI pigs. Therefore, in consideration of the complexity of RFI 
and the inconsistency from study to study, the molecular mechanisms underlying RFI in pigs are 
still largely unclear. 
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To incorporate RFI into animal breeding programs for improving feed efficiency, feed 
intake, body weight gain and back fat depth must be recorded on individual pigs. As it is very 
expensive and time-consuming to record feed intake on individual animals [140, 141], 
convenient and predictive biomarkers for RFI that can be measured at an early age are in 
demand. In cattle, Chen et al. [161] successfully used 14 DEGs identified in the liver of Angus 
bulls that were divergently selected for RFI to classify Angus steers from the same divergent RFI 
lines, and Al-Husseini et al. [162] developed a RFI predictor using 8 of these 14 DEGs and 
validated it in an independent Angus population. These biomarkers are, however, not very 
practical because invasive liver biopsies are needed. 
The peripheral blood is an informative tissue not only because it carries a variety of cells 
directly involved in immunity and inflammation, but also because it interacts with every organ 
and tissue in the body via bioactive circulating factors, such as nutrients, metabolites, cytokines, 
hormones and exosomal cargoes, which are released from the same or different organs or tissues 
[177]. These bioactive factors interact with blood cells and thus might modify the gene 
expression profiles of the blood cells dynamically. Molecular signatures in circulating blood, 
including gene expression profiles, have been shown to reflect the physiopathological status, 
growth stage and lifestyle of subjects [177-181]. Due to its easy accessibility and 
informativeness, blood has become a popular sample (direct or as a surrogate) for disease 
diagnosis, prediction, prognosis, and biomarker discovery [177, 178]. Interestingly, the 
concentration of IGF-1 in serum at a young age has been shown to be different between animals 
with divergent RFI in poultry and livestock, including pigs [145, 152, 182, 183]. Blood cell 
profiles at early growth stages have also been found to be different between livestock with 
divergent RFI phenotypes, including pigs [184] and cattle [185]. These results suggest that 
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animals with divergent RFI phenotypes, measured later in life, have early physiological 
differences in circulating blood that may be reflected in blood gene expression profiles at these 
early stages. 
In this study, our objective was to determine the blood transcriptomic differences 
between post-weaning pigs from two lines divergently selected for RFI, to explore potential 
molecular mechanisms underlying RFI in peripheral blood and to develop a list of candidate 
biomarkers for RFI prediction. We hypothesized that post-weaning expression levels of some 
genes in whole blood were correlated with RFI phenotype measured during the grow-finish 
phase. We identified 1,972 DEGs with q ≤ 0.15 and 4 co-expression modules that were 
differentially expressed between the low and high RFI groups. A set of selected DEGs were 
validated by reverse transcription-quantitative PCR (RT-qPCR). Several interesting biological 
processes underlying DEGs and differential co-expression modules were suggested. We also 
identified several candidate biomarkers for RFI. 
Methods 
Animals, blood sample collection and complete blood count (CBC) test 
The experimental protocols for this study were approved by the Institutional Animal Care 
and Use Committee (IACUC) at Iowa State University under permit number 11-1-4996-S. All 
pigs were from parity 2 of generation 9 of the two lines divergently selected for residual feed 
intake: the low and high RFI lines [141, 154, 184]. Bunter et al. found that the IGF-1 
concentration in blood measured between 35 to 42 days of age differed between the two lines 
and were genetically correlated with RFI measured later during the grow-finish phase [145]. So 
blood samples were collected from the jugular vein into Tempus
TM
 Blood RNA tubes (Life 
Technologies, Grand Island, NY) for long-term storage at -80 °C from 233 post-weaning piglets 
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of the two lines in this age range. Meanwhile, blood from those animals was also collected into 
EDTA tubes (BD, Franklin Lakes, NJ) and kept at 4 °C before CBC tests, which were performed 
on the bleeding day, if possible, or the next morning as described [184, 224]. Differences in CBC 
profiles between the two lines have been published elsewhere [35]. At 107.0 ± 8.3 (mean ± 
standard deviation) days of age and 42.2 ± 7.2 kg of body weight (BW), 88 gilts and 78 barrows 
were randomly assigned to 12 mixed-line, mixed-sex finishing pens with electronic single-space 
feeders (FIRE, Osborne Industries Inc., Osborne, KS) for feed efficiency test, with 6 pens being 
randomly assigned to either of two diets: a high-fiber, low-energy diet (HFD) and a low-fiber, 
high-energy diet (LFD) [247]. The animals on feed efficiency test consisted of 21 barrows and 
22 gilts from the low RFI line plus 14 barrows and 23 gilts from the high RFI line fed the HFD, 
and 23 barrows and 23 gilts from the low RFI line plus 20 barrows and 20 gilts from the high 
RFI line fed the LFD. All pigs had ad libitum access to feed and water. Individual feed intake 
was real-time recorded, body weight was recorded biweekly, and backfat (BF) depth above the 
10
th
 rib and loin muscle area were recorded at the end of the test, when the pigs were 227.0 ± 1.4 
days of age and 127.7 ± 8.8 kg of body weight. RFI of individual pigs were calculated as 
described [154] with modifications and shown in Table B.1. Briefly, average daily feed intake 
(ADFI) was estimated by fitting a quadratic polynomial regression model of the daily feed intake 
from the on-test day to the off-test day on the number of days on test for each pig and individual 
average daily gain (ADG) was estimated as the slope from simple linear regression of bi-weekly 
BW on the number of days on test [141]. A single trait animal model was used to analyze ADFI 
with adjustments for fixed covariates of metabolic mid-body weight (average body weight during 
the test period raised to the power of 0.75, MBW), ADG, BF, deviation of the on-test weight 
from 50 kg, deviation of the off-test weight from 118 kg, and deviation of the on-test age from 
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90 days, and the random effect of pen. The RFI value for each pig was estimated as the residual 
of the fitted model (Young J. and Dekkers J.C.M., unpublished.). The growth performance and 
feed intake data of these animals have been published [248]. 
RNA extraction and globin depletion 
Based on the RFI phenotype of individual pigs, the juvenile blood samples of 32 out of 
the 88 gilts were selected for RNA-seq. In detail, for the low RFI line, we selected eight samples 
from animals with extremely low RFI values on the LFD and eight samples from animals with 
extremely low RFI values on the HFD (designated as low RFI group) while for the high RFI line, 
we selected eight samples from animals with extremely high RFI values on the LFD and eight 
samples from animals with extremely high RFI values on the HFD (designated as high RFI 
group) (Figure 3.1). Total RNA extraction of the 32 samples was processed in four batches such 
that for each batch, two samples were randomly selected from each line by diet combination. 
Within each batch, the processing order of samples was randomized beforehand and followed in 
all subsequent procedures where blocking was necessary. The total RNA was extracted from 
blood samples using preserved blood RNA purification kit I (Norgen Biotek Corp, Thorold, 
Ontario) by following the kit‟s manual. On-column DNA digestion was performed as described 
using DNase I (Qiagen, Valencia, CA). Globin transcripts (HBB [ENSSSCG00000007978] and 
HBA [ENSSSCG00000014725]) were depleted by following an RNase H-mediated method 
[223]. The quantity and integrity of the RNA were determined by using Nanodrop 2000 (Thermo 
Scientific, Waltham, MA) and Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA) before 
and after globin depletion. The efficiency of globin depletion of each sample was checked by 
conventional RT-qPCR with β-actin (ACTB) and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) as the internal reference genes. The total RNA of one selected blood sample from the 
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low RFI line on the LFD was dropped from this study due to its low RNA quality (original RNA 
integrity number (RIN) was 7.5, lower than our criterion of RIN ≥ 8.0 before globin depletion). 
The average RIN for the 31 remaining samples before and after globin depletion were 9.05 ± 
0.31 and 8.26 ± 0.30, respectively. Detailed information about the selected samples, including 
pedigree, RNA quality, batch, and CBC is available in Table B.1. 
RNA-sequencing 
Library construction and sequencing were performed by the DNA facility at Iowa State 
University. Briefly, the RNA-seq libraries were constructed using the Illumina TruSeq RNA 
Sample Preparation Kit v2 (Illumina, San Diego, CA) according to manufacturer‟s instructions. 
For each sample, poly (A)-containing transcripts was enriched with oligo-dT-coated magnetic 
beads from 0.7 to 2 µg of total RNA with globin transcript depleted. The enriched RNA was 
fragmented by heat and reverse transcribed with hexamer random primers. For each sample, 
adapters with unique barcodes were ligated to the end-polished cDNA fragments. The libraries 
were linearly amplified by PCR, size selected and quantitated. The individual libraries were 
diluted to 2 nM and pooled in approximately equimolar amounts according to the processing 
batches mentioned above with 8 libraries per pool, except for one pool of 7 libraries. 100 base 
paired-end sequencing was run on an Illumina Hiseq2000 platform with one pool per lane on a 
flow cell. The RNA-seq data are available in ArrayExpress under accession number: [E-MTAB-
4179, http:// https://www.ebi.ac.uk/arrayexpress/]. 
Quality control, preprocessing and alignment of RNA-seq reads 
Read quality was checked by using FastQC (version 0.10.1) [249]. Adapters and low 
quality bases were trimmed by running Trimmomatic (version 0.32) [250] in the paired-end 
mode with the following options, ILLUMINACLIP:adapters.fa:2:30:10:1:true LEADING:3 
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TRAILING:3  SLIDINGWINDOW:4:15 LEADING:3 TRAILING:3 MINLEN:36, such that the 
average base quality was not lower than 15 for every sliding window of 4 bases and the 
minimum length of kept reads was 36 bases. For each set of raw paired-end reads, Trimmomatic 
outputted a pair of files for the kept paired-end reads, a file for unpaired forward reads (R1), and 
a file for unpaired backward reads (R2). Trimmed paired-end and unpaired reads were separately 
aligned to the pig reference genome Sscrofa 10.2 (version 77, Ensembl) using 2-pass rna-STAR 
(version 2.3.0), using the default settings [228, 229]. Read counts per gene per library were 
summarized by using featureCounts (version 1.4.4) [92], with the resulting SAM files for 
uniquely mapped, paired-end and unpaired reads as inputs, separately, and using the pig genome 
GTF file (version 77, Ensembl) as the genomic annotation reference file. The default settings for 
other featureCounts options were used [92]. A final table of read counts per gene of the 31 
samples (designated as the count table) was generated by summing up the individual count tables 
for paired-end and unpaired reads. Prior to differential expression analysis, hemoglobin genes 
(HBA and HBB) and genes with few reads (average read count no larger than 8, or 28 or more 
zero read counts across the 31 samples) were removed from the count table to obtain a final 
count table with 12,280 genes. This count table was used for the subsequent differential 
expression analysis and weighted gene co-expression network analysis (WGCNA) after further 
transformation and adjustment. 
Differential expression analysis 
The statistical programming language R (version 3.1.0) was used for all statistical 
analyses, unless indicated otherwise. Differential expression analysis was carried out by using 
the R package “QuasiSeq” (version 1.0-4) [101]. For each of the 12,280 genes in the final count 
table, we used QuasiSeq to fit a full generalized linear model with a negative binomial response 
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and a log link function that included an upper-quartile normalization offset [43] and the fixed 
effects of RFI group (low and high RFI groups), diet (low and high fiber diets), batch (sample 
processing batches 1 to 4), and the linear covariates of RFI phenotype (estimated RFI value), 
pre_conc (RNA concentration before globin depletion), pre_RIN (RIN before globin depletion), 
post_conc (RNA concentration after globin depletion), post_RIN (RIN after globin depletion), 
and concentrations of neutrophils, lymphocytes, monocytes, eosinophils and basophils. Note 
that, although blood was collected before pigs were fed the different diets, a diet effect was 
included in our initial full model because diet affected the component traits that were used to 
estimate RFI and thus the estimation of RFI. Because not all the variables included in the initial 
full model may be associated with transcript levels, we used a backward variable selection 
algorithm to identify the most relevant variables [251]. The final model included RFI group, 
batch, pre_conc, post_RIN, and the concentrations of neutrophils, lymphocytes, monocytes and 
basophils as independent variables. The default settings for arguments in all function calls were 
used unless specified otherwise. In the QL.fit function, the “method” argument was set to 
“optim”. The reported p-values, q-values and log2(fold change) associated with all tests of 
significance were calculated by using the QLSpline method. 
Weighted gene co-expression network analysis (WGCNA) 
Before co-expression analysis using the R package “WGCNA” (version 1.46) [252], the 
expression levels for the 12,280 genes in the count table were adjusted for all independent 
variables in the final model used for differential expression analysis except RFI group. Briefly, 
log-counts per million (designated as log-cpm) were calculated using the voom function of the 
Bioconductor package “limma” (version 3.20.9) with the upper-quartile normalized counts as 
input [233, 253]. The lmFit function was used to fit a linear model with log-cpm per gene feature 
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as the responsible variable, and RFI group, batch, and the linear covariates of pre_conc, 
post_RIN, and concentrations of neutrophils, lymphocytes, monocytes and basophils as 
independent variables. Effects associated with relevant variables (batch, pre_conc, post_RIN, 
and the concentration of neutrophils, lymphocytes, monocytes and basophils) were subtracted 
from the original log-cpm, to create adjusted transformed gene expression values. The data 
matrix consisting of adjusted log-cpm per gene for the 31 samples (hereafter called the adjusted 
transformed gene expression matrix) was used as the input for WGCNA. WGCNA was 
performed by following tutorial I [254], with slight modifications as needed. In WGCNA, all 
correlation coefficients between gene pairs were calculated by using Pearson‟s method. A soft-
thresholding power of 7 was used by assuming the topology of the unsigned weighted gene co-
expression network was scale-free. The average linkage method was used for all clustering 
procedures. The function cutTreeDynamic was used for identification of modules. Only modules 
with a minimum of 30 genes were considered. Modules with eigengene correlations no less than 
0.75 were merged using the mergeCloseModules function with cutHeight  = 0.25. The eigengene 
of a module is the first principal component of the gene expression values of that module and can 
be considered as a representation of the expression profiles of genes in the module [252]. We 
then fitted linear regression models with expression levels of the module eigengenes as the 
response variable and RFI group as the independent variable. The estimated effect of RFI group 
and the associated p-value for the null hypothesis that the RFI group term was not useful in 
explaining expression of the eigengene of the module were used to quantify the strength and 
significance of the association between the eigengene of a module and RFI group. 
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Hierarchical clustering, generation of heat map, and multi-dimension scaling analysis 
The adjusted gene expression matrix was used for hierarchical clustering, heatmap 
generation, and multi-dimensional scaling (MDS) analyses. Spearman correlation coefficients for 
gene expression between samples were calculated and 1 minus this correlation coefficient was 
used as the distance between a pair of samples for both hierarchical clustering and heatmap 
construction. The Ward method was used in the function hclust for hierarchical clustering of the 
samples. A heatmap was generated with the heat.map2 function to visualize the DEGs (q ≤ 
0.05). MDS with the first two dimensions was used to visualize the relationships of samples with 
each other by using the function plotMDS from the Bioconductor package “limma” (version 
3.20.9) [233]. For MDS, the distance between each pair of samples was the Euclidian distance 
between them based on the expression of all 12,280 genes. 
Gene ontology term and pathway enrichment analyses 
For all GO term and Ingenuity Pathway Analysis (IPA)-based pathway enrichment 
analyses, unadjusted p-values were reported [255]. We used Bioconductor package “topGO” 
(version 2.16.0) [255] to perform gene ontology (GO) term analysis, including GO biological 
process (GO-BP), GO molecular function (GO-MF) and GO cellular component (GO-CC). GO 
terms associated with each gene were downloaded from Ensembl Biomart (version 79). The 
“classical” algorithm, which treats all GO terms to be independent of each other, and Fisher‟s 
exact test were used to estimate significance of such enrichment using the function runTest. For 
GO term enrichment analysis of DEGs (q ≤ 0.15), we analyzed DEGs with higher and lower 
expression in the low versus high RFI group separately, while for GO term enrichment analysis 
of WGCNA modules, genes in a whole module were analyzed together. The maximum subset of 
the 12,280 genes that was associated with at least one GO-BP, GO-MF or GO-CC term, 
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respectively, was used as the reference set (also known as background) in the corresponding GO 
term enrichment analyses. Significantly enriched GO terms associated with more than 10 
annotated genes in the pig genome annotation (version 79) were reported. 
We performed other enrichment analyses of the DEGs (q ≤ 0.15) using Ingenuity 
Pathway Analysis (IPA, 2015 spring release) and the Integrated Pathway Analysis Database 
(IPAD) for Systematic enrichment analysis [256]. For IPA-based analysis, 8,965 of the 12,280 
genes could be mapped to IPA identifiers via the gene symbols of pig genes and these genes 
were used as the reference set. For networks and upstream regulator analysis, both direct and 
indirect relationships were considered. The options, “all data sources”, “confidence” and 
“mutation”, were checked. For species, “all mammals” was checked. For tissues and cell lines, 
only data on tissues and primary cells were considered. The cutoff for the log2(fold change) was 
set to 0 and the q-value cutoff was set to 0.15. All DEGs were analyzed together, with 1,488 of 
1,972 DEGs mapped to IPA identifiers. For IPAD-based analysis of DEGs, the IPAD web server 
[257] was used. Of the 1,972 DEGs (q ≤ 0.15), 1,536 genes with human gene symbols were 
analyzed together. The default reference set was used, as the IPAD server does not allow the user 
to provide a reference set. The raw p-values were corrected for multiple testing using the “BH” 
method [227] for IPAD-based analysis. 
Validation by RT-qPCR 
We attempted to validate DEGs between the RFI groups with q ≤ 0.15, |log2 (fold 
change)| ≥ 1 and averaged FPKM (fragments per kilobase of exon per million fragments 
mapped) [258] within either RFI group ≥ 1, which resulted in 46 genes. All pairs of primers 
corresponding to the 46 DEGs and 6 internal reference genes were designed and synthesized by 
the Fluidigm Corporation (Fluidigm, San Francisco, CA), such that the two primers of each pair 
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were separated by exon-exon boundaries and could amplify all isoforms of the target gene if 
possible (see Table B.2). The efficiency of each primer pair was tested by conventional RT-
qPCR on the DNA Engine Opticon 2 system (BioRad, Hercules, California) by using the 
standard curve method [259] and only primer pairs with amplification efficiency no less than 
0.95 were further considered. As for specificity, only primer pairs that gave products with single 
peaks in melting curve analyses were used for the downstream RT-qPCR assays. This resulted in 
37 pairs of primers for DEGs and two for internal reference genes (YWHAZ and RPL32) 
passing the test (Table B.2). The samples we used for RT-qPCR validation of the DEGs included 
24 of the 31 RNA samples that we had sequenced by RNA-seq, and another 24 novel samples 
from gilts from the same contemporary group of pigs, with 6 samples from each line by diet 
combination. The 24 novel blood samples were selected such that the RFI phenotypes of the 
corresponding animals were evenly distributed across the distribution of RFI phenotypes that 
was not covered by the RFI phenotypes of the 24 animals originally selected for RNA-seq 
(Figure 3.1). Detailed information about the 48 samples used for validation of DEGs is in Table 
B.1. RNA was extracted from the novel samples as above in three batches, with two samples 
from each line by diet combination per batch. The concentration and quality of 24 novel RNA 
samples were determined as above. Total RNA without undergoing globin depletion was used 
for cDNA synthesis. By following the Fluidigm User Guide for Real-Time PCR Analysis [225], 
Real Time-qPCR was done on a 48.48 dynamic array chip (Fisher Scientific, Pittsburgh, PA) 
using the Biomarker HD system (Fluidigm, San Francisco, CA). Data were analyzed with the 
Fluidigm Real-Time PCR analysis software with the default settings, to obtain raw Ct values. 
The raw Ct values were corrected for differences in the amount of input RNA by using the 
geometric mean of the Ct values of the two internal reference genes for the same RNA samples 
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to get – ∆Ct = – (Ct gene – Ct reference) [260, 261]. Differential expression analysis was performed 
by fitting linear models with – ∆Ct values as the response variables and RFI group, RNA 
extraction batch, and the linear covariates of the concentrations of neutrophils, lymphocytes, 
monocytes and basophils as independent variables. With the high RFI group as the reference, the 
estimated effects on – ∆Ct for RFI group were defined as the –∆∆Ct values. The p-values 
associated with the effect of RFI group were adjusted to get q-values by using the “BH” method 
[227]. If the q-value of the significance test of the RFI group was less than 0.15, the 
corresponding gene was considered differentially expressed between the low and high RFI 
groups by RT-qPCR. Because the amplification efficiencies (see Table B.2) of the primers were 
close to 1, the fold changes of gene expression between the low and high RFI group were 
calculated as 2
–∆∆Ct
 [260]. 
Association analysis of (eigen)gene expression with RFI phenotype 
For association analysis of the expression levels of eigengenes of modules identified by 
WGCNA with RFI phenotype, the eigengene expression levels were first analyzed with a linear 
model that included RFI group and diet as fixed effects and RFI phenotype as a covariate, along 
with the two-way and three-way interactions among these three factors. We did not include RNA 
processing batch, RIN, and concentrations of the blood cell types in the linear model because the 
eigengene expression levels were calculated based on gene expression values that had already 
been adjusted for these effects. Gene expression determined by RT-qPCR was also used to 
identify genes associated with RFI phenotype. The – ∆Ct values for the 37 target genes in the 48 
samples were calculated as above and analyzed with a linear model that included RFI group, 
RNA extraction batch and diet as fixed effects, and RFI phenotype and the concentrations of 
neutrophils, lymphocytes, monocyte and basophils as covariates, along with the two-way and 3-
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way interactions among RFI group, diet and RFI phenotype. However, none of the interaction 
terms were significant after correcting for multiple testing with the “BH” method (q > 0.15), thus 
interaction terms were removed from the models. The p-values associated with the regression 
coefficient(s) on the RFI phenotype covariate were adjusted to get q-values by the “BH” method 
[227]. If the q-value was less than 0.05, the association between the (eigen)gene and the RFI 
phenotype was considered significant. 
Results 
Differentially expressed genes between low and high RFI groups  
Mauch et al. [248] showed that the low RFI line had significantly lower RFI than the 
high RFI line on the LFD (p < 0.007), but the low RFI line only tended to have lower RFI than 
the high RFI line on the HFD (p > 0.05). Thus, to maximize the contrast, we selected blood 
samples for RNA-seq from gilts of the low RFI line with extremely low RFI values when fed the 
LFD or the HFD (designated as low RFI group), and from gilts of the high RFI line with 
extremely high RFI values when fed the LFD or the HFD (designated as low RFI group) (Figure 
3.1). The metadata, including RNA concentration, RINs before and after globin depletion, RFI 
phenotype and CBC test results are in Table B.1. The distribution of the RFI values for all gilts 
of each line by diet combination is in Figure 3.1. To increase the power to detect lowly expressed 
genes in the whole blood transcriptome, we depleted the most highly expressed transcripts, 
hemoglobin A and B (HBA and HBB), using the RNase H-mediated method [223]. Alignment of 
RNA-seq reads to the reference genome showed that globin transcripts had been effectively 
reduced (Table B.3). After globin depletion, on average, only 0.22 ± 0.29 % and 1.86 ± 2.70 % 
of the trimmed reads mapped to the HBA and HBB genes, respectively. The numbers of raw 
reads, trimmed reads, and mapped reads for each sample are in Table B.3. In summary, 20.4 ± 
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7.8 million pairs of 100-bp raw reads were sequenced per sample. After trimming, 81.4 ± 8.0% 
of raw paired-end reads were kept as paired-end reads, while 17.6 ± 8.0% of raw forward reads 
(R1) and 0.27 ± 0.05% of raw reverse reads (R2) were unpaired reads. 91 ± 1% of trimmed 
fragments were mapped to the pig reference genome, with 83.0 ± 1.2% (mean ± sd) of trimmed 
fragments being uniquely mapped. After removing genes with extremely low expression (See 
Methods), and HBA and HBB from the count table, we had expression data for 12280 genes for 
downstream analyses. 
Mpetile et al. [184] showed that pigs at 35 to 42 days of age from the low RFI line had 
lower concentrations of lymphocytes, monocytes and basophils than those from the high RFI line 
in their peripheral blood. Therefore, we decided to account for the concentration of different 
blood cell types in our analyses so that we could adjust gene expression for these concentration 
differences. Although the animals were randomly assigned to one of the two diets after the blood 
samples were collected, we started with a full model that included diet and RFI phenotype 
(estimated RFI value) and performed backward selection to establish a final model for the 
following reasons: 1) the samples for RNA-seq were selected based on the RFI phenotype of the 
animals; 2) the RFI phenotype depended on both line and diet effects3) we were interested in 
identifying genes that might be associated with RFI phenotype. However, after accounting for 
RFI group (i.e. the low RFI and high RFI groups) and other variables identified via backward 
selection (batch, pre_conc, post_RIN, and the concentrations of neutrophils, lymphocytes, 
monocytes and basophils), we found the RFI phenotype, diet, pre_RIN, post_conc and the 
concentration of eosinophils were not significantly associated with the expression levels of most 
genes (p > 0.05). With our final selected model, we found expression levels of 836, 0, 3, and 42 
genes to be significantly associated with the concentrations of neutrophils, lymphocytes, 
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monocytes and basophils, respectively (q ≤ 0.05) (Table B.4). However, we were most interested 
in DEGs whose expression differences were primarily dependent on line differences. Therefore, 
for all downstream analysis, we only considered DEGs between the low and high RFI groups, 
while accounting for the effects of relevant variables: batch, post_RIN, and the concentrations of 
neutrophils, lymphocytes, basophils and monocytes. 
The numbers of DEGs between the low and high RFI groups based on different 
stringencies in terms of q-value and fold change cutoffs are in Table 3.1. A full list of the 1972 
DEGs for q ≤ 0.15 is in Table B.4. Differential expression of the 454 DEGs with q ≤ 0.05 is 
shown in Figure 3.2A. As the volcano plot (Figure 3.2B) shows, the fold change between the low 
and high RFI groups was small for most genes. For a q-value cutoff of 0.05, only 50 DEGs had a 
fold change ≥ 2 or a fold change ≤ 0.5. However, the transcriptomes of the two groups of 
animals were collectively different, as the 31 samples were grouped into two clusters by RFI 
group based on hierarchical clustering and MDS analyses (Figure 3.2C and Figure B.1). 
Annotation of differentially expressed genes by GO term and pathway enrichment analyses 
To understand the biological differences between RFI groups based on the differential 
expression analyses, we carried out GO term analysis of DEGs using a less stringent cutoff of q-
value (q ≤ 0.15) such that we could detect a broader group of significant GO terms. These 
analyses were conducted separately for DEGs with higher and lower expression in the low versus 
high RFI group. GO-BP term analysis showed that genes involved in small molecule 
biosynthesis, carboxylic acid biosynthesis, organic acid biosynthesis, steroid biosynthesis, 
antigen processing and presentation of peptide antigen via MHC (major histocompatibility 
complex) class I, and organic hydroxy compound biosynthesis were overrepresented among 
DEGs with higher expression in the low versus high RFI group (p < 0.001, Table 3.2). Among 
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the DEGs with lower expression in the low RFI group, genes involved in signal transduction, 
bone mineralization, regulation of phosphorylation, and phosphorylation were overrepresented (p 
< 9E-05). Interestingly, GO-CC term analysis showed that genes functioning in the proteasome 
complex or the mitochondrion were enriched among the DEGs with higher expression in the low 
versus high RFI group (p < 5E-06). 
In addition, we conducted pathway enrichment analyses of the DEGs (q ≤ 0.15) by 
assuming pig genes have similar biological functions as their human orthologs. Detailed results 
from these IPA-based analyses are in Table B.5. In summary, IPA-based analysis suggested 
genes functioning in several canonical pathways tended to be enriched among the DEGs, 
including p53 signaling (p =2.18E-03), T cell receptor signaling (p = 1.25E-02), antigen 
presentation (p = 1.63E-02), IL-15 signaling (p = 2.16E-02) and IL-9 signaling (p = 2.21E-02). 
But after correcting for multiple testing, none of these pathways were significantly enriched 
among the DEGs (q > 0.1). In addition, IPA-based analyses suggested that activities of genes 
involved in regulating the quantity of T lymphocytes (p = 7.46E-05), consumption of oxygen (p 
= 1.33E-04), insulin resistance (p = 1.98E-04), cell survival (p = 4.67E-04), glucose metabolism 
and transport (p < 5.64E-03), respiration of mitochondrion (p = 5.74E-03) and body mass index 
(p = 1.03E-02) were different between the two RFI groups. IPA-based analysis also suggested 
several potential upstream regulators of the DEGs, including IL15, which had a higher 
expression in the low versus high RFI group (p < 3.6E-03). The inferred regulatory network for 
IL15 is shown in Figure B.2. 
Using the Integrated Pathway Analysis Database (IPAD) for Systematic Enrichment 
Analysis [256], we found genes involved in the immune system (pathway ID: 168256) (q = 
0.013) and metabolism (pathway ID: 1430728) (q = 0.066) were enriched among the DEGs. 
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IPAD-based disease-associated gene enrichment analysis suggested genes involved in several 
diseases were overrepresented among DEGs (q < 1E-05), including taste disorder, eating 
disorder, anorexia, hyperphagia, obesity, insulin resistance, mitochondrial diseases and 
lymphocytosis.  Details are in Table B.6. This is consistent with the phenotypic differences in 
feeding behavior [144], body composition [147], and growth rate [145] that have been observed 
between the two RFI lines. 
Validation of DEGs  
We used RT-qPCR to validate the differential expression of 37 DEGs that were selected 
based on average expression levels within RFI group (FPKM > 1), differential expression levels 
between RFI groups (|log2 (fold change)| ≥ 1 and q ≤ 0.15) and primer performance. To test 
whether the expression differences we detected were due to differences between the lines, rather 
than due to the comparison of pigs of the low RFI group to pigs of the high RFI group, we 
selected another 24 samples from the same parity of the 9
th
 generation of the two RFI lines. 
These 24 samples were selected such that the RFI values of the corresponding animals were 
roughly evenly distributed across the ranges of RFI values for each line by diet combination, 
which were not covered by the RFI values of the 24 animals originally selected for RNA-seq 
(Figure 3.1). The RNA from these new samples as well as the 24 samples used for RNAseq 
analyses were used in RT-qPCR analyses. Data from the original 24 samples and the new 24 
samples were analyzed independently as well as jointly. A total of 24 of the 37 DEGs were 
confirmed in the joint analysis of all 48 samples (q < 0.15, Figure 3.3), while 22 of the 37 DEGs 
were confirmed when analyzing the original 24 samples (q < 0.15). However, only 9 of the 37 
DEGs were validated in the analysis of the novel 24 samples (q < 0.15, Table B.7). 
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Based on the RT-qPCR results of the 48 samples, we found the expression of 5 of the 37 
DEGs (determined by RNA-seq) to be significantly associated with RFI phenotype (q < 0.05). 
They were LRP6 (low density lipoprotein receptor-related protein 6), ENSSSCG00000024900 
(T-cell receptor beta chain), ENSSSCG00000008771, PDL1 (CD274 molecule) and 
ENSSSCG00000020945 (Table B.8). 
Co-expressed gene modules associated with RFI 
Since conventional differential expression analysis considers each gene independently 
and suffers from loss of power due to correction for multiple testing, we performed weighted 
gene co-expression gene network analysis (WGCNA) [252] based on the adjusted gene 
expression matrix (see Methods) to identify modules (groups of co-expressed genes) 
differentially expressed between the RFI groups and associated with RFI phenotype. We 
identified four modules, designated as C1-lightcyan, C2-darkturqoise, C3-skyblue3, and C4-
black, whose eigengene expression levels were significantly differentially expressed between the 
low and high RFI groups (Table 3.3 and Table B.9). The eigengene of a module is a weighted 
average of the expression profiles of genes in the module, calculated as the first principal 
component score. The expression levels of the eigengenes for the 31 samples are shown in 
Figure 3.4A. Among the genes in module C1-lightcyan, those involved in lipid metabolism-
related biological processes, such as lipid metabolic process, lipid biosynthesis and steroid 
biosynthesis were overrepresented (p < 0.006). In module C2-darkturqoise, genes involved in 
biological processes related to bone mineralization, immunity and stress response and lipid 
metabolism were overrepresented (Table B.10). We also found that DEGs identified by RNA-seq 
(q ≤ 0.15) significantly overlapped with each of the four differentially expressed modules (Figure 
3.4B), which suggests that the modules identified by WGCNA are not computational artifacts as 
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they were enriched for the DEGs between the RFI lines. In addition, we found that the 
expression levels of the eigengenes of modules C3-skyblue3 were significantly associated with 
RFI phenotype (q < 0.05) (Table B.11). 
Discussion 
Small but significant blood transcriptomic differences between the low and high RFI 
groups 
By transcriptomic analyses, we identified 454, 1185 and 1972 DEGs between the low and 
high RFI groups at q-value cutoffs of 0.05, 0.1 and 0.15, respectively.  We validated 24 of the 37 
selected DEGs by RT-qPCR in a joint analysis of 48 samples: 24 of the 31 samples used for 
RNA-seq plus 24 novel samples from the same population (Figure 3.1, Figure 3.3 and Table 
B.7). We validated 22 of the 37 selected DEGs by RT-qPCR when using 24 of the 31 samples 
that were used for RNA-seq, but only 9 of the 37 selected DEGs were validated when using only 
the 24 novel samples (Figure 3.1 and Table B.7). Our validation rate by RT-qPCR of DEGs 
detected by RNA-seq was low compared to the high validation rate reported by Wang et 
al.[262], especially when based on the 24 novel samples. There are several possible reasons for 
failure to validate some of the 37 DEGs that were detected by RNA-seq by RT-qPCR in this 
study. First, some of the selected DEGs could be false positives, especially as we selected DEGs 
with q ≤ 0.15 for validation, although we did not detect an obvious association between the 
validation rate and the q values for the DEGs. Second, the primers used for RT-qPCR maybe did 
not quantify all isoforms that were measured by RNA-seq. Although the primers were designed 
to amplify all isoforms, these designs were based on poorly annotated gene models: most of the 
37 genes only have one isoform in the Ensembl pig genome annotation (Table B.2). Third, the 24 
novel samples used for RT-qPCR were not the exact biological replicates of the 24 samples used 
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for RNA-seq given their different RFI phenotype. In addition, as observed in other differential 
expression analyses between low and high RFI groups conducted in poultry, pigs and cattle [158, 
263-266], the magnitude of the differential expression in terms of fold change was generally 
small for most genes. This could be because the experimental units for the low and high RFI 
groups were genetically heterogeneous within each group, which cancelled out some differences 
between extreme individuals of the two groups. In addition, the experiments were conducted 
without strong external stimuli, thus the expression levels of genes were in their normal 
physiological range. It was also possible that the differences in gene expression in blood at the 
post-weaning stage were not as dramatic as during the grow-finish phase when feed efficiency 
was tested. However, it is possible that small changes in the transcript abundance of some genes 
involved in metabolism, transcription regulation, and signal transduction, could have significant 
effects on RFI phenotype. As our differential analysis indicated, a significant portion of genes 
involved in several biosynthetic processes, signal transduction, and regulation of phosphorylation 
were differentially expressed between the low and high RFI groups. Lastly, we cannot exclude 
the possibility that there is a weak or indirect relationship between early blood gene expression 
and later RFI phenotype. Nevertheless, based on the adjusted global gene expression profiles of 
all samples, hierarchical clustering and MDS analyses revealed that the post-weaning blood 
transcriptome was different between the two RFI groups. 
Potential relationship of the DEGs and differentially co-expressed gene modules in blood 
with RFI  
Although we did not attempt to validate most of the DEGs or the differentially co-
expressed gene modules between the two RFI groups due to the generally small fold changes, we 
found some interesting biological processes and cellular components underlying them, which 
suggested their potential relationships with RFI phenotype. GO term enrichment analysis of 
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DEGs suggested that genes involved in small molecule (including organic acid, carboxylic acid, 
and alcohol) biosynthesis, antigen processing and presentation of peptide antigen via MHC class 
I, and steroid biosynthesis were enriched among DEGs with higher expression in the low versus 
high RFI group. DEGs involved in small molecular biosynthesis included FADS1, FADS2, and 
ELOVL3. FADS1 and FADS2 are important genes in regulating the synthesis of polyunsaturated 
fatty acids, which have pleiotropic influences on health and diseases by functioning in several 
pathways, including metabolism and immunity [267]. Of note, FADS2 also had a higher 
expression level in the liver in the low RFI versus high RFI group of Nelore steers [263]. 
ELOVL3 encodes one of the rate-limiting enzymes in elongation of very long chain fatty acids 
(with more than 17 carbon atoms). In mice, a proposed physiological function of ELOVL3 is to 
maintain lipid homeostasis by replenishing the intracellular pool of triacylglycerol [268]. 
MAT2B, is one of the genes associated with steroid biosynthesis but had lower expression in the 
low versus high RFI group. It encodes a regulatory subunit of methionine adenosyltransferase, 
MAT II, which catalyzes the synthesis of S-adenosyl methionine (SAM). SAM is a key methyl 
donor in transmethylation reaction and polyamine biosynthesis and also functions as a cofactor 
in key metabolic pathways. Down-regulation of MATIIB expression causes a 6 to10-fold 
increase in intracellular SAM levels [269]. Taken together, the expression difference of genes 
involved in small molecule biosynthesis and steroid biosynthesis might have significant effects 
on overall metabolism, immunity and beyond. 
Seven of the 20 genes associated with GO term GO:0002474 (antigen processing and 
presentation of peptide antigen via MHC class I) had higher expression in the low RFI group. 
These included SLA-3 and TAP1. It has been shown that in post-weaning pigs resistant to 
Escherichia coli F18, SLA-3 has higher expression level than in susceptible pigs [270]. TAP1 
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transports antigens from the cytoplasm to the endoplasmic reticulum for loading antigen peptide 
onto MHC class I molecules [271]. In addition, we found 14 of the 15 DEGs associated with GO 
term GO:0000502 (proteasome complex) to have higher expression in the low versus high RFI 
group. The only exception was PSMD5, which had lower expression in the low versus high RFI 
group. It has been shown that overexpression of PSMD5 inhibits assembly and activity of 26S 
proteasome [272], which is an important component in processing and presenting intracellular 
peptide antigen via MHC class I to CD8
+
 T cells. Antigen presenting cells (APC) have both 
constitutive proteasomes and immunoproteasomes, both of which are important for antigen 
peptide processing [273]. Notably, an immunoproteasome subunit PSMB8 (also known as β5i) 
had the largest difference in expression level among the 15 DEGs that function in the proteasome 
complex. Given the increased expression levels of non-inhibitory proteasomal components in 
blood of the low RFI group, it is likely that proteasomal activity is higher in blood from the low 
versus high RFI group. Taken together, the expression differences of genes involved in antigen 
processing and peptide antigen presentation suggest that low RFI animals might have a more 
active system of antigen peptide processing and presentation, which might improve the 
robustness of their immune system of the low RFI animals. Consistent with this speculation, 
Dunkelberger et al. [274] recently showed that the low RFI line was less affected by 
experimental infection with porcine reproductive and respiratory syndrome virus (PRRSv), 
which mainly infects mature macrophages, derivatives of monocytes. In view of the lower 
concentration of monocytes in the low RFI line, the putative higher activity of antigen processing 
and peptide antigen presentation might lead to an increased efficiency of innate immunity in the 
low RFI pigs. It would be interesting to test the activity of the blood proteasome in more detail in 
these lines for a role in feed efficiency. 
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Another interesting finding was that genes functioning in the mitochondrion were 
significantly overrepresented among DEGs with higher expression in the low versus high RFI 
group. Of the 955 blood genes associated with GO-CC term mitochondrion (GO:0005739), 116 
were DEGs with higher expression in the low versus high RFI group. Mitochondria play 
important roles in many biological processes, including fatty acid metabolism, amino acid 
metabolism, and steroidogenesis [275]. Importantly, mitochondrial function has been associated 
with feed efficiency in poultry, cattle and lambs [276, 277]. As well, it has been shown that the 
mitochondrial proteome profiles are different between these low and high RFI lines of pigs and 
the mitochondria from the liver and LD muscle of the low RFI pigs produced less ROS [149-
151]. Interestingly, we found that four genes involved in detoxification of ROS, GPX3, SOD1 
and CAT, had higher expression in the low versus high RFI group. Another interesting gene that 
functions in mitochondria is G0S2, which is a noncompetitive inhibitor of adipose lipase, a rate-
limiting lipase of triglyceride hydrolysis [278]. G0S2 had higher expression in the low versus 
high RFI group. It has been shown that G0S2 can inhibit ROS production in endothelial cells 
[279]. In addition, we found higher expression in blood from the low RFI group for genes that 
encode 14 mitochondrial ribosomal proteins (MRPL3, 9, 10, 11, 18, 20, 24, 38, 40, 46MRPS10, 
11,15, 27), 9 components of mitochondrial complex I (NDUFA4, 8NDUFB3, 7, 9NDUFS2, 
7NDUFAB1, NDUFAF3), one component of complex II (SDHA), cytochrome c (CYCS) and 
four components of complex IV (COA3, COA6, COX5B, COX7C), two components of the 
complex V (ATP5D, ATP5G3), four key enzymes of the TCA cycle (ACO1, IDH2, IDH3A, 
SDHA, SUCLG1), four enzymes involved in mitochondrial DNA repair (APEX2, FEN1, OGG1, 
UNG), and two enzymes involved in nucleotide metabolism (DUT, MTHFD1), and three 
translocases of the inner/outer membranes (TIMM50, TOMM7, TOMM40). Taken together, it is 
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reasonable to speculate that the low RFI group has more efficient mitochondria and can more 
efficiently handle oxidative stress. 
Among the 1972 DEGs (q ≤ 0.15), 288 genes were associated with GO:0007165 (signal 
transduction), and genes involved in signal transduction were significantly enriched among 
DEGs with lower expression in the low versus high RFI group. DEGs associated with signal 
transduction were mainly cytokines, receptors and kinases. Signal transduction-related genes 
with much lower expression in the low versus high RFI group included LRP6, WNT10B, and 
FZD6. LRP6 belongs to the low-density lipoprotein receptor family and plays a key role in 
lipoprotein endocytosis and as a co-receptor in Wnt/β–catenin signaling. LRP6 is also involved 
in regulating lipid homeostasis and body fat mass [280], while LRP6, WNT10B and FZD6 can 
function together in the Wnt/β-catenin signaling pathway. Besides playing important roles in 
bone metabolism, the Wnt/β-catenin signaling pathway also takes part in glycolysis and regulates 
mitochondrial physiology and insulin sensitivity and is thus linked to metabolic diseases [281, 
282]. On the other hand, we found a few genes involved in signal transduction but with much 
higher expression in the low versus high RFI group, such as IL15 and IRS1. IL15 plays 
important roles as a pleiotropic cytokine in innate and adaptive immunity [283]. IRS1 is an 
important player in both the insulin signaling and the IGF-1 signaling pathways and IGF-1 is an 
important anabolic hormone, playing a key role in growth. Note that juveniles from the low RFI 
line have been shown to have lower serum concentration of IGF-1 and the low RFI line grows 
only slightly slower than the high RFI line. The higher expression of IRS1 might partially 
compensate for the lower level of IGF-1 in the low RFI line. It is interesting to investigate the 
expression and activity of IRS1 in other tissues of the two lines, such as the muscle. The 
differential expression of many genes associated with signal transduction might be related to 
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differences in metabolism and immune response between the RFI lines. Lastly, we found four 
co-expression modules to be differentially expressed between the RFI groups, and these modules 
shared a significant portion of their genes with the list of DEGs. The eigengene expression of 
module C1-lightcyan was lower in the low RFI group than in the high RFI group. The top highly 
connected genes in this module were MAT2B, CPT1A, and LRP6. These genes were also 
differentially expressed between the low and high RFI groups. Since we have already discussed 
MAT2B and LRP6, we focus on CPT1A herein. CPT1A had lower expression in the low versus 
high RFI group and plays an important role in importing long chain fatty acids into 
mitochondria, by catalyzing the primary step of mitochondrial fatty acid oxidation [284]. 
Inhibition of hypothalamic CPT1A has been shown to decrease feed intake and glucose 
production in rats [285]. Thus it will be interesting to investigate its expression in other tissues 
including the hypothalamus. In addition, GO-BP term analysis showed that genes involved in 
lipid metabolism-related processes were enriched in module C1-lightcyan. Because low RFI pigs 
have less body fat and are leaner [147] and that deposition of energy as fat costs more energy 
than as protein[286], genes in this module might be relevant to differences in RFI. 
Potential predictive biomarkers for RFI 
DEGs whose expression levels are associated with the phenotype of interest, as well as 
genes whose expression profiles are similar to the eigengenes of co-expression modules 
associated with the phenotype are often considered as good candidate biomarkers for the 
phenotype. Based on our association tests, the best candidate biomarkers included LRP6, 
ENSSSCG00000024900, ENSSSCG00000008771, PDL1 and ENSSSCG00000020945. LRP6 
and ENSSSCG00000024900 were ones of the DEGs between the two RFI groups and ones of 
the highly connected, eigengene-like genes in modules C1-lightcyan and C2-darkturqoise, 
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respectively (Table B.9). Notably, we only found a very few genes whose expression levels were 
significantly associated with RFI phenotype, which might be because the estimated RFI values 
were residuals which represented both random errors and true feed efficiency and thus were not 
accurate, or because there were not many genes whose post-weaning expression levels in blood 
were well associated with the RFI values measured during the grow-finish phase in blood, or 
because there may be little or no relationship of blood gene expression in blood and RFI 
phenotype regardless of age. 
Conclusions 
As far as we know, this is the first study to explore transcriptomic differences in blood 
between pig lines with divergent RFI by RNA-seq. We found that the blood transcriptome was 
clearly different between the low and high RFI groups, although only a small number of genes 
showed large fold changes of expression between the two groups. The two RFI groups may be 
different in mitochondrial and proteasomal activities, small molecule biosynthetic process, and 
signal transduction. These blood transcriptomic differences may be related to the difference in 
feed efficiency between these two groups, although the observed relationships of post-weaning 
blood gene expression with RFI phenotype measured during the grow-finish phase were not 
strong. The top candidate biomarkers for predicting RFI included LRP6, 
ENSSSCG00000024900, ENSSSCG00000008771, PDL1 and ENSSSCG00000020945. 
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Table 3.1. The number of differentially expressed genes identified at different q-value and 
fold change cutoffs. 
 
Cutoff of q-value 
Cutoff of fold change 
│log2(FC)│ > 0 
a
 │log2(FC)│ ≥ log2 1.5 │log2(FC)│ ≥ 1 
q ≤ 0.05 454 140 50 
q ≤ 0.1 1185 266 80 
q ≤ 0.15 1972 344 93 
a
FC, fold change calculated as the ratio of mean gene expression in the low RFI group to mean gene expression in 
the high RFI group after accounting for the other relevant variables (see Methods). 
 
 1 
Table 3.2. GO terms overrepresented among differentially expressed genes. 
GO terms overrepresented among DEGs with higher expression in the low RFI group than in the high RFI group 
ID Domain Term Annotated 
a
 Significant 
b
 Expected 
c
 p-value 
GO:0044283 BP small molecule biosynthetic process 170 33 13.77 1.70E-06 
GO:0046394 BP carboxylic acid biosynthetic process 113 22 9.15 8.70E-05 
GO:0016053 BP organic acid biosynthetic process 113 22 9.15 8.70E-05 
GO:0006694 BP steroid biosynthetic process 44 12 3.56 0.00014 
GO:0046165 BP alcohol biosynthetic process 48 12 3.89 0.00033 
GO:0002474 BP 
antigen processing and presentation of peptide antigen 
via MHC class I 
20 7 1.62 0.00067 
GO:1901617 BP organic hydroxy compound biosynthetic process 60 13 4.86 0.00084 
GO:0004298 MF threonine-type endopeptidase activity 15 9 1.18 3.50E-07 
GO:0005839 CC proteasome core complex 15 9 1.23 5.10E-07 
GO:0000502 CC proteasome complex 39 14 3.2 1.20E-06 
GO:0005739 CC Mitochondrion 955 116 78.35 4.60E-06 
GO:0005689 CC U12-type spliceosomal complex 17 8 1.39 2.50E-05 
GO:0043227 CC membrane-bounded organelle 5518 491 452.73 0.00039 
GO:0032991 CC macromolecular complex 2416 237 198.23 0.00041 
       
       
       
       
       
1
0
0
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(Table 3.2 Continued) 
GO terms overrepresented among DEGs with lower expression in the low RFI group than in the high RFI group 
ID Domain Term Annotated
a
 Significant
b
 Expected
c
 p-value 
GO:0065007 BP biological regulation 4577 285 237.14 1.10E-06 
GO:0050789 BP regulation of biological process 4395 272 227.71 7.00E-06 
GO:0007165 BP signal transduction 2117 149 109.68 9.70E-06 
GO:0030282 BP bone mineralization 45 11 2.33 1.30E-05 
GO:0023052 BP Signaling 2276 156 117.92 2.50E-05 
GO:0044700 BP single organism signaling 2276 156 117.92 2.50E-05 
GO:0007166 BP cell surface receptor signaling pathway 979 79 50.72 2.90E-05 
GO:0031214 BP biomineral tissue development 49 11 2.54 3.10E-05 
GO:0050794 BP regulation of cellular process 4126 254 213.77 4.40E-05 
GO:0007154 BP cell communication 2328 157 120.61 5.70E-05 
GO:0042325 BP regulation of phosphorylation 525 48 27.2 7.10E-05 
GO:0016310 BP Phosphorylation 1024 80 53.05 8.10E-05 
GO:0044763 BP single-organism cellular process 5419 315 280.76 0.00021 
GO:0018212 BP peptidyl-tyrosine modification 125 17 6.48 0.00023 
GO:0001932 BP regulation of protein phosphorylation 407 38 21.09 0.00027 
GO:0006468 BP protein phosphorylation 774 62 40.1 0.0003 
GO:0051716 BP cellular response to stimulus 2670 171 138.33 0.00041 
       
1
0
1
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(Table 3.2 Continued) 
ID Domain Term Annotated
a
 Significant
b
 Expected
c
 p-value 
GO:0060070 BP canonical Wnt signaling pathway 86 13 4.46 0.00044 
GO:0016477 BP cell migration 405 37 20.98 0.0005 
GO:0051239 BP regulation of multicellular organismal process 841 65 43.57 0.00056 
GO:0018108 BP peptidyl-tyrosine phosphorylation 123 16 6.37 0.00058 
GO:2000026 BP regulation of multicellular organismal development 526 44 27.25 0.00099 
GO:0040011 BP Locomotion 511 43 26.48 0.00101 
GO:0060089 MF molecular transducer activity 409 41 21.42 4.30E-05 
GO:0044459 CC plasma membrane part 537 45 27.48 0.00063 
aNumber of genes detected in the blood and associated with a given GO term. 
bNumber of DEGs associated with a given GO term. 
cExpected number of DEGs associated with a given GO term. 
 
1
0
2
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Table 3.3. Summary of WGCNA modules differentially expressed between the low and 
high RFI groups. 
 
ID Size Reg. coef.
a
 p-value Adjusted R
2 
 
C1_lightcyan 198 -0.33 4.7E-13 0.83 
C2_darkturquoise 142 0.30 2.9E-09 0.70 
C3_skyblue3 89 0.29 2.7E-08 0.65 
C4_black 786 -0.28 3.9E-07 0.58 
a
Reg. coef., regression coefficient estimated by regressing the expression level of the eigengene of a module on 
RFI groups, with the high RFI group as the reference. 
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Figure 3.1. Distribution of RFI values and sample selection for RNA-seq and RT-qPCR 
assays. Post-weaning blood samples of 16 pigs (8 per diet) with extremely low RFI from 
gilts of the low RFI line (LRFI) and 16 pigs (8 per diet) with extremely high RFI from gilts 
of the high RFI line (HRFI) fed the high-fiber, low-energy diet (HFD) or the low-fiber, high-
energy diet (LFD) were selected for RNA-seq. One sample in the LRFI-LFD group was 
excluded from RNA sequencing because of low quality RNA, leaving a total of 31 samples 
for RNA-seq. The green and red dots represent individuals selected for RNA-seq.  Twelve 
samples from each line by diet combination were selected for RT-qPCR validation of DEGs 
such that the corresponding RFI phenotypes were representative. The red and blue dots 
represent the samples selected for RT-qPCR assays. The 24 novel blood samples were 
selected such that the RFI values of the corresponding animals were roughly evenly 
distributed across the ranges of RFI not covered by the RFI phenotypes of the 24 animals 
originally selected for RNA-seq. The distribution of RFI values of barrows from each line by 
diet combination is also shown for reference. 
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Figure 3.2. Differentially expressed genes and transcriptomic differences between the 
low and high RFI groups. (A) Heatmap showing 454 DEGs (q ≤ 0.05) between low and 
high RFI groups identified by RNA-seq. Sample names are designated as RFI line followed 
by the pig identifier. LRFI, low RFI line; HRFI, high RFI line. Animals with sample names 
in blue were fed the high-fiber, low-energy diet (LFD), while animals with sample names in 
black were fed the low-fiber, high-energy diet (HFD). The relative orders of genes and 
samples were determined by two-way hierarchical clustering based on the adjusted 
transformed gene expression of the 454 DEGs. The adjusted gene expression was gene-wise 
106 
standardized to get the z-score as displayed. (B) Volcano plot showing the magnitude and 
significance of differential expression of genes between low and high RFI groups. Black 
vertical dash lines correspond to │log2 (fold change)│ = 1, while red horizontal dash line 
correspond to q-value of 0.15. FC, fold change calculated as the ratio of mean gene 
expression in the low RFI group to mean gene expression in the high RFI group after 
accounting for the other relevant variables. (C) Hierarchical clustering showing relationship 
of the 31 RNA-seq samples. The samples were hierarchically clustered by using Ward 
method with 1 minus Spearman correlation as distance. The Spearman correlations between 
pairs of samples were calculated based on the adjusted transformed expression of the 12,280 
genes. 
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Figure 3.3. Validation of DEGs by RT-qPCR. 24 of the 37 selected DEGs between low 
and high RFI groups were confirmed by RT-qPCR when using the 48 samples, 24 of which 
were used for RNA-seq  and another 24 of which were novel, as shown in this figure (q ≤ 
0.15)22 of the 37 selected DEGs were confirmed by RT-qPCR when using the 24 samples 
that were used for RNA-seq (q ≤ 0.15)but only 9 of the 37 selected DEGs were validated by 
RT-qPCR when using the 24 novel samples (q ≤ 0.15) (Table B.7). For comparison, the log2 
(fold change) of these genes determined by RNA-seq were also displayed. Genes were 
ordered based on their log2 (fold change) as determined by RT-qPCR for display. Error bars 
for RT-qPCR assays show the standard errors of mean log2 (fold change). DEGs not 
confirmed by RT-qPCR are labeled in red. Genes without corresponding human orthologs 
are labeled with the last 5 digits of their Ensembl gene IDs, with common prefix 
“ENSSSCG000000” omitted for simplicity. For example, the ID for “29500” should be 
ENSSSCG00000029500. 
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Figure 3.4. Co-expression modules differentially expressed between the low and high 
RFI group. (A) Distribution of eigengenes of modules highly associated with RFI groups. 
(B) Venn diagram showing overlapping between module genes and DEGs. 
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CHAPTER 4. A HIGH-QUALITY ANNOTATED TRANSCRIPTOME OF SWINE 
PERIPHERAL BLOOD 
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Abstract 
Background: High throughput gene expression profiling assays of peripheral blood 
are widely used in biomedicine, as well as in animal genetics and physiology research. 
Accurate, comprehensive, and precise interpretation of such high throughput assays relies on 
well-characterized reference genomes and/or transcriptomes. However, neither the reference 
genome nor the peripheral blood transcriptome of the pig have been sufficiently assembled 
and annotated to support such profiling assays in this emerging biomedical model organism. 
We aimed to assemble published and novel RNA-seq data to provide a comprehensive, well-
annotated blood transcriptome for pigs by integrating a de novo assembly with a genome-
guided assembly. 
Results: A de novo and a genome-guided transcriptome of porcine whole peripheral 
blood was assembled with ~162 million pairs of paired-end and ~183 million single-end, 
trimmed and normalized Illumina RNA-seq reads (~6 billion initial reads from 146 RNA-seq 
libraries) from five independent studies by using the Trinity and Cufflinks software, 
respectively. We then removed putative transcripts (PTs) of low confidence from both 
assemblies and merged the remaining PTs into an integrated transcriptome consisting of 
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132,928 PTs, with 126,225 (~95%) PTs from the de novo assembly and more than 91% of 
PTs spliced. In the integrated transcriptome, ~90% and 63% of PTs had significant sequence 
similarity to sequences in the NCBI NT and NR databases, respectively; 68,754 (~52%) PTs 
were annotated with 15,965 unique GO terms; and 7,618 PTs annotated with Enzyme 
Commission codes were assigned to 134 KEGG pathways. Full exon-intron junctions of 
17,528 PTs were validated by PacBio IsoSeq full-length cDNA reads from 3 other porcine 
tissues, NCBI pig RefSeq mRNAs and transcripts from Ensembl Sscrofa10.2 annotation. 
Completeness of the 5‟ termini of 37,569 PTs was validated by public cap analysis of gene 
expression (CAGE) data. By comparison to the Ensembl transcripts, we found that (1) the 
deduced precursors of 54,402 PTs shared at least one intron or exon with those of 18,437 
Ensembl transcripts; (2) 12,262 PTs had both longer 5‟ and 3‟ termini than their maximally 
overlapping Ensembl transcripts; and (3) 41,838 spliced PTs were totally missing from the 
Sscrofa10.2 annotation. Similar results were obtained when the PTs were compared to the 
pig NCBI RefSeq mRNA collection. 
Conclusions: We built, validated and annotated a comprehensive porcine blood 
transcriptome with significant improvement over the annotation of Ensembl Sscrofa10.2 and 
the pig NCBI RefSeq mRNAs, and laid a foundation for blood-based high throughput 
transcriptomic assays in pigs and for advancing annotation of the pig genome. 
 
Keywords: Sus scrofa, peripheral blood, de novo transcriptome assembly, genome-guided 
transcriptome assembly 
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Background 
In higher animals, peripheral blood is a complex and informative tissue type, 
consisting of acellular plasma and multiple types of cells at various differentiation states 
[177, 287]. Peripheral blood cells can be roughly classified into anucleated red blood cells 
(RBCs) and platelets, and nucleated white blood cells (WBCs), with WBCs most 
transcriptionally active [287-293]. The WBCs can be further divided into neutrophils, 
eosinophils, basophils, B lymphocytes, T lymphocytes and monocytes. Each cell type is 
composed of continuously differentiating subtypes, leading to variability in RNA content of 
the overall peripheral blood transcriptome. Peripheral blood is also a highly dynamic tissue 
type with a high rate of cell turnover, resulting in high diversity of RNA content over time 
[294]. In addition, peripheral blood interacts with every organ and tissue in the body, and 
consequently presents gene expression profiles that can reflect the physiopathological status, 
behaviors, growth stage and lifestyle of subjects [177, 178, 180, 181, 295-298]. Combined 
with easy and minimally invasive accessibility, the reflective relationship to body status 
makes peripheral blood a highly desirable tissue type for disease prediction, diagnosis, 
monitoring, prognosis, and biomarker development [177, 299]. 
Due to the high similarity in anatomy, genetics and physiology of pigs and humans, 
pigs have been recognized as a more appropriate animal model for many human diseases 
than rodents [213, 300, 301]. However, the widely used swine reference genome Sscrofa10.2 
(SSC10.2 for short) [301] is neither well-assembled nor well-annotated [13]. For example, 
only 43% of the 25,510 transcripts of the 21,630 coding genes have both a 5‟ and 3‟ UTRs 
defined. On average, less than 1.2 isoforms per protein-coding gene and only 3,124 non-
coding genes have been identified in SSC10.2. More recently, Warr reported that more than 
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33% of SSC10.2 is not correctly assembled or is otherwise unreliable [15]. In addition, there 
are many gaps and thousands of fragmented, unplaced contigs in the assembly, with many 
known genes missing from the reference genome [15, 16]. Furthermore, the approximate 
number of genes with detectable expression in porcine peripheral blood is still unknown. The 
lack of a detailed catalog and annotation of the pig genome and transcriptome hinders 
annotation-based high throughput studies [302, 303]. Fortunately, two independent 
assemblies of the pig genome have been recently initiated using a PacBio long read-based 
approach [15, 17] and are currently being annotated. 
Public porcine RNA-seq data have rapidly accumulated over the past few years and 
are continuously being produced in labs around the world. These data are valuable resources 
for evidence-based genome annotation, due to their broad coverage, great depth and high 
resolution [304-306]. The unassembled RNA-seq reads can be used for genome annotation 
by mapping them directly to the reference genome, but an assembled transcriptome is more 
useful and less susceptible to mapping artifacts. In addition, RNA-seq read-based 
transcriptome assembly can reduce the amount of information to be tracked, help identify 
transcript boundaries and splice isoforms, and facilitate the discovery of novel transcripts 
whose genes are not included in the reference genome [306]. Currently, there are two popular 
strategies for transcriptome assembly: de novo assembly and genome-guided assembly, each 
with its own advantages and disadvantages [105, 307]. Integration of de novo assembly and 
genome-guided assembly, also known as a hybrid transcriptome assembly method, was 
proposed as an effective way to reconstruct comprehensive transcriptomes [105, 113, 308]. 
We here report the build and annotation of a comprehensive blood transcriptome by 
using blood RNA-seq data from several independent studies using pigs of different genetic 
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backgrounds and physiopathological conditions via the hybrid transcriptome assembly 
strategy. The resulting integrated transcriptome was assessed, validated and extensively 
annotated with different sources of knowledge and evidence. This integrated transcriptome 
lays a reliable foundation for future blood-based high throughput gene expression studies of 
pig diseases and physiology, and will also contribute towards annotation of the emerging 
improved porcine reference genome assemblies. 
Methods 
RNA-seq data collection 
Publicly available porcine peripheral blood Illumina RNA-seq data were downloaded 
from the European Nucleotide Archive (ENA) and Ensembl FTP sites, while RNA-seq data 
from LPS- or saline-treated pigs were from an unpublished study in our lab (H. Liu, K. Feye 
et al., unpublished). A detailed description of these RNA-seq data is available in Table 4.1. 
In summary, over 6 billion Illumina RNA-seq reads from146 independent libraries made of 
blood RNA samples from 76 pigs of different breeds, age, treatments and health status were 
used for the blood transcriptome assembly [309-312]. 
Pig reference genomes 
The sequence and annotation file of the pig reference genome, SSC10.2, were 
downloaded from the Ensembl FTP site [313]. Another pig reference genome, 
USMARCv1.0, was recently assembled using 65  coverage of PacBio long reads from the 
DNA of lung tissue of a cross-bred pig and is on the order of 100  more contiguous than 
SSC10.2 (T. Smith et al. unpublished). 
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Preprocessing and normalizing Illumina RNA-seq reads 
Quality of the raw RNA-seq data was first assessed with FASTQC (v0.10.1) [314] for 
each library. Then, the Illumina sequencing adaptor sequences and low quality bases were 
trimmed from the raw reads by using the Trimmomatic software (v0.32) [250] in a sliding 
window mode with options: ILLUMINACLIP:adapters.fa:2:30:10:1:true LEADING:3 
TRAILING:3  SLIDINGWINDOW:4:20 LEADING:3 TRAILING:3 MINLEN:25, such that the 
average base quality score (Phred +33) was at least 20 for every 4-base sliding window, the 
quality scores of leading and trailing bases were at least 3 and the minimum length of kept 
reads was 25 bases.  Because large amounts of reads were available for the transcriptome 
assembly, to reduce cost and runtime of de novo assembly, the trimmed reads were in silico 
normalized by using a k-mer abundance-based utility, insilico_read_normalization.pl, in the 
Trinity package (v2.1.1) [107, 315]. The paired-end and single-end reads were normalized 
separately with the following explicit option settings: --max_cov 100 --pairs_together --
PARALLEL_STATS for paired-end reads and --max_cov 100 for single-end reads. 
Blood transcriptome assembly 
The normalized paired-end and single-end reads from peripheral blood were 
combined and assembled by using the de novo Trinity software (v2.1.1), with an explicit 
option setting --min_kmer_cov 2, as described in [107]. By default, only assembled products 
longer than 200 bases were output. To supplement the de novo transcriptome, a genome-
guided transcriptome assembly was also performed as follows. First, the normalized paired-
end and single-end reads were separately aligned to the USMARCv1.0 reference genome by 
using the STAR (v2.4.1a) software [228] with Cufflinks-compatible options. The alignment 
output was subsequently sorted and merged after format conversion. The resulting BAM file 
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was used for genome-guided transcriptome assembly independent of genome annotation by 
using the Cufflinks software (v2.2.1) with the following option settings: -F 0.10  -u  -j 0.25 -I 
1000000 --min-intron-length 20  --overlap-radius 10 [258]. Assembled products of 200 bases 
or shorter were discarded before further analysis. Hereafter, the assembled products from 
both the de novo and genome-guided assemblies were called putative transcripts (PTs). 
Quality assessment, filtering, and annotation of the transcriptome assemblies 
The normalized RNA-seq reads were mapped back to the de novo transcriptome 
assembly and the mapping results were assessed using Trinity utilities, as described in [107, 
315]. The number of full-length PTs in the de novo transcriptome was estimated based on the 
percentage of coverage of manually curated protein sequences and porcine RefSeq mRNA 
sequences in the Swiss-Prot and the NCBI nucleotide databases by PTs as determined by 
using BLASTX and BLASTN software (v2.5.0) with E-value cutoffs of 10
-10
 and 10
-20
, 
respectively [107]. 
The coding potential of each PT was predicted by using the PLEK software (v1.2) 
based on the default classification model for human transcripts [316]. The PLEK software is 
an efficient long noncoding RNA (lncRNAs) predicting tool, which can distinguish lncRNAs 
from mRNAs based on an improved k-mer scheme and a support vector machine (SVM) 
algorithm, independent of genomic sequences and annotation [316]. PTs with coding 
potentials less than zero were considered lncRNAs, with the remaining PTs considered as 
protein-coding PTs. The coverage per base (CPB) was calculated by using the Bedtools 
genomecov utility (v2.26.0) [317] based on the normalized reads mapped to the 
USMARCv1.0 genome assembly as above. 
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The genomic origins of the PTs in the de novo assembly were determined by mapping 
them to the two reference genomes, SSC10.2 and USMARCv1.0, using the GMAP software 
(version 2016-09-23) [90] with the following option settings:  -n 0 -f samse. Spliced versus 
unspliced transcripts were determined based on the alignment results. A uniquely mapping 
PT was considered spliced if there was at least one “N” in its CIGAR column of the SAM 
file; a translocation mapping transcript was considered spliced if it was mapped to two 
locations on two different scaffolds or more than 2 Mb apart on the same scaffold, and there 
was at least one “N” in its CIGAR column of the SAM file for either mapped part. The splice 
status of transcripts that mapped to multiple locations or that were not mappable was not 
determined. The splice status of PTs in the genome-guided assembly was determined based 
on the number of exons of each PT in the GTF file output by Cufflinks. 
PTs not derived from the pig genome were identified for removal from the de novo 
assembly by comparing their sequences to the NCBI NT database through running DC-
megaBLAST. Only alignments with E-value <10
-20
 were considered significant to insure that 
true pig transcripts were not inadvertently removed. A PT was considered “contaminant” if 
its top match was a non-vertebrate sequence, unless it had a better scored alignment with the 
pig reference genomes than to the non-vertebrate sequence. The PTs in the de novo assembly 
were also aligned to sequences in the NCBI NR database with BLASTX, using the following 
explicit option settings: -outfmt 5 -evalue 1e-6 -word_size 5 -show_gis -num_alignments 10 -
task blastx-fast -max_hsps 20, which provided protein-level annotation of transcripts in the 
de novo assembly. Spliced PTs and unspliced non-intronic PTs in the genome-guided 
assembly were aligned with sequences in the NT and NR databases by using DC-
megaBLAST and BLASTX with the same option settings as above. 
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One possible type of “transcriptional noise” is unspliced PTs that overlap intron 
intervals, either with or without exonic sequence (collectively called unspliced intronic PTs).  
339,342 intron intervals were determined from (i) the splicing junctions of the spliced, 
uniquely or translocation mapping PTs of the de novo transcriptome, (ii) the splicing 
junctions of spliced PTs of the genome-guided assembly, and (iii) splice junctions supported 
by at least 3 uniquely mapped, spliced RNA-seq reads. The two assemblies were filtered to 
remove potential “contaminants” and “transcriptional noise” in the following order: (i) PTs 
with top megaBLAST hits on sequences derived from mitochondrial genomes or 
transcriptomes were excluded because the pig mitochondrial genome has already been well-
annotated [318]; (ii) unspliced intronic PTs were discarded; (iii) PTs from the de novo 
assembly with top megaBLAST hits on sequences from non-vertebrates in the NCBI NT 
database and without better scored alignments against the two pig reference genomes were 
filtered out; (iv) unspliced non-intronic PTs within genomic regions for which the maximal 
CPB was below 50  were removed; (v) multi-mapping and non-mapping PTs from the de 
novo assembly without significant hits or with non-RNA sequences as top megaBLAST hits 
in the NT database were excluded. 
Comparing and integrating the de novo and genome-guided transcriptome assemblies 
Unspliced non-intronic PTs and spliced PTs in the genome-guided transcriptome that 
remained after removing “transcriptional noise” were compared to their counterparts in the 
de novo assembly. For unspliced non-intronic PTs, the comparison was simply done by using 
the Bedtools intersect utility (v2.26.0) [317] to look for overlapping PTs from both 
assemblies without considering strandedness, which was difficult to determine. On the other 
hand, because the strandedness of PTs assembled by de novo Trinity could be wrong, the 
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sense strand of the spliced transcripts was first identified based on the splice site consensus 
sequences, as determined by aligning them to the USMARCv1.0 assembly using GMAP 
(version 2016-09-23) [90]. Then, the Bedtools intersect utility (v2.26.0) [317] and custom 
Perl scripts were used to find intersections between the spliced PTs from the de novo 
assembly and from the genome-guided assembly from the same sense strands. Spliced PTs 
from the de novo assembly that did not overlap any spliced PT from the genome-guided 
assembly were considered unique to the de novo assembly, and vice versa. Transcripts from 
the same sense strand that shared at least one intron or exon were considered to arise from 
the same gene. 
The integrated transcriptome included (i) all spliced PTs from the de novo assembly; 
(ii) spliced PTs that were unique to the genome-guided assembly; (iii) unspliced non-intronic 
PTs from the filtered de novo assembly; (iv) unspliced non-intronic PTs from the filtered 
genome-guided assembly that did not overlap counterparts in the de novo assembly; and (v) 
multi-mapping or non-mapping PTs from the de novo assembly that survived the filtering 
processes. The BLASTX results were then used to annotate these transcripts with GO terms, 
Enzyme Commission (EC) codes, and KEGG pathways, by using BLAST2GO with default 
settings [121, 319]. 
The integrated porcine peripheral blood transcriptome assembly has been deposited at 
DDBJ/EMBL/GenBank under the accession GFLN00000000. The version described in this 
paper is the first version, GFLN01000000. 
Similarity analysis of porcine blood transcripts to their homologous transcripts in 
humans 
Human transcripts were downloaded from the GENCODE database (v25) [320]. 
Reciprocal DC-megaBLAST was conducted to find the putative homologous transcripts of 
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pigs in humans [321]. Only the best reciprocal BLAST hits with E-value <10
-20
 were 
considered significantly similar. 
Validation of the PTs with PacBio IsoSeq full-length cDNA reads 
IsoSeq full-length cDNA sequences are assembly-free, so they can be considered as 
gold standards to validate the PTs from a transcriptome assembly, especially when the 
genome annotation is poor. Transcriptomes of three tissues (liver, thymus and spleen) of a 
single cross-bred pig, from which the USMARCv1.0 pig reference genome was assembled, 
were sequenced by using the IsoSeq technology (H. Liu and T. Smith et al., unpublished). 
The resulting full-length, non-chimeric reads were error-corrected with preprocessed 
Illumina RNA-seq reads from the same RNA samples as those that were used for the IsoSeq. 
A detailed description of IsoSeq and error-correction processes is available in Additional file 
1: Supplementary Methods. Error-corrected IsoSeq full-length cDNA reads and stranded 
RNA-seq data for porcine spleen, thymus and liver are available from the NCBI SRA under 
accession numbers: SRX2380861 and SRX2353179;  SRX2342762 and SRX2353173; and 
SRX2342761 and SRX2353180,  respectively. The 448,771 error-corrected IsoSeq full-
length cDNA reads were first aligned to the USMARCv1.0 reference genome using GMAP 
(version 2016-09-23) [90] and the splice status and the sense strand of the reads were 
determined as above. To exclude potential genomic DNA contamination from the data, only 
the spliced, uniquely mapping transcripts from both the integrated transcriptome and IsoSeq 
reads were compared by using Bedtools (v2.26.0) [317] and custom Perl scripts, after 
determining the correct sense strands. Transcripts that shared the same exon-intron structures 
were considered identical. A PT was considered to be fully validated if we found that it had 
the same exon-intron junctions as at least one IsoSeq full-length cDNA read. 
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Assessing completeness of the 5’ termini of the PTs 
Published CAGE data from pig macrophages [13] were reanalyzed to estimate the 
proportion of PTs that have complete 5‟ ends. Briefly, adapter sequences and low quality 
bases were removed from the raw reads using Trimmomatic (v0.32) [250] with following 
settings: ILLUMINACLIP:adapters.fa:2:30:10:1:true LEADING:3 TRAILING:3 
SLIDINGWINDOW:4:10 LEADING:3 TRAILING:3 MINLEN:20. Then, the trimmed reads 
were mapped to the USMARCv1.0 reference genome using STAR (v2.4.1a) [228]. The 
R/Bioconductor package CAGEr (v1.14.0) [322] was used to obtain transcription starting site 
(TSS) clusters, as described in its documentation. Sequences of 50 bases that flanked the 
dominant TSS of each TSS cluster were assumed to be proximal promoters. In addition, the 
pig genomic regions that matched the mouse and human promoters were retrieved from 
SSC10.2 based on the published information [13] and realigned to the USMARCv1.0 
assembly by using GMAP (version 2016-09-23) [90]. All mapped human and mouse 
promoters plus the pig promoters identified in macrophages by CAGE were used to evaluate 
completeness of the 5‟ termini of the spliced, uniquely mapping blood PTs from the 
integrated transcriptome assembly by using the Bedtools closest utility (v2.26.0) [317] in 
consideration of strandedness of PTs and orientations of promoters. A PT was assumed to 
have a complete 5‟ terminus, if a promoter overlapped the first exon or the 500 bp of the 5‟ 
extremity of the first exon when the first exon was longer than 500 bp. 
Comparison of PTs in the integrated transcriptome assembly with the annotated pig 
transcripts in SSC10.2 and pig RefSeq mRNA sequences 
30,585 transcripts annotated in the Ensembl SSC10.2 (Ensembl transcripts) and 
47,439 RefSeq mRNA sequences curated by the NCBI were separately aligned to the 
USMARCv1.0 assembly using GMAP (version 2016-09-23) [90]. Only uniquely mapping 
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spliced PTs from the integrated transcriptome assembly were compared to their counterparts 
from the Ensembl transcripts on the same sense strands by using Bedtools (v2.26.0) [317]. 
The spliced PTs that did not overlap any spliced Ensembl transcripts were considered as 
novel transcripts. PTs that shared at least one intron or exon with the Ensembl transcripts 
from the same sense strand were considered to originate from the same gene. Similarly, a 
comparison was conducted between uniquely mapping spliced PTs and pig RefSeq mRNAs. 
Gene loci for PTs were named after the HGNC gene symbols or Ensembl gene IDs of the 
transcripts of SSC10.2 and pig RefSeq mRNAs if they were considered to originate from the 
same gene loci. 
Tissue or cell type origin of PTs in the integrated transcriptome 
Lists of human genes specifically or preferentially expressed in given tissue or cell 
types were downloaded from the CTen database [323]. By assuming porcine and human 
orthologous genes have preferential expression in same tissues or cell types, the cell or tissue 
origins of the PTs were inferred. 
Results 
A de novo RNA-seq read-based porcine blood transcriptome 
Our goal was to provide a transcriptome resource to facilitate blood-based, high-
throughput gene expression studies and to simultaneously improve annotation of the pig 
genome.  To this end, we first assembled a de novo porcine blood transcriptome that 
incorporates a broad range of RNA-seq data from 146 independent libraries from 5 studies of 
blood gene expression in 76 pigs of varied genetic backgrounds and physiological status 
(Table 4.1). Raw reads composed of 2.14 billion pairs of paired-end and 1.77 billion single-
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end reads were trimmed to remove adaptor sequences and low quality bases. Table C.1 
shows the effect of trimming on each library. The trimmed reads, consisting of 1.97 billion 
pairs of paired-end and 1.71 billion single-end reads, were further digitally normalized to 
reduce the cost and runtime of transcriptome assembly, which resulted in 162.29 million 
pairs of paired-end and 183.17 million single-end reads. The length distribution of the 
normalized and trimmed reads is shown in Figure C.1, with most reads of 49, 51 or 100 bases 
in length. Subsequently, the normalized reads were assembled into putative transcripts (PTs), 
by using de novo Trinity [315] (Figure C.2). The raw de novo transcriptome assembly 
included 490,209 PTs that were longer than 200 bases, which potentially originated from 
397,560 putative genes (PGs). Figure C.3A shows the length distribution of these PTs; the 
longest PT was of 22,969 bases. PLEK [316] prediction indicated that the assembly 
potentially included 56,973 protein-coding PTs and 433,236 PTs without open reading 
frames (ORFs) that exceeded the minimum length requirements. 
Assessment, annotation, and filtering the de novo blood transcriptome assembly 
The representation of the entire transcriptome predicted by RNA-seq reads in the de 
novo assembly was assessed by mapping all normalized RNA-seq reads to the de novo 
assembly. The results showed that 66.2% of normalized reads could be mapped back to the 
de novo assembly, demonstrating that the de novo assembly is relatively comprehensive. 
A de novo transcriptome assembly usually results in many fragmented transcripts 
[107, 315]. Thus, the de novo transcriptome were assessed from different aspects as 
summarized in Table 4.2. To assess the extent to which the assembled PTs were full-length, 
we first aligned the PTs to the protein sequences in the Swiss-Prot database with BLASTX. 
Based on the best high-scoring segment pairs (HSPs) of the top hits, the de novo assembly 
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included 22,831 PTs that covered more than 80% of the full length of 10,097 protein 
sequences in the Swiss-Prot database. If the overall percentage of coverage of a protein 
sequence by its best matching PT was calculated based on all HSPs between them, then we 
obtained 35,541 PTs that covered 11,645 protein sequences in the database by more than 
80% of their length (Figure C.3B). We also aligned all the PTs to the pig RefSeq mRNA 
using megaBLAST, resulting in 16,010 PTs that covered more than 80% of the full length of 
9,228 pig RefSeq mRNAs (7,760 genes), which is 19.5% of the 47,439 RefSeq mRNA 
entries (24,122 genes) (Figure C.3C). 
Whether the PTs were derived from the pig genome and whether they were 
“transcriptional noise” was initially determined by mapping them to the two available pig 
reference genomes, SSC10.2 and USMARCv1.0 (Figure C.2). This analysis indicated that 
94.2% and 99.4% of the PTs could be mapped to SSC10.2 and USMARCv1.0, respectively, 
suggesting that nearly all of the PTs were of porcine origin and the USMARCv1.0 assembly 
had better representation of the pig genome. This result led us to rely on the USMARCv1.0 
reference genome whenever a pig reference genome was used. As summarized in Figure C.2, 
mapping the PTs on the USMARCv1.0 reference genome identified 115,862 spliced and 
359,012 unspliced PTs among the uniquely or translocation mapping PTs. Among the 
unspliced PTs, 331,774 (92.4%) PTs overlapped intron intervals, most of which were likely 
intronic sequences that were detected by RNA-seq. We also identified 19,184 unspliced non-
intronic PTs which were mapped to genomic regions for which the maximal coverage per 
base (CPB) by the normalized RNA-seq reads was below 50×. We designated these 
unspliced intronic PTs and unspliced non-intronic PTs mapped to genomic regions of relative 
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low CPB collectively as “transcriptional noise”, which were to be removed from the de novo 
assembly. 
An additional screen to identify non-porcine contaminants among the PTs was 
performed by searching for sequences with significant similarity to the PTs in the NCBI NT 
database using DC-megaBLAST. We found 340,286 (69.42%) PTs with significant top DC-
megaBLAST hits on sequences from the NT database Figure C.2). There were also 2,567 
(0.5%) PTs that had top BLAST hits on sequences from non-vertebrate species, including 
bacteria, plants, fungi, and viruses, and no better alignment against the pig reference 
genomes. These 2,567 PTs very likely did not belong to the blood transcriptome. Thus they 
were to be removed from the de novo assembly. The species distribution of the top BLAST 
hits on sequences in the NT database is shown in Figure C.3D. The distributions of 
percentage of identity, percentage of query coverage, bit score and E-value of top BLAST 
hits are shown in Figure C.3E. The biotypes of the top hits were mRNA/cDNA, ncRNA, 
misc_RNA, genomic DNA and mitochondrial DNA for 114937, 5736, 10970, 206024 and 52 
PTs, respectively (Figure C.2). 
The PTs were also aligned to protein sequences curated in the NCBI NR database 
using BLASTX to get protein-level annotation. This analysis identified 107,237 (21.9%) PTs 
whose putative proteins had significant similarity to sequences in the NR database, with E-
values ≤ 10-6. The species distribution of the top BLASTX hits in the NR database is shown 
in Figure C.3F; over half were similar to pig protein sequences. The distributions of 
percentage of identity, percentage of query coverage, bit score and E-value of top BLASTX 
hits are shown in Figure C.3G, and show that, on average, 38% of the length of PTs was 
covered by the cognate proteins in the database and the percentage of identity was over 95%. 
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The de novo transcriptome assembly was filtered to remove mitochondrial genome-
derived sequences, “contaminants” and “transcriptional noise” as described in Materials and 
Methods. The filtered de novo assembly consisted of 126,225 PTs (57,272 PGs) that included 
115,859 spliced, uniquely or translocation mapping PTs; 8,042 unspliced non-intronic PTs; 
and 2,324 multi-mapping or non-mapping PTs with RNA sequences as top BLASTN hits 
(Figure C.2). 
Supplementing the de novo assembly with a genome-guided transcriptome assembly 
To augment the de novo Trinity assembly, a genome-guided assembly of the blood 
transcriptome was also performed using Cufflinks with the USMARCv1.0 reference genome 
as the guide (see schema in Figure C.4). The input was the same normalized RNA-seq reads 
as was used for de novo Trinity assembly, and the output assembly contained 208,210 PTs, of 
which 162,294 (78%) were longer than 200 bases (see Figure C.5A for length distribution). 
The latter included 30,885 spliced and 131,409 unspliced PTs, which included 98,983 
intronic PTs and 32,426 non-intronic PTs (Figure C.4). The genome-guided assembly after 
these steps includes only PTs that were not intronic and longer than 200 bases. 
We validated the resulting genome-guided assembly by searching the NT and NR 
databases for sequences of significant similarity. Of the remaining 63,311 PTs, 53,436 PTs 
(84.4%) had significantly similar sequences in the NT database (Figure C.5B). The biotypes 
of the top hits were mRNA, ncRNA, misc_RNA, genomic DNA and mitochondrial DNA for 
24864, 648, 1897, 256013, and 14 PTs, respectively (Figure C.4). On the other hand, 30,018 
PTs (47.4%) potentially encoded protein sequences that were significantly similar to protein 
sequences in the NR database (Figure C.5C). 
126 
Finally, we removed 30,604 unspliced non-intronic PTs that mapped to genomic 
regions with relatively low CPB by normalized RNA-seq reads, and 14 mitochondrial 
genome-derived PTs from the genome-guided transcriptome assembly. The filtered genome-
guided assembly that was used for comparison to the de novo transcriptome was thus 
composed of 32,702 PTs, including 30,885 spliced and 1,817 unspliced non-intronic PTs 
(Figure C.4). 
Comparing and integrating the de novo and genome-guided porcine blood 
transcriptomes 
The use of different assembly approaches for the de novo and genome-guided 
assemblies resulted in significant differences between the predicted transcripts. Integration of 
the two sets of transcripts was performed as shown in Figure C.6. Of the 115,859 spliced PTs 
in the filtered de novo assembly, 113,286 PTs had identifiable sense strands. Among the 
30,885 spliced PTs in the filtered genome-guided assembly, 24,913 shared at least one intron 
or exon with 60,702 spliced PTs with identifiable sense strands from the filtered de novo 
assembly. Of the spliced PTs in the genome-guided assembly, 45 and 8,967 PTs had exactly 
the same exon-intron structures and same exon-intron junctions as 47 and 10,008 spliced 
PTs, respectively, in the filtered de novo assembly. On the other hand, among the 1,817 
unspliced non-intronic PTs in the filtered genome-guided assembly, 1,086 PTs overlapped 
1,885 of the 8,042 unspliced non-intronic PTs in the filtered de novo assembly. 
The final integrated transcriptome was composed of 132,928 PTs, including (i) 
115,859 spliced PTs from the filtered de novo assembly; (ii) 5,972 spliced PTs unique to the 
filtered genome-guided assembly; (iii) 8,042 unspliced non-intronic PTs from the filtered de 
novo assembly; (iv) 731 unspliced non-intronic PTs from the filtered genome-guided 
assembly, which did not overlap counterparts from the filtered de novo assembly; and (v) 
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2,324 multi-mapping or non-mapping PTs with known RNA sequences as BLAST top hits. 
Based on PLEK [316] prediction, 47,463 PTs (35.7% of total PTs; 40.0% of spliced PTs) 
potentially encode proteins. 
The distributions of the length, number of exons, and number of isoforms of PTs in 
the integrated transcriptome are shown in Figure 4.1A-4.1C. In total, 119,463 (~90%) and 
83,828 (63%) of the PTs shared significant similarities to sequences in the NCBI NT and NR 
databases, respectively. The biotypes of the top megaBLAST hits in the NT database were 
mRNA/cDNA, misc_RNA, ncRNA and genomic DNA for 80825, 6904, 1616 and 30118 
PTs, respectively. The distributions of percentage of identity, percentage of query coverage, 
bit score and E-value of top megaBLAST and BLASTX hits against the NT and NR 
databases are shown in Figure 4.1D and 4.1E, respectively. 
We then compared the PTs in the integrated transcriptome assembly to the human 
transcriptome to determine their similarity at the nucleotide level. The distributions of 
percentage of identity, percentage of query coverage, bit score and E-value of the best 
reciprocal DC-megaBLAST hits of 19,398 porcine blood PTs on 19,398 human transcripts 
are shown in Figure 4.1F. The percentage of identity between porcine blood PTs and their 
best human reciprocal DC-megaBLAST hits was above 65%, with a median of 85%. 
The PTs in the integrated transcriptome were annotated with GO terms, EC codes, 
and KEGG pathways by using BLAST2GO. Schematic summaries of mapping and 
annotation of GO terms by BLAST2GO are shown in Figure C.7. The distribution of PTs 
that were annotated with GO terms and EC codes are shown in Figure 4.2A and 4.2B, 
respectively. In summary, 68,754 PTs were annotated with 15,965 unique GO terms (Table 
C.2) and 7,618 PTs associated with EC codes were further annotated with 134 KEGG 
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pathways (Table C.3). Consistent with the fact that blood was the source of the RNA 
samples, a GO-BP term, GO:0002376 (immune system process) ranked as a
 
level-two BP 
term associated with 7,785 PTs (Figure 4.2A). More specific immune system process-related 
GO terms associated with PTs are displayed in Figure C.8. Among them, immune response, 
innate immune response, and inflammatory response were the top three GO-BP terms that 
were associated with many PTs. The purine metabolism KEGG pathway was associated with 
the largest number of PTs, as shown in Figure C.9. 
In addition, we inferred the tissues or cell types where the PTs were expressed by 
assuming humans and pigs share the same lists of genes highly or specifically expressed in 
given tissues and cell types [323]. Transcripts of porcine genes whose human counterparts 
highly or specifically expressed in whole blood, T cells, B cells, monocytes, myeloid cells, 
NK cells, early erythroid, B lymphoblasts, and many other solid tissues were included in the 
integrated transcriptome assembly (Table C.4). 
Validation of PTs in the integrated blood transcriptome 
Many assembled PTs were validated by mapping the PTs to the reference genomes, 
and similarity searches in the NT, NR and Swiss-Prot databases, and in the NCBI pig RefSeq 
mRNA collection. However, due to the complexity of the pig genome and the short length of 
the RNA-seq reads, RNA-seq read-based transcriptome assembly is error-prone. Common 
errors include chimerism and artificial splice isoforms. Thus, the integrated transcriptome 
was validated from different perspectives (See summary in Table 4.2). To further validate the 
authenticity of the PTs, we compared 111,002 spliced PTs that uniquely mapped to the pig 
reference genome and that had identifiable sense strands in the integrated transcriptome to 
448,771 error-corrected, assembly-free PacBio IsoSeq full-length cDNA reads with 
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determined sense strands from three porcine tissues: the liver, thymus and spleen (H. Liu, T. 
Smith et al, unpublished.). We found that (i) 15,303 PTs and 106,483 IsoSeq sequences had 
the same exon-intron junctions (Figure C.8A); and (ii) 63,845 uniquely mapping, spliced PTs 
shared at least one intron or exon with 390,943 IsoSeq reads (See an example in Figure 
4.3A). 
IsoSeq reads are generally considered as high-quality transcript standards for 
evaluating correctness and completeness of gene structural annotation. However, not all 
IsoSeq transcripts that have switching oligonucleotide and polyA tracts actually have 
complete 5‟ and 3‟ UTRs due to various artifacts of the library preparation process. In 
particular, the switching oligonucleotide that is used to identify the 5‟ end may not accurately 
represent the 5‟ terminal cap structure. This type of artifacts is more pronounced for long 
transcripts, for which the cDNA synthesis may not have reached the 5‟ termini. Thus, we 
used available pig macrophage CAGE data [13] and human and mouse CAGE data from the 
FANTOM5 project [324] to verify the completeness of 5‟ termini of the above-mentioned 
111,002 spliced, uniquely mapping PTs. In summary, we found 8,529 proximal promoters in 
the pig macrophage data that were less than 50 bases from the 5‟ termini of 19,172 PTs (See 
examples in Figures 4.3B and 4.4). Based on all promoters identified by CAGE in humans, 
mice and pigs, we found 43,845 proximal promoters that were less than 50 bases away from 
the 5‟ termini of 37,569 PTs in total. The distribution of distance from the pig macrophage or 
human/mouse/pig proximal promoters to the 5‟ termini of the nearest PTs is shown in Figure 
C.10A and C.10B, respectively. 
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Comparison of the putative blood transcripts with SSC10.2 transcripts and pig RefSeq 
mRNA sequences 
The extent to which the integrated transcriptome PTs improved the existing 
annotation was evaluated by comparing the PTs with the transcript sets of the SSC10.2 and 
pig RefSeq mRNA collections, after mapping them to the USMARCv1.0 reference genome. 
To avoid ambiguity, we only compared the 111,002 spliced, uniquely mapping PTs with 
identifiable sense strands separately to the 23,565 spliced, uniquely mapping SSC10.2 pig 
transcripts and the 42,931 spliced, uniquely mapping RefSeq mRNA sequences. We found 
that (i) 4,155 and 6,641 PTs shared the same exon-intron junctions as 4,010 SSC10.2 
annotated transcripts and 6,418 RefSeq mRNA sequences, respectively; and (ii) 54,402 and 
60,180 PTs shared at least one intron or one exon with 18,437 SSC10.2 transcripts and 
33,870 RefSeq mRNA sequences, respectively. 
Notably, we also found that (1) 12,262 PTs that had both longer 5‟ and 3‟ termini 
than the maximally overlapping SSC10.2 transcripts; (2) 9,764 PTs had only longer 3‟ 
termini; (3) 14,650 PTs had only longer 5‟ termini; and (4) 17,726 PTs had both shorter 5‟ 
and 3‟ termini. Similar results were seen when the lengths of PTs was compared with those 
of RefSeq mRNA sequences (Figure 4.5). These length comparisons are shown in Figure 
C.11A and C.11B. A specific example in Figure 4.4 shows that PTs that arose from the 
Artemis gene (DCLRE1C, ENSSSCG00000011049), loss-of-function mutations of which 
cause SCID disorder in pigs [325], had an extended 3‟ UTR and one more isoform relative to 
the SSC10.2 transcript, ENSSSCT00000012093. In conclusion, a large number of PTs were 
longer than their maximally overlapping transcripts in the two reference sets, although many 
PTs were shorter than their maximally overlapping transcripts in the two reference sets. 
These shorter PTs included both transcript fragments and real intact transcript isoforms 
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which were shorter than their maximally overlapping transcripts in the two reference sets. 
Gene symbols or Ensembl gene IDs of Ensembl SSC10.2 transcripts or pig RefSeq mRNA 
sequences were assigned to PTs arising from the same gene loci (Table C.4). Interestingly, 
there frequently was a one-to-one relationship between overlapping PTs and pig RefSeq 
mRNAs; but in many cases, one PT corresponded to more than one overlapping SSC10.2 
transcript, which might indicate some of these SSC10.2 transcripts were actually fragments 
of long transcripts. 
In addition, we also found 41,838 and 35,738 spliced PTs that did not overlap any 
spliced, uniquely mapping SSC10.2 transcripts or with any spliced, uniquely mapping pig 
RefSeq mRNA sequences, respectively, by these comparisons. These PTs were potentially 
novel transcripts relative to the corresponding reference sets of transcripts used for 
comparison. The distribution of exon number of the two sets of potentially novel PTs is as 
shown in Figure C.11C. 
Discussion 
We assembled a comprehensive, verified transcriptome of porcine peripheral blood 
by using large amounts of RNA-seq short reads from multiple independent studies with pigs 
of different genetic backgrounds and physiopathological conditions. The final transcriptome, 
consisting of 132,928 PTs, was mainly composed of 126,225 PTs from the de novo 
transcriptome assembly, supplemented with 6,703 PTs from the genome-guided assembly. 
We discuss below our choices that led to this large number of PTs, which centered on 
maximizing the discovery of genes expressed in porcine whole blood, while minimizing the 
inclusion of contamination and technical artifacts. Primarily, we focus on two aspects of 
these results: (1) possible reasons why we obtained such a large number of assembled 
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transcripts and (2) our approaches to controlling the quality and validating the accuracy of 
these transcripts. 
Why so many assembled PTs? 
The most recent version of GENCODE (version 25) annotated 58,037 genes for the 
human genome, including 19,950 protein-coding genes, 15,767 long noncoding RNA genes, 
7,258 small noncoding RNA genes, and 14,650 pseudogenes [326]. These genes are 
associated with 198,093 transcripts, which include a wide range of transcript types [320, 
326]. Given the similarities of the porcine genome to that in human, we assume porcine and 
human genomes encode similar numbers of genes and transcripts. Thus we predict that this 
number of assembled PTs is much higher than the actual, yet unknown, number of expressed 
transcript isoforms in pig blood. We consider five sources that may have contributed to the 
high number of assembled PTs as follows. 
a) Intermediate splicing by-products and genomic DNA contamination 
More than 500 million normalized reads, representing more than 6 billion raw reads, 
were used to create both the de novo and genome-guided transcriptome assemblies. We took 
this assembly strategy because it has been shown that this strategy can significantly reduce 
the runtime and cost of transcriptome assembly and increase the chance of gene discovery 
when the post-normalization k-mer coverage was no less than 50  [107]. Cellular transcripts 
have a very broad range of abundance, such that some transcripts are so abundant that the 
other lowly expressed transcripts have a vanishingly small chance to be sequenced in a 
routine RNA-seq run, which makes it difficult to confidently reconstruct transcripts of such 
low expression levels from the resulting RNA-seq reads. In addition, gene expression 
depends on genetic background, developmental stage, and internal and external conditions. 
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By combining large amounts of RNA-seq reads from diverse studies that sampled animals 
with different genetic backgrounds, ages and treatment conditions, we alleviated the issue of 
poor read coverage of lowly expressed genes and increased the chances of detecting 
expressed genes. 
However, a side effect of this strategy was that it increased the occurrence of 
“transcriptional noise” and genomic DNA contamination in the resulting assembly. For 
example, more than 67.7% and 61.0% of the PTs from the de novo and genome-guided 
assemblies, respectively, were unspliced and overlapped intron intervals. These might mainly 
arise from incompletely processed RNA or from spliced but not yet decayed intronic 
fragments, although most nascent transcription is co-transcriptionally spliced [327]. The 
portion of unspliced PTs resulting from DNA contamination as discussed in [328-330] is 
probably small, because we saw many more intragenic unspliced PTs than intergenic 
unspliced PTs, although the genic portion of the genome is much smaller than the intergenic 
portion. Although RNA samples usually undergo DNase I digestion and oligo-dT-coated 
bead selection, it is possible that some genomic DNA fragments carried over into library 
construction [328-330]. One interesting finding was that there was a considerable number of 
unspliced PTs that had at least one stretch (> 20) of A‟s or T‟s in their sequence, which 
suggested some genomic fragments and intronic pieces with a stretch of A‟s might have been 
enriched by oligo-dT bead capture. In addition, given the dynamics of RNA biogenesis, for 
highly expressed genes, it is possible that some nascent transcripts containing intronic 
sequences due to incomplete splicing were captured during library construction and 
eventually sequenced, although they were poly(A)-free. Also, by visualizing the reads 
aligned to the reference genome in IGV [331], we found that often a long stretch downstream 
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of the 3‟ termini of highly expressed transcripts was transcribed and sequenced. This might 
be due to alternative polyadenylation sites or because termination of transcription of RNA 
polymerase II occurred downstream, far away from the polyadenylation site. Reads from 
these regions often assembled into several fragmented PTs, which could account for a 
significant portion of the unspliced non-intronic PTs. Sequencing of the porcine blood 
transcriptome by using PacBio IsoSeq will help determine the real scenarios. 
b) Some assembled sequences are from sources other than the porcine genome  
Another side effect of using normalized reads from large amounts of raw RNA-seq 
data was that it increased the chance to detect contamination of non-pig genome origins. For 
example, we assembled 2,567 PTs for which a similarity search by using DC-megaBLAST 
suggested they were likely from feed, parasites, fungi, bacteria and viruses, and had poorer, if 
any, alignments to the pig reference genomes. These contaminants might have been from 
sample collection and/or manipulation processes, but could also derive from the microbiome 
in the peripheral blood of pigs and absorbed dietary RNA from feed the pig consumed. 
Traditional microscopy and current deep sequencing technology have clearly shown that 
there are parasites, fungi, bacteria and viruses in the bloodstream in diseased or non-diseased 
situations in humans [332-335]. As pigs are usually kept in dirty environments, they likely 
carry some parasites, fungi and other microbes in their bloodstream, which could come from 
blood exposure to the oral cavity, respiratory or intestinal tracts, although they may not show 
clinical symptoms. Notably, chronic inflammatory diseases can increase the chance for gut 
microbiome to translocate into the circulating blood, where they may be in a dormant state 
[334]. In two of the five independent studies that were used here, pigs suffered from chronic 
inflammation due to Salmonella infection [310] or chronic LPS stimulation (H. Liu and  K. 
Feye et al. unpublished). In addition, diet-derived miRNAs have been detected in the 
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bloodstream and adipose tissue of animals [336-338]. So it is possible that some amount of 
dietary RNA could survive in the circulating blood in pigs, especially when gut integrity is 
compromised during inflammation. 
c) PTs derived from porcine endogenous retroviruses, non-blood exosomal cargos, and 
beyond 
Another source of PTs of non-blood origins is endogenous retroviruses in pigs. It is 
known that a variety of endogenous retroviruses can be active in pigs [339-341]. We 
identified 61 PTs derived from pig endogenous retroviruses in the de novo assembly. 
Furthermore, exosomal RNAs from non-blood cells and non-exosomal, cell-free RNAs in 
circulating blood, which have been identified in humans [342, 343], could further diversify 
the apparent peripheral porcine blood transcriptome. 
d) Fragmented transcripts due to technical limitations 
Another reason why so many PTs were assembled was that de novo transcriptome 
assembly based on RNA-seq reads tends to result in fragmented transcripts due to sequencing 
errors, genetic polymorphisms, uneven read coverage, and repetitive sequences. In this study, 
sequencing adapters and low quality bases were removed from reads and trimmed reads were 
digitally normalized before assembly, which can partly alleviate problems caused by 
sequencing errors and uneven read coverage for most transcribed genes in circulating blood. 
However, the use of RNA-seq reads from multiple studies with pigs of different genetic 
backgrounds could aggravate the issue of genetic polymorphisms, which are more common 
in non-coding regions, such as UTRs. In fact, we found that many 3‟ UTRs, which were 
well-covered by reads, were assembled into fragments separate from the corresponding 
coding regions (data not shown). In addition, a small fraction of repetitive sequences in the 
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mature transcripts, as evidenced by multiple mapping RNA-seq reads, can contribute to 
fragmented assembly of some transcripts. 
e) Complexity of the transcription landscape in the pig genome 
Lastly, the large number of PTs in the transcriptome assembly can also be due to the 
complexity of the landscape of eukaryotic transcriptomes [326, 344-346]. 198,093 transcripts 
associated with 58,037 genes have been annotated for the human genome (GENCODE 
v25)[320]. Given the similarities between the pig and human genomes, it is very possible that 
the transcription landscape of the pig genome is also very complex and significantly 
underestimated in the current pig genome annotation [301]. Our de novo assembled blood 
transcriptome at least partly supports this inference, although it might overestimate the total 
number of transcripts due to technical limitations of de novo assembly as discussed above. 
The initial transcriptome assemblies were filtered by mapping the PTs to reference 
genomes or by comparison to existing transcript databases, to remove PTs which were (i) 
most likely not derived from the pig genome, (ii) genomic DNA contamination or (iii) 
intermediate splicing transcription products. These filtering steps may remove some true 
porcine transcripts that happened to be mono-exonic and derived from intronic regions, such 
as intronic ncRNAs, or that by chance had high similarity to non-vertebrate nucleic acid 
sequences. However, on balance, such filtering is appropriate and conservative, and we 
believe that, as the majority of protein-coding and long ncRNA transcripts are spliced [347], 
the few true porcine transcripts that were removed by this procedure is outweighed by the 
potential for a large number of false transcripts that may be included in the assembly without 
filtering. 
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How accurate and comprehensive was the assembled final transcriptome? 
Short RNA-seq read-based transcriptome assembly usually results in a large portion 
of transcript fragments, as discussed above, thus leading to overestimation of the number of 
transcripts or genes in the target tissue or cell. To assess the quality of the integrated 
transcriptome assembly, which mainly consisted of PTs from the de novo assembly, we 
evaluated the assemblies in various ways, which led to three major conclusions. 
a) The de novo assembly represented a majority of the normalized blood RNA-seq data, and 
covered nearly the full length of many curated protein sequences, and porcine RefSeq 
mRNAs. 
More than 66% of total input RNA-seq reads could be mapped to the de novo 
transcriptome, which was comparable to those reported mapping rates (65 -85%) for other 
similar assemblies [120]. In addition, we verified 35,541 and 16,010 PTs that covered more 
than 80% of the full length of the Swiss-Prot protein and pig RefSeq mRNA sequences, 
respectively. Note that this may underestimate the number of full-length PTs, as the 
transcriptome and proteome for porcine tissues are poorly annotated. 
b) The short read-based transcriptome assembly was substantially verified by PacBio IsoSeq 
long-read data, CAGE data, as well as by existing porcine gene annotations. 
A global sequence alignment-based method for assessing the quality of the assembled 
transcriptome may not reveal some structural details of the assembled transcripts, such as 
correctness of the exon-exon junctions of the isoforms and completeness of transcript ends. 
Therefore, we used the assembly-free, PacBio IsoSeq long cDNA reads from the three 
porcine tissues (liver, thymus and spleen), which were the IsoSeq data available, to validate 
the correctness of the fine structures of the PTs. These non-blood sources of cDNA reads are 
applicable because (i) different tissues usually share a significant portion of expressed 
transcripts, (ii) all three tissue biopsies contained some blood, (iii) the thymus and spleen are 
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primary immune tissues, with substantial proportions of cells found in blood such as  
monocytes and lymphocytes[348]. We found that 15,311 PTs (14% of the PTs in the 
integrated transcriptome assembly) and 106,484 IsoSeq reads shared the same intron 
arrangement. However, some peripheral blood-specific transcripts may not be validated by 
these PacBio IsoSeq reads. In addition, we made use of the extant human and mouse CAGE 
data from the FANTOM5 project [324] as well as pig macrophage CAGE data [13], to check 
the completeness of the 5‟ extremities of the PTs. We found that 37,569 PTs had complete or 
nearly complete 5‟ termini. These analyses indicated that many of the PTs were correctly 
reconstructed in terms of exonic architecture and completeness of 5‟ termini. Completeness 
of the 3‟ termini could be further verified by using the 3‟ T-fill sequencing technology [349]. 
Comparison of PTs in the integrated transcriptome to SSC10.2 annotation identified 
4,155 PTs with shared intron arrangements to 4,010 annotated transcripts, representing 17% 
of all SSC10.2 transcript annotations. Further, we found that 12,262 PTs had both longer 5‟ 
UTRs and longer 3‟ UTRs than the maximally overlapping counterparts in the SSC10.2 
annotation. Notably, we also found 41,838 novel spliced PTs that were missing in the 
SSC10.2 annotation. Similar results were found when the PTs in the integrated transcriptome 
were compared to the pig RefSeq mRNA set. This suggests that our PTs were useful in 
expanding the annotation of the pig reference genomes. 
c) The integrated transcriptome was well-annotated functionally. 
Functional annotation of a transcriptome on a large scale currently depends mainly on 
sequence similarities between novel and annotated sequences, often across species. By 
searching the NCBI NT and NR databases, we identified significantly similar sequences for 
119,463 (~90%) and 83,828 (63%) PTs, respectively, of the integrated transcriptome 
assembly; 80,825 (~61%) PTs were potentially mRNA, while the others were potentially 
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ncRNA, misc_RNA, or artifacts. PTs which encoded putative proteins significantly similar to 
protein sequences in the NR database were further annotated with GO terms, EC codes and 
KEGG pathways. In total, 68,754 (82%) and 7,618 (9%) of the PTs with significant 
BLASTX hits were annotated with 15,965 unique GO terms and 134 KEGG pathways, 
respectively. We found that a level-two GO-BP term, immune system process, and many 
more specific terms related to the immune system process were well represented by PTs in 
the integrated transcriptome, consistent with the whole blood origin of the RNA-seq data. 
Conclusions 
We constructed a comprehensive peripheral blood transcriptome for the pig by 
combining de novo and genome-guided assemblies of extensive RNA-seq data from multiple 
experiments. The resulting transcriptome has been carefully filtered to maximize useful 
information content, validated on a large scale, and well-annotated by using a series of 
methods. The transcriptome had significant improvement over the SSC10.2 annotation and 
the pig RefSeq mRNAs. Thus, the transcriptome we assembled can be used to analyze data 
from future blood-based high throughput gene expression studies and will help more fully 
annotate the newly assembled pig reference genomes. 
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Table 4.1. RNA-seq data used for the blood transcriptome assembly 
Study Accession Sample Description Read 
Length 
Layout Total Raw 
Read Count 
Breed Source  Run 
Accession 
Reference 
PRJEB5250 16 pigs (7 weeks old) were infected with Salmonella 
enterica serovar Typhimurium. Whole blood was 
sampled before infection (day 0) and day 2 post 
infection. Globin was depleted from the total RNA. 
51 SE 1,611,707,563 Yorkshire 
crossbred  
ENA ERR413315 - 
ERR413346 
[310] 
PRJNA189967 Whole blood from 3 individual healthy pigs  51 SE 106,157,368 unknown ENA SRR747924-
SRR747926 
[311]  
Swine Genome 
Sequencing 
Consortium 
Whole blood from one healthy pig 83 SE 48,973,230 Duroc ENSEMBL(ftp://
ftp.ensembl.org/
pub/release-
83/bamcov/sus_s
crofa/genebuild/
whole_blood_me
rged_sorted.bam
) 
Unknown  http://www.ensemb
l.org/info/genome/g
enebuild/2012_04_s
us_scrofa_genebuil
d.pdf 
PRJEB12300 Whole blood was sampled from 31 post-weaning (5 
~ 6 weeks old) pigs from lines divergently selected 
for residual feed intake. Globin was depleted from 
the total RNA. 
100 PE 2   
632,557,790 
Yorkshire ENA ERR1199492-
ERR1199522 
[309]  
PRJEB20136 28 pigs (~ 63 kg of body weight) from lines 
divergently selected for residual feed intake were 
muscularly injected with E. coli LPS or saline at 
time 0, and 48, 96h and 144 hours post the first 
injection. Whole blood was sampled immediately 
before first injection and 2, 6, 24 and 168 hours post 
first injection. Globin was depleted from the total 
RNA. 
49 PE 2   
1,509,173,972 
Yorkshire ENA ERR1898446-
ERR1898477 
H. Liu, K. Feye et 
al., unpublished 
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Table 4.2. Summary of assessment of the de novo and integrated transcriptome assemblies 
Transcriptome 
assembly 
Type of assessment Purpose Reference data Software Results 
The de novo 
transcriptome 
assembly 
RNA-seq read 
representation of the 
assembly 
To determine representation 
of RNA-seq reads 
Normalized RNA-seq 
reads 
Trintiy[107, 
315] 
66.2% of normalized RNA-seq reads could be mapped back to the de 
novo assembly 
Representation of 
full-length assembled 
protein-coding 
transcripts 
To assess the number of 
full-length PTs 
All protein sequences 
in the Swiss-Prot 
database 
BLASTX [350] 22,831 (nearly) full-length PTs covered more than 80% of the full 
length of 10,097 protein sequences in the Swiss-Prot database 
Representation of 
full-length assembled 
transcripts 
To assess the number of 
full-length PTs 
NCBI pig RefSeq 
mRNAs 
DC-
megaBLAST 
[350] 
16,010 (nearly) full-length PTs covered more than 80% of the full 
length of 9,228 pig RefSeq mRNAs  
Origin of assembled 
transcripts 
To assess whether the 
assembled PTs were of 
porcine genomic origin 
Pig reference 
genomes: SSC10.2 
and USMARCv1.0 
GMAP [90] 94.2% and 99.4% of the PTs could be mapped to SSC10.2 and 
USMARCv1.0, respectively 
Similarity-based 
assessment 
To annotate the assembled 
PTs with known sequences 
of significant similarity 
Sequences in the 
NCBI NT and NR 
databases 
DC-
megaBLAST 
and BLASTX 
[350] 
69.42% and 21.9% of the PTs shared significant similarities to 
sequences in the NCBI NT and NR databases, respectively 
The integrated 
transcriptome 
assembly 
Similarity-based 
assessment 
To annotate the assembled 
PTs with known sequences 
of significant similarity 
Sequences in the 
NCBI NT and NR 
databases 
DC-
megaBLAST 
and BLASTX 
[350] 
~90% and 63% of the PTs shared significant similarities to sequences in 
the NCBI NT and NR databases, respectively 
Correctness of exon-
intron splicing 
junctions of PTs 
To validate the exon-intron 
splicing junctions of PTs 
Porcine IsoSeq full-
length cDNA read 
data from the liver, 
spleen and thymus, 
SSC10.2 transcripts 
and NCBI RefSeq 
mRNAs 
Bedtools [317] 
and custom Perl 
scripts 
15,303 PTs and 106,483 IsoSeq sequences had the same exon-intron 
junctions; and 63,845 uniquely mapping, spliced PTs shared at least one 
intron or exon with 390,943 IsoSeq reads; 4,155 and 6,641 PTs shared 
the same exon-intron junctions as 4,010 SSC10.2 annotated transcripts 
and 6,418 RefSeq mRNA sequences, respectively; 54,402 and 60,180 
PTs shared at least one intron or one exon with 18,437 SSC10.2 
transcripts and 33,870 RefSeq mRNA sequences, respectively  
Completeness of 5' 
termini of PTs 
To validate the 
completeness of 5' termini 
of PTs 
FANTOM5 CAGE 
data for humans and 
mouse, and porcine 
macrophage CAGE 
data  
CAGEr [322], 
Bedtools [317] 
and custom Perl 
scripts 
Completeness of the 5' termini of 37,569 PTs were verified by 43,845 
proximal promoters determined by CAGE data 
Length extension of 
existing transcripts 
To determine to what extent 
the assembled PTs improved 
over the existing porcine 
annotation 
SSC10.2 transcripts 
and NCBI pig 
RefSeq mRNAs 
Bedtools [317] 
and custom Perl 
scripts 
12,262 PTs had both longer 5‟ and 3‟ termini than the maximally 
overlapping SSC10.2 transcripts; 9,764 PTs had only longer 3‟ termini; 
and14,650 PTs had only longer 5‟ termini 
Novelty of PTs  To determine novel PTs SSC10.2 transcripts 
and NCBI pig 
RefSeq mRNAs 
Bedtools [317] 
and custom Perl 
scripts 
41,838 and 35,738 spliced PTs that did not overlap any spliced, 
uniquely mapping SSC10.2 transcripts or with any spliced, uniquely 
mapping pig RefSeq mRNA sequence were potential novel transcripts 
relative to the two reference sets, respectively 
1
4
1
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Figure 4.1. Characterization of the integrated transcriptome assembly. (A) Length 
distribution of the PTs of the integrated transcriptome;  (B) Exon number distribution for the 
uniquely mapping spliced PTs of the integrated transcriptome; (C) Distribution of the number 
of isoforms per PT for PTs with at least two isoforms in the integrated transcriptome;  (D, E) 
Boxplots showing the distributions of percentage of identity, percentage of query coverage, 
bit scores and E-values of the top BLAST hits of the PTs in the NCBI NT (D) and NR (E) 
databases by using DC-megaBLAST (D) and BLASTX (E), respectively. (F) Boxplots 
showing the distributions of percentage of identity, percentage of query coverage, bit scores 
and E-values of the best reciprocal DC-megaBLAST hits of the PTs in the human 
transcriptome (GENCODE v25). For clearer visualization, larger outliers of bit scores and E-
values are not displayed in D-F. 
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Figure 4.2. GO terms and EC code annotation of the integrated transcriptome 
assembly. (A) Distribution of the top 20 GO terms at level two, where available; (B) 
Distribution of the six main EC classes. 
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Figure 4.3. IsoSeq full-length cDNA reads (A) and CAGE data (B) validate fine 
structures of PTs in the integrated transcriptome assembly. (A) An example showing one 
assembled PT shadowed gray in the “Assembly” panel was validated by one IsoSeq full-
length cDNA read shadowed gray in the “IsoSeq” panel in terms of intron arrangement. For 
references, from top to bottom displayed are genomic coordinates, genome coverage by the 
normalized RNA-seq reads, aligned RNA-seq reads, pig RefSeq mRNAs, SSC10.2 
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transcripts and IsoSeq alignments. In the panel labeled as “RNA-seq Cov”, heights of the 
gray or colored bars represent CPB by the RNA-seq reads. In the “RNA-seq” panel, purple 
and blue boxes represent reads mapped to the forward and reverse strands of the 
chromosome; while the thin segments represent introns spanned by spliced reads. In the 
panels labeled as “Assembly”, “RefSeq”, “SSC10.2” or “IsoSeq”, red boxes represent exons, 
and thin segments stand for introns, with arrows indicating the orientation of the sense strand. 
The “Assembly” panel shows PTs mapped to this genomic window. (B) An example 
showing a conserved proximal promoter among pigs, humans and mice, determined by 
CAGE, overlaps the 5‟ termini of several assembled isoforms of a gene, indicating 
completeness of the 5‟ termini of those PTs. Meaning of the symbols is the same as those in 
(A); in addition, the blue boxes stand for proximal promoters determined by CAGE in 
porcine macrophage, human and mouse cells in the three panels labeled with “Pig CAGE”, 
“Human CAGE” or “Mouse CAGE”. 
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Figure 4.4. The integrated blood transcriptome assembly improves the structural 
annotation of the porcine genome compared to the SSC10.2 annotation. The example 
shown is for the ARTEMIS gene locus, annotation of which in SSC10.2 was improved by 
extending the 3‟ UTR and adding novel isoforms. Meaning of the symbols is the same as 
those in Figure 4.3. The two assembled ARTEMIS isoforms are verified by IsoSeq reads, 
which show many more isoforms for the ARTEMIS gene. For references, also shown are 
proximal promoters determined by CAGE data and a RefSeq mRNA of the Artemis gene. 
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Figure 4.5. Length comparison between PTs and transcripts in the reference sets. The 
lengths of uniquely mapping spliced PTs were compared with those of SSC10.2 transcripts 
and pig RefSeq mRNAs. The number of PTs with longer 5‟ and 3‟, only longer 3‟, and only 
longer 5‟ termini, or neither terminus than their maximally overlapping reference transcripts 
in SSC10.2 annotation (red) and RefSeq mRNA collection (blue), respectively is as 
displayed. 
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CHAPTER 5. GENERAL CONCLUSION 
 
 
Summary and General Discussion 
Effect of selection for RFI on the immune system in response to systemic inflammation 
It was unclear whether selection for improved feed efficiency would compromise a 
pig‟s immune response to pathogens or virulent components of pathogens. In a study 
presented in Chapter 2, we intramuscularly injected pigs from two lines divergently selected 
for RFI with an inflammatory stimulant, LPS. LPS injection induced systemic inflammation 
in pigs of both lines and excited very similar responses in terms of dynamics of body 
temperature, CBC, and levels of several cytokines in plasma. Both lines also showed a very 
similar transcriptomic response to LPS stimulation in terms of biological pathways and 
processes involved in this stimulation. Only a very small number of genes was differentially 
expressed between the two lines at all time points surveyed and negligible line-by-time 
interaction effects on gene expression were detected. Interestingly, the low RFI line had a 
slightly lower level of inflammatory response than the high RFI line at each time point post 
LPS injection. Genes involved in protein translation, defense and immune response, and 
signaling formed individual clusters in response to LPS stimulation. 
Compared to human data from a similar experiment [214], pig‟s inflammatory 
response observed in this study was much weaker, regardless of much higher dosage of LPS 
injected in pigs than in humans. Many pathways and biological processes were specifically 
involved in human response, but only a few were pig-specific. However, hundreds of key 
pathways and biological processes were shared between the two species. A core set of 1,543 
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porcine genes and their human orthologs were differentially expressed in response to LPS 
stimulation in both species. Nearly one third of these genes shared very similar dynamic 
expression patterns over the time course. These conserved genes mainly functioned in 
biological processes including translation, RNA catabolism, signaling, apoptosis, immune 
response and inflammatory response. But caution should be taken with the differences seen 
in humans and pigs, due to differences in routes of LPS administration, dosage and sources 
of LPS, blood fractionation, and completeness of genome annotation in both species. 
To conclude, pigs from the two lines divergently selected for RFI responded to 
systemic inflammation triggered by LPS injected intramuscularly in a very similar way, 
though the low-RFI animals seemed to have a lower level of inflammation across the time 
points post LPS stimulation. Pigs and humans shared similar response to systemic 
inflammation induced by LPS at both pathway and gene levels, though many more biological 
processes and pathways were specifically involved in inflammatory response in humans and 
only a few were preferentially involved in pigs. 
Again, in this study bulk gene expression profiling was conducted, which can mask 
some differences existing in some special cell types or blood fractions. Surrogate variables 
instead of variables recorded as metadata were used to adjust for unwanted/hidden variations 
in detected gene expression because (1) the CBC parameters were not accurately measured; 
(2) no CBC tests were done for some samples; (3) RNA processing batches were not always 
followed from RNA preparation to sequencing. Removing unwanted/hidden variation by 
using surrogate variables has been shown to be successful and powerful [102, 351]. Sample 
clustering based on expression data with or without adjustment for surrogate variables, or 
with adjustment for only available nuisance parameters also indicated that surrogate 
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variables-based adjustment was best in terms of separation of clusters and compactness of 
clusters. 
Another concern about the data analysis is that correlation in within-individual gene 
expression resulting from repeated measures was not taken into account in the differential 
expression analysis, although it was considered in gene set enrichment analysis run in a 
paired-comparison mode. These might decrease the power of detecting more DEGs between 
time points post LPS injection and baseline. Thus the number of conserved DEGs detected 
between humans and pigs might be different. However, the general conclusion will not be 
affected because that was based on paired-sample gene set enrichment analysis. 
Profiling blood transcriptome of RFI lines for developing predictive biomarkers for 
RFI 
Given the high cost in terms of money and time of current implementation of genetic 
selection for low RFI to improve feed efficiency in pigs, an exploratory study was conducted 
to search for predictive biomarkers for RFI in blood transcriptome. The results were 
presented in Chapter 2. DEGs between the two groups of animals with extreme RFI 
phenotypes were identified by using RNA-seq. Although the magnitudes of differential 
expression of these genes in the low-RFI group versus the high-RFI group were not large, 
collectively they did differentiate these two groups. Genes involved in small molecule 
biosynthetic process, antigen processing and presentation of peptide antigen via major 
histocompatibility complex (MHC) class I, and steroid biosynthetic process were 
overrepresented among DEGs that had higher expression in the low versus high RFI animals. 
Genes known to function in the proteasome complex or mitochondrion were also 
significantly enriched among genes with higher expression in the low versus high RFI 
animals. Alternatively, genes involved in signal transduction, bone mineralization and 
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regulation of phosphorylation were overrepresented among DEGs with lower expression in 
the low versus high RFI animals. The DEGs significantly overlapped with genes associated 
with disease, including hyperphagia, eating disorders and mitochondrial diseases. A weighted 
gene co-expression network analysis (WGCNA) identified four co-expression modules that 
were differentially expressed between the low and high RFI groups. Genes involved in lipid 
metabolism, regulation of bone mineralization, cellular immunity and response to stimulus 
were overrepresented within the two modules that were most significantly differentially 
expressed between the low and high RFI groups. We also found five of the DEGs and one 
co-expression module that were significantly associated with RFI phenotype of individual 
animals (q < 0.05). 
To conclude, the post-weaning blood transcriptomes were globally different between 
the low and high RFI groups. The identified DEGs suggested potential differences in 
mitochondrial and proteasomal activities, small molecule biosynthetic process, and signal 
transduction between the two RFI groups and provided potential new insights into the 
molecular basis of RFI in pigs, although the observed relationship between the post-weaning 
blood gene expression and RFI phenotype measured during the grow-finish phase was not 
strong. DEGs and representative genes in co-expression modules that were associated with 
RFI phenotype provide a preliminary list for developing predictive biomarkers for RFI in 
pigs. 
It is worth noting that due to possible reasons as discussed in Chapter 2, the validation 
rate of these DEGs by RT-qPCR was not high. Only 24 of 37 selected DEGs were validated 
in a joint analysis of 24 (12 per line) of the 31 samples that were used for RNA-seq plus 24 
(12 per line) novel samples from the same contemporary group of pigs. Using an analysis of 
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the 24 novel samples alone, only 9 of the 37 selected DEGs were validated. So many of these 
genes may only be differentially expressed between the two groups of extreme animals, but 
not necessarily differentially expressed between the two RFI populations. Caution should be 
taken with validation of these candidate biomarkers in the future. 
In this study, whole blood was used for bulk gene expression profiling. Although the 
gene expression data was roughly adjusted for the concentration of four types of WBCs in 
whole blood, the complexity of the peripheral blood in composition mentioned above might 
mask some differences that exist in special cell types/subtypes or blood fractions. 
Deconvolving the bulk gene expression profiling with sophisticated methods or performing 
cell-type specific gene expression profiling might be helpful in discovering some hidden 
differences between the two groups of animals for biomarker development. This will further 
be discussed later. 
For the sake of biomarker development for predicting RFI, exosomal contents might 
be a focus of importance in the future. A large number of exosomes exist in bloodstream, 
which are dynamically released by different types of tissues, including tissues more related to 
feed efficiency, such as hypothalamus, liver, muscle, fat and intestine. mRNAs, miRNAs and 
proteins carried by those dynamic exosomes might better reflect the states of their source 
tissues ([352, 353], see reviews [354-356]). 
A potential issue of the experimental design in this study was that the blood samples 
were collected at 5 ~ 6 weeks of age and before the pigs were fed diets, based on which the 
feed efficiency of individual animals was tested. The experimental design assumed the 
transcriptomic differences at a very early life stage could be significantly associated with 
future differences in feed efficiency. Given the dynamic gene expression during 
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development, this assumption might be risky. It might be more reasonable to collect a time-
series blood samples before and during feed efficiency test. Then transcriptomic analysis of 
blood fractions or whole blood is conducted to find the earliest stage when the differences in 
blood can best predict RFI measured at the end of test. 
Advancing swine blood transcriptome 
In sight of the limitations of the annotation and assembly of current pig reference 
genome, a de novo and a genome-guided transcriptome of porcine whole peripheral blood 
was assembled a large amount of RNA-seq short reads from five independent studies by 
using the Trinity and Cufflinks software, respectively. After removing putative transcripts 
(PTs) of low confidence from both assemblies, an integrated transcriptome consisting of 
132,928 PTs were complied, a majority of which was from the de novo assembly and were 
spliced transcription products. These PTs can be clustered into 27,782 transcription loci, of 
which 22,752 loci were composed of spliced PTs. Transcripts in the integrated transcriptome 
were further annotated via homolog search in the NCBI NT and NR databases. They were 
further annotated with GO terms, Enzyme Commission codes and assigned to 134 KEGG 
pathways. Full exon-intron junctions of 17,528 PTs were validated by PacBio IsoSeq full-
length cDNA reads from 3 other porcine tissue types, NCBI pig RefSeq mRNAs and 
transcripts from Ensembl Sscrofa10.2 annotation. Completeness of the 5‟ termini of 37,569 
PTs was validated by public CAGE data. By comparison to the Ensembl transcripts, we 
found the deduced precursors of 54,402 PTs shared at least one intron or exon with those of 
18,437 Ensembl transcripts and 12,262 PTs had both longer 5‟ and 3‟ UTRs than their 
maximally overlapping Ensembl transcripts. 41,838 spliced PTs were totally missing from 
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the Sscrofa10.2 annotation. Similar results were obtained when the PTs were compared to the 
pig RefSeq mRNAs. 
To conclude, we built, validated and annotated a comprehensive porcine blood 
transcriptome with significant improvement over the annotation of Ensembl Sscrofa10.2 and 
the pig RefSeq mRNAs, and laid a foundation for blood-based high throughput 
transcriptomic assays in pigs and for advancing annotation of the pig genome. 
Because the blood transcriptome assembly was based on RNA-seq short reads there 
were definitely some errors, such as artifacts of fused transcripts formed by transcripts from 
adjacent genes on the genome, transcripts with retained introns due to sequencing of 
unprocessed transcript intermediates, transcripts with truncated 3‟ and 5‟ UTRs and 
fragmented transcripts. Manual editing of these assembled transcripts along with supporting 
RNA-seq reads, ESTs, cDNA and protein sequences by using tools like Web Apollo [357] or 
Otterlace [358, 359], will help correct some of the errors. Stranded RNA-seq data will be 
extremely helpful in distinguishing genomic DNA contamination from real mono-exonic 
transcripts and resolving artificially fused transcripts and antisense transcripts. Also due to 
the short reads used for assembly, some transcripts or transcript isoforms may not be 
assembled at all. Blood transcriptome sequencing by IsoSeq will complement this short 
reads-based sequencing. 
Because whole blood was used for transcriptome profiling, transcripts only expressed 
in rare cell types might be not well represented in the assembly. And it is also impossible to 
ascertain which type of cells a transcript or transcript isoform was derived from. Recent 
progress in flow cytometric cell sorting, especially the index sorting technology, and 
microfluidics, makes it possible to isolate single cells for transcriptome profiling by single 
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cell RNA-seq sequencing. This will be further discussed later. A single cell IsoSeq 
technology has emerged [360]. Cell type-specific or single cell transcriptome will be 
expected in the near coming future for pigs. 
Current challenge in swine blood transcriptomics 
Although many blood-based transcriptomic analyses have been performed in the last 
decade, using a variety of gene expression microarrays or RNA-seq, to address diseases-
related biological questions in pigs, all these analyses were actually bulk gene expression 
analyses, that is, averaged gene expression over tens of different blood cell types/subtypes at 
different states. DEGs detected by these experiments were a confounding result of change of 
cell proportions in blood and real expression level change in cells due to treatment. This 
makes it difficult or even impossible to discover biological mechanisms underlying some 
biological phenomena when the mechanisms only exist in special cell types/subtypes of low 
proportion or opposite effects exist on different cell types. It is even possible to get 
misleading results. In the past years, dozens of statistical methods have been developed, 
aiming at deconvolving gene expression in heterogeneous samples, such as blood and 
tumors. However, most of these methods depend on cell type-specific expression signatures, 
which are usually not available in most species and it is not trivial to develop such signatures; 
and most of them are not designed for differential expression analysis [361]. A few tools 
which could be used for differential expression analysis rely on known cell proportions in 
samples [362, 363]. A recent developed tool for deconvolving gene expression in complex 
samples, CellCODE, can be used for differential expression analysis with neither cell-type-
specific expression signatures nor cell proportion information [361]. However, given the 
pronounced dynamic and heterogeneity of blood tissue, none of these deconvolution tools are 
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good enough to capture the real details hidden in blood fractions, or special rare cell types, 
such as circulating tumor cells and hematopoietic stem and progenitor cells. 
Another limitation is the poor quality of the widely used pig reference genome 
Sscrofa10.2. Previously, gene expression microarrays were designed based on known gene 
sequences and poor genome annotation could compromise the design of microarray 
platforms and limit the functional annotation of probesets even if they were included in the 
platforms. Recently developed RNA-seq technology is not limited by a priori knowledge 
about the genome, but a well-annotated genome or transcriptome is still needed to accurately 
interpret the gene expression profiles under different conditions. New generations of the pig 
reference genome will facilitate a new round of discovery in swine biology, when their 
annotations are greatly improved by integrating all existing evidence, such as ESTs, RNA-
seq data, cDNA, protein sequences from pigs and related mammals, and ab initio genome 
annotation, which is expected to be available in months. 
Future Direction: Blood Single Cell Transcriptomics 
As mentioned above, blood is strikingly heterogeneous and also very dynamic. 
Quickly evolving single cell RNA-seq (scRNA-seq) is a promising choice for blood 
transcriptomic studies. Low-throughput, high-cost scRNA-seq technologies have existed for 
several years. For these technologies, usually sequencing libraries are constructed for 
individual cells, which is labor-intensive and expensive. But the advantage is that 80 to 90% 
of the transcriptome of a single-cell can be sequenced. Single cell isolation and library 
preparation have been recently reviewed [364, 365]. They have been used in blood 
transcriptomic studies, such as discovering new subtypes of immune cells [366], tracing T 
cell clonality [367], and HIV infection [368]. 
157 
With the development of the scRNA-seq technology in the past eight years [369], it is 
now of higher throughput and more automated and scalable. Tens of thousands of single cells 
can be isolated and sequenced in one run [370, 371]. More importantly, the cost of scRNA 
per cell has been greatly reduced due to the recently developed scRNA technology, Drop-Seq 
[370] and Seq-Well [371]. 
The Drop-seq technology can offer 16 million barcodes in its bead library. scRNA-
seq based on this technology can analyze the transcriptome of a single cell at a cost of 6.5 
cents [370]. Using the Seq-Well technology, the cost of scRNA-seq per cell is below $1 and 
the sample preparation system is highly portable; well loading is under easy control and cell 
lysis is more efficient than Drop-Seq [371]. These technologies have been used to study 
transcriptomic heterogeneity of macrophages and their response to tuberculosis infection 
[371] and HIV infection in humans, cell states during cell cycle and cell type identification in 
complex tissues [370]. 
A common limitation of these high-throughput, low-cost scRNA-seq technologies is 
their low capture capacity of transcripts. Currently, only 10 to 15 % of the total number of 
transcripts in a cell can be captured and analyzed with this process. And only polyA(+) 
mRNA can be captured. Thus only medium to highly abundant mRNA transcripts can be 
reliably profiled [370, 371]. However, the limited transcriptomic information captured by 
these methods is very valuable in providing answers to questions which were impossible to 
answer with bulk gene expression analysis. 
In the future, it is expected that scRNA-seq will see broad application in discovering 
novel immune cell subpopulations, investigating differential gene expression, differential 
splicing and single cell gene regulatory networks, and understanding autoimmune, allergic 
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and infectious diseases at the single cell level in organisms including pigs. For example, the 
high-throughput scRNA-seq technology can be used to study the process of PRRSv 
pathogenesis in pigs by profiling single cell gene expression of porcine alveolar macrophages 
from pigs infected with PRRSv. All current gene expression studies of PRRSv infection have 
been based on bulk gene expression [372, 373], which have masked the cell-specific 
response to PRRSv infection and the dynamic process of viral infection. By single cell study, 
it is possible to identify new drug targets for drug therapy. 
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APPENDIX A. SUPPLEMENTARY MATERIALS FOR CHAPTER 2 
 
 
Supplementary Methods 
Parameter settings for clustering of gene expression data using STEM 
Supplementary Figures 
Figure A.1. 3D-PCA plots showing relationship of pig blood samples before and after 
LPS injection. H, high RFI; L, low RFI; Tx, time point x hpi. 
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Figure A.2. Enriched KEGG pathways among deregulated genes in RFI lines post LPS 
injection. Only gene sets significantly enriched under at least one condition (q < 0.05) are 
displayed. HRFI, high RFI; LRFI, low RFI; Tx, time point x hpi.  
-log10(q-value) 
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Figure A.3. Enriched KEGG disease gene sets among deregulated genes in RFI lines 
post LPS injection. Only gene sets significantly enriched under at least one condition (q < 
0.05) are displayed. HRFI, high RFI; LRFI, low RFI; Tx, time point x hpi. 
  
-log10(q-value) 
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Figure A.4. Enriched transcription factor targets among deregulated genes in RFI lines 
post LPS injection. Only gene sets significantly enriched under at least one condition (q < 
0.05) are displayed. HRFI, high RFI; LRFI, low RFI; Tx, time point x hpi. 
  
-log10(q-value) 
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Figure A.5. Enriched canonical pathways other than KEGG pathways among 
deregulated genes in RFI lines post LPS injection. Only gene sets significantly enriched 
under at least one condition (q < 0.05) are displayed. HRFI, high RFI; LRFI, low RFI; Tx, 
time point x hpi. 
  
-log10(q-value) 
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Figure A.6. Enriched GO-BP gene sets among deregulated genes in RFI lines post LPS 
injection. Only enriched gene sets with q < 0.05 are displayed. HRFI, high RFI; LRFI, low 
RFI; Tx, time point x hpi. 
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Figure A.7. Enriched GO-CC gene sets among deregulated genes in RFI lines post LPS 
injection. Only gene sets significantly enriched under at least one condition (q < 0.05) are 
displayed. HRFI, high RFI; LRFI, low RFI; Tx, time point x hpi.  
-log10(q-value) 
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Figure A.8. MDS plots based on gene expression abundance with (A) and without (B) 
adjustment for surrogate variables, showing relationship of human blood samples 
treated with LPS or saline (labeled as “Placebo”). Adjusting for surrogate variables 
dramatically improves separation of samples under different conditions and clustering of 
samples under the same conditions. 
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Figure A.9. Heatmap showing differentially expressed probesets in humans in response 
to LPS injection. Shown on in the left and right halves are for the LPS treatment group and 
the saline control group, respectively. Px_Ty, samples from human individual x at y hpi. 
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Figure A.10. Enriched KEGG pathways in deregulated genes in humans and pigs post 
LPS injection. Only gene sets significantly enriched under at least one condition (q < 0.05) 
are displayed. HRFI, high RFI; LRFI, low RFI; Tx, time point x hpi. 
  
-log10(q-value) 
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Figure A.11. Enriched transcription factor targets in disturbed genes in humans and 
pigs post LPS injection. Only enriched gene sets with q < 0.05 are displayed. HRFI, high 
RFI; LRFI, low RFI; Tx, time point x hpi. 
Figure A.12. Enriched GO-BP gene sets in disturbed genes in humans and pigs post 
LPS injection. Only enriched gene sets with q < 0.05 are displayed. HRFI, high RFI; LRFI, 
low RFI; Tx, time point x hpi. 
Figure A13. Enriched GO-CC gene sets in disturbed genes in humans and pigs post 
LPS stimulation. Only enriched gene sets with q < 0.05 are displayed. HRFI, high RFI; 
LRFI, low RFI; Tx, time point x hpi. 
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Figure A.14. Clusters of significant profiles in humans and pigs in response to LPS 
stimulation showed similar patterns and/or biological functions. Common GO terms 
overrepresented by similar clusters in humans and pigs are shown. The clusters of humans 
and pigs in the top row shared 396 common genes.  
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Supplementary Tables 
Table A.1. Metadata for pig RNA-seq samples. 
Table A.2. Primers used to confirm transcriptional response to LPS stimulation in pigs 
by Fluidigm RT-qPCR. 
Table A.3. Summary statistics of dynamic change of CBC parameters during 
inflammation in pigs treated with LPS or saline. 
 
Cell Type Treatment group Contrast Effect SE p-value 
Neutrophils* 
Saline 
0 -2 hpi -0.45 0.18 0.02 
0-24 hpi 0.02 0.13 0.89 
LPS 
0 -2 hpi 1.42 0.17 < 0.00001 
0-24 hpi -0.97 0.12 < 0.00001 
Lymphocytes 
Saline 
0 -2 hpi 0.15 0.18 0.42 
0-24 hpi 0.20 0.07 0.005 
LPS 
0 -2 hpi 1.40 0.16 < 0.00001 
0-24 hpi 0.44 0.06 < 0.00001 
Basophils 
Saline 
0 -2 hpi 0.14 0.35 0.70 
0-24 hpi 0.16 0.20 0.45 
LPS 
0 -2 hpi 0.74 0.33 0.03 
0-24 hpi 0.42 0.18 0.03 
Eosinophils* 
Saline 
0 -2 hpi 0.07 0.14 0.62 
0-24 hpi 0.00 0.12 0.98 
LPS 
0 -2 hpi 1.89 0.12 < 0.00001 
0-24 hpi -0.35 0.11 0.003 
Monocytes 
Saline 
0 -2 hpi 0.15 0.29 0.60 
0-24 hpi 0.08 0.11 0.50 
LPS 
0 -2 hpi 2.06 0.26 < 0.00001 
0-24 hpi 0.97 0.10 < 0.00001 
Notes: SE, standard error 
    * Unstructured covariance was considered for neutrophils and eosinophils analysis; For other cell types, 
heterogeneous compound symmetry covariance was considered. 
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Table A.4. Summary statistics of dynamic change of cytokine levels during 
inflammation in pigs treated with LPS or saline. 
 
Cytokine Treatment Test Effect SE p value 
IFNα 
Saline 
0 -2 hpi 1.83 0.95 0.07 
0-24 hpi 0.75 0.61 0.23 
LPS 
0 -2 hpi -0.06 0.93 0.95 
0-24 hpi -0.02 0.53 0.97 
IFNγ* 
Saline 
0 -2 hpi 0.68 0.71 0.34 
0-24 hpi 0.12 0.80 0.88 
LPS 
0 -2 hpi -0.83 0.67 0.23 
0-24 hpi -0.52 0.70 0.46 
IL10 
Saline 
0 -2 hpi -0.37 0.51 0.48 
0-24 hpi 0.00 0.07 1.00 
LPS 
0 -2 hpi -2.48 0.50 0.0003 
0-24 hpi -0.15 0.06 0.02 
IL1b 
Saline 
0 -2 hpi 0.73 0.89 0.43 
0-24 hpi 0.27 0.55 0.63 
LPS 
0 -2 hpi -1.15 0.86 0.20 
0-24 hpi 0.21 0.48 0.66 
IL4 
Saline 
0 -2 hpi 0.21 0.36 0.56 
0 -24 hpi -0.03 0.06 0.66 
LPS 
0 -2 hpi -0.77 0.35 0.04 
0 -24 hpi 0.12 0.05 0.04 
IL6 
Saline 
0 - 2 hpi -1.09 0.78 0.18 
0 -24 hpi 0.07 0.10 0.52 
LPS 
0 -2 hpi -3.87 0.74 0.00003 
0-24 hpi 0.07 0.09 0.44 
IL8 
Saline 
0 -2 hpi -0.05 0.56 0.93 
0-24 hpi 0.13 0.27 0.64 
LPS 
0 -2 hpi -1.56 0.57 0.01 
0 -24 hpi 0.33 0.25 0.19 
TNFα 
Saline 
0 -2 hpi -0.41 0.79 0.60 
0-24 hpi 0.81 0.40 0.05 
LPS 
0 -2 hpi -2.55 0.74 0.002 
0 -24 hpi 0.52 0.35 0.15 
Notes: SE, standard error 
    *Heterogeneous compound symmetry covariance was considered for IFNγ analysis; For other cytokines, 
unstructured covariance was considered. 
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Table A.5. A full list of between-line, within-line and averageline DEGs in pigs. 
Table A.6. Gene sets enriched in differentially expressed genes between the two lines at 
each time point. 
Table A.7. Gene sets enriched in average line deregulated genes at time points post 
treatment compared to baseline. 
Table A.8. GO terms overrepresented by co-expression clusters. 
Table A.9. Differentially expressed probesets and genes in humans in response to LPS 
infusion at each time point post treatment compared to baseline. 
Table A.10. Gene sets enriched among deregulated genes in humans at each time point 
post LPS injection compared to baseline. 
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APPENDIX B. SUPPLEMENTARY MATERIALS FOR CHAPTER 3 
 
 
Supplementary Figures 
 
Figure B.1. MDS plot showing relationships of RNA-seq samples. 
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Figure B.2. Subnetwork consisting of differentially expressed genes regulated by the 
inferred upstream regulator IL-15. Nodes were colored based on the log ratio of averaged 
expression levels of genes between groups, with up-regulated genes in red and down-
regulated genes in green. 
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Supplementary Tables 
Table B.1. Meta data for RNA-seq and RT-qPCR assays. 
Table B.2. Primers used to validate differentially expressed genes by RT-qPCR. 
Table B.3. Statistical summary of raw, trimmed, mapped and residual globin reads. 
Table B.4. Differentially expressed genes identified by RNA-seq. 
Table B.5. Summary of Ingenuity IPA-based pathway analyses. 
Table B.6. Summary of IPAD-based pathway and disease enrichment analyses. 
Table B.7. Validation of differentially expressed genes by RT-qPCR assays. 
Table B.8. Association of gene expression with RFI phenotype. 
Gene.ID/Gene.symbol 
Regression coefficient and significance 
RFI.phenotype p-value q-value 
LRP6 1.082 0.000 0.005 
ENSSSCG00000024900 -0.647 0.001 0.021 
ENSSSCG00000008771 -1.333 0.002 0.021 
PDL1 -1.320 0.003 0.023 
ENSSSCG00000020945 -0.164 0.002 0.023 
CLEC12B -1.502 0.019 0.130 
 
Table B.9. Differentially expressed WGCNA modules between the RFI groups. 
Table B.10. GO-BP terms enriched in the WGCNA modules. 
Table B.11. Association of module eigengenes with RFI phenotype. 
Module 
Regression coefficient and significance   
RFI.phenotype  p-value q-value Adjusted R
2
 
C1-lightcyan 0.11  0.14 0.19 0.84 
C2-darkturquoise 0.11  0.26 0.26 0.69 
C3-skyblue3 -0.27 0.0075 0.03 0.73 
C4-black -0.20 0.09 0.18 0.60 
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APPENDIX C. SUPPLEMENTARY MATERIALS FOR CHAPTER 4 
 
 
Supplementary Methods 
This appendix is to provide supplementary methods for generating of three-tissue 
IsoSeq and RNA-seq data, and error correction of the IsoSeq data with RNA-seq data for 
Chapter 4. The error-corrected IsoSeq data were used to validate the putative blood 
transcripts generated by de novo transcriptome assembly. The raw IsoSeq and RNA-seq data 
were generated by Dr. Timothy Smith in US-MARC, USDA-ARS. I established a pipeline to 
perform error correction of the IsoSeq data as described here. It is not tightly related to 
Chapter 4, so I presented it as an appendix. The other materials included in the appendix are 
supplementary figures and tables which are usually too big to include in Chapter 4. 
Sequencing the transcriptomes of three porcine tissues by using the PacBio IsoSeq and 
Illumina RNA-Seq technologies 
The transcriptomes of three tissues (liver, spleen and thymus) from a single cross-
bred pig, from which the PacBio long read-based reference genome was assembled by using 
DNA of lung tissue, was sequenced by the Meat Animal Research Center (MARC, USDA, 
Clay Center, NE) using the Illumina NextSeq500 and PacBio RSII platforms for RNA-Seq 
and IsoSeq, respectively. Total RNA from each of the three tissues was extracted using 
Trizol reagent (ThermoFisher Scientific) and the provided protocol. Briefly, approximately 
100 mg of tissue was ground in a mortar and pestle cooled with liquid nitrogen, and the 
powder was transferred to a tube with 1 ml of Trizol reagent added and mixed by vortexing. 
After 5 minutes at room temperature, 0.2 mL of chloroform was added and the mixture was 
shaken for 15 seconds and left to stand another 3 minutes at room temperature. The tube was 
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centrifuged at 12,000 x g for 15 minutes at 4°C. The RNA was precipitated from the aqueous 
phase with 0.5 mL of isopropanol. The RNA was further purified with extended DNase I 
digestion to remove potential DNA contamination. The RNA quality was assessed with a 
Fragment Analyzer (Advanced Analytical Technologies Inc., IA). Only RNA samples of 
RQN above 7.0 were used for library construction. PacBio IsoSeq libraries were constructed 
per the PacBio IsoSeq protocol. Briefly, starting with 3 μg of total RNA, cDNA was 
synthesized by using SMARTer PCR cDNA Synthesis Kit (Clontech, CA) according to the 
IsoSeq protocol (Pacific Biosciences, CA). Then the cDNA was amplified using KAPA HiFi 
DNA Polymerase (KAPA Biotechnologies) for 10 or 12 cycles followed by purification and 
size selection into 4 fractions: 0.8-2 kb, 2-3 kb, 3-5 kb and > 5kb. The fragment size 
distribution was validated on a Fragment Analyzer (Advanced Analytical Technologies Inc, 
IA) and quantitated on a DS-11 FX fluorometer (DeNovix, DE). After a second round of 
large scale PCR amplification and end repair, SMART bell adapters were separately ligated 
to the cDNA fragments.  Each size fraction was sequenced on 4 or 5 SMART Cells v3 using 
P6-C4 chemistry and 6 hour movies on a PacBio RS II sequencer (Pacific Bioscience, CA). 
Short read RNA-Seq libraries were prepared using TruSeq stranded mRNA LT kits and 
supplied protocol (Illumina, CA), and sequenced on a NextSeq500 platform using v2 
sequencing chemistry to generate 2 x 75 paired-end reads. These data were then provided to 
the ISU Tuggle group for analysis. 
Error-correction and redundancy reduction of PacBio IsoSeq full-length cDNA reads 
The Read of Insert (ROI) were determined by using consensustools.sh in the SMRT-
Analysis pipeline v2.0, with reads which were shorter than 300 bp and whose predicted 
accuracy was lower than 75% removed. Full-length, non-chimeric cDNA reads were 
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identified by running the classify.py command. Primer sequences as well as the poly(A) tails 
were trimmed prior to further analysis. Paired-end Illumina RNA-Seq reads from each tissue 
sample were trimmed to remove the adaptor sequences and low-quality bases using 
Trimmomatic (v0.32) [250] with explicit option settings: ILLUMINACLIP:adapters.fa: 
2:30:10:1:true LEADING:3 TRAILING:3 SLIDINGWINDOW: 4:20 LEADING:3 
TRAILING:3 MINLEN:25, and overlapping paired-end reads were merged using the PEAR 
software (v0.9.6) [374]. Subsequently, the merged and unmerged RNA-Seq reads from the 
same tissue samples were in silico normalized in a mode for single-end reads by using a 
Trinity (v2.1.1) [315] utility, insilico_read_normalization.pl, with the following settings: --
max_cov 50 --max_pct_stdev 100 --single. Errors in the full-length, non-chimeric cDNA 
reads were corrected with the preprocessed RNA-Seq reads from the same tissue samples by 
using proovread (v2.12) [375]. Untrimmed sequences with at least some regions of high 
accuracy in the .trimmed.fq files were extracted based on sequence IDs in .untrimmed.fa files 
to balance off the contiguity and accuracy of the final reads. 
To reduce the redundancy of the PacBio IsoSeq reads of the three tissues, the error-
corrected reads from all three tissues were combined after assigning unique identifiers to 
them, and mapping them to USMARCv1.0 using GMAP (version 2016-09-23) [90]. The 
sense strands of the spliced reads were determined on the basis of the splice site consensus 
sequences. Mapped reads were clustered based on chromosome coordinates and strand 
information using Bedtools [317] and custom Perl scripts. Reads in each cluster were 
collapsed if they met the following criteria: (1) they shared compatible intron-exon junctions; 
(2) they had compatible 5‟ termini; (3) they differed in the 3‟ termini by less than 100 bases 
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in length (https://github.com/Pacific.Biosciences/cDNA_primer/wiki/tofu-Tutorial-
(optional)-Removing-redundant-transcripts). 
Supplementary Figures 
 
 
 
Figure C.1. Length distribution of the normalized trimmed RNA-seq reads used for the 
porcine blood transcriptome assembly. 
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Figure C.2. Flowchart for de novo blood transcriptome assembly, annotation and 
filtering. The diagram shows the steps involved in construction and filtering of the de novo 
assembly, and includes the number of PTs that resulted from each step, where appropriate. 
Refer to the Materials and Methods section for details. Quality of the raw RNA-seq reads for 
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each library was first checked with FASTQC. Subsequently, sequencing adaptors and low 
quality bases were trimmed from the raw reads. These trimmed reads were then digitally 
normalized to reduce k-mer redundancy. Normalized reads were assembled into putative 
Trinity transcripts (PTs), which are collectively called “de novo transcriptome assembly”. 
This assembly was then analyzed in several ways. First, the coding potentials of the PTs were 
predicted by using PLEK, with PTs of coding potentials higher than zero considered as 
potentially protein-coding. Then all PTs were separately aligned to the two pig reference 
genomes, USMARCv1.0 and SSC10.2, by using GMAP. Finally, sequences for the top 
BLAST hits of the PTs were retrieved from the NCBI NT and NR databases by using DC-
megaBLAST and BLASTX, with E-value cutoffs of 10
-20
 and 10
-6
, respectively. Because the 
alignment frequency of the assembly to the USMARCv1.0 reference genomes was much 
higher than to the SSC10.2 assembly, the de novo transcriptome was filtered based on the 
USMARCv1.0 mapping results. PTs with top megaBLAST hits on sequences from non-
vertebrates and without better alignments with the two reference genomes were considered as 
“contaminants” and were filtered out. The potential biotypes of the PTs were determined 
based on the biotypes of their top megaBLAST hits if available. Other removed PTs were (i) 
PTs with top megaBLAST hits on sequences of mitochondrial genomes; (ii) unspliced 
intronic PTs; (iii) unspliced nonintronic PTs mapped to genomic regions of maximal 
coverage per base (CPB) lower than 50  (low-CPB regions); and (iv) multiple mapping or 
nonmapping PTs on the USMARCv1.0 assembly without top megaBLAST hits on RNA 
sequences in the NT database. The final filtered de novo transcriptome assembly was 
composed of 126,225 PTs. 
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Figure C.3. (Legend on next page) 
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Figure C.3. Characterization of the de novo transcriptome assembly. (A) Length 
distribution of PTs in the de novo transcriptome assembly. (B-C) Full-length assessment by 
using Swiss-Prot protein (B) and pig RefSeq mRNA (C) sequences as standards. In (B), 
percentage of coverage of the sequences as standards by PTs were calculated based only on 
the best high-scoring segment pairs (HSP) (“ungrouped percentage of coverage” calculation 
method) or based on all HSPs (“grouped percentage of coverage” calculation method) 
between the two aligned sequences. (D, F) Species distribution of top DC-megaBLAST (D) 
and BLASTX (F) hits of the PTs in the NT and NR databases, respectively. (E, G) Boxplots 
showing the distributions of percentage of identity, percentage of query coverage, bit scores 
and E-values of the top BLAST hits of the PTs in the NCBI NT and NR databases by using 
DC-megaBLAST (E) and BLASTX (G), respectively. For clearer visualization, larger 
outliers of bit scores and E-values are not displayed. 
  
185 
 
Figure C.4. Flowchart for genome-guided transcriptome assembly, annotation and 
filtering. The diagram shows the steps involved in construction and filtering of the genome-
guided assembly, and includes the number of PTs that resulted from each step, where 
appropriate. Refer to the Methods section for details. The raw RNA-seq reads that were 
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preprocessed as above (see the legend of Figure C.2) were mapped to the USMARCv1.0 
reference genome by using STAR, and then assembled into PTs by using Cufflinks. PTs of 
200 bases or shorter in length were removed from the resulting genome-guided transcriptome 
assembly before further analysis. Splicing status of the 162,294 PTs was determined and 
unspliced intronic PTs were discarded. Sequences of top BLAST hits to the remaining 
63,311 PTs were retrieved from the NCBI NT and NR databases by using DC-megaBLAST 
and BLASTX, respectively. The potential biotypes of the PTs were determined based on the 
biotypes of their significant DC-megaBLAST hits. To complete the filtering, we removed 
from the remaining PTs: (i) PTs with top DC-megaBLAST hits on sequences originating 
from mitochondrial genomes; and (ii) PTs mapped to genomic regions of maximal CPB 
lower than 50  (low-CPB regions). The final filtered genome-guided transcriptome 
consisted of 32,702 PTs. 
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Figure C.5. Characterization of the genome-guided transcriptome assembly. (A) Length 
distribution of PTs in the genome-guided transcriptome assembly. (B, C) Boxplots showing 
the distributions of percentage of identity, percentage of query coverage, bit scores and E-
values of the top BLAST hits of the PTs in the NCBI NT and NR databases by using DC-
megaBLAST (B) and BLASTX (C). For clear visualization, larger outliers of bit scores and 
E-values are not displayed.  
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Figure C.6. Integration of the de novo and genome-guided assemblies. This diagram 
shows the steps used to integrate the two assemblies that were described in Figures 1 and 2, 
and includes the number of PTs that resulted from each step, where appropriate; the overall 
goal was to identify those genome-guided assemblies that added information to the de novo 
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assembly. The sense strands of 113,286 spliced PTs from the de novo assembly (Set A) were 
first determined based on consensus splice site sequences after alignment to the 
USMARCv1.0 reference genome. The spliced PTs in the filtered de novo transcriptome were 
then compared to their counterparts in the filtered genome-guided transcriptome (Set B) by 
using the Bedtools intersect utility and custom Perl scripts. If a spliced PT from the de novo 
assembly shared at least one intron or exon, or all introns and exons with a spliced PT from 
the genome-guided assembly mapped on the sense strand, then they were considered 
overlapping or exactly the same, respectively. In addition, unspliced PTs from the de novo 
and genome-guided assemblies were directly compared, without considering their sense 
strands, by using Bedtools intersect utility. PTs from the de novo transcriptome assembly, 
which did not overlap PTs from the genome-guided transcriptome assembly were claimed to 
be de novo transcriptome assembly-specific, and vice versa. The final integrated 
transcriptome consisted of 132,928 PTs, which included all 126,225 PTs from the filtered de 
novo transcriptome assembly and 6,703 PTs specific to the filtered genome-guided 
transcriptome, including both 5,972 spliced and 731 unspliced PTs. 
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Figure C.7. Schematic summary of BLAST2GO mapping and annotation. (A) 
Distribution of source databases based on which GO terms were mapped to PTs in the 
integrated transcriptome assembly. (B) Distribution of the number of GO terms mapped to 
PTs of the integrated transcriptome assembly. (C) Distribution of evidence codes of the 
annotated GO terms mapped to PTs of the integrated transcriptome assembly. (D) 
Distribution of the number of GO terms mapped to PTs of the integrated transcriptome 
assembly. (E) Distribution of GO terms at different levels of the hierarchy of GO terms. (F) 
Distribution of annotation scores of GO terms. 
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Figure C.8. Distribution of GO terms related to immune system process. 
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Figure C.9. The purine metabolism KEGG pathway highlighted with enzymes encoded 
by PTs of the integrated transcriptome. Different enzyme codes are highlighted with 
different colors. 
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Figure C.10. The distributions of the distance between proximal promoters defined by 
pig macrophage CAGE data (A) or all available human/mouse/pig CAGE data (B) to 
the nearest 5' termini of spliced, uniquely mapping PTs in the integrated transcriptome 
assembly.  The vast majority of these distances were less than 50 bp, which strongly 
suggested that the 5‟ termini of many PTs were completely assembled. 
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Figure C.11. Comparison of PTs of the integrated transcriptome assembly to the IsoSeq 
cDNA reads, transcripts annotated in Ensembl SSC10.2 and NCBI pig RefSeq mRNA 
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sequences. (A) Venn diagram showing the number of PTs with their intron arrangements 
validated by the IsoSeq reads, pig RefSeq mRNA sequences and SSC10.2 transcripts. (B) 
Distribution of exon number of novel spliced transcripts not found in the SSC10.2 annotation 
or pig RefSeq mRNA set, which provides good evidence of significant extension of current 
genome annotation. (C) Length comparison between PTs and their maximally overlapping 
SSC10.2 transcripts. (D) Length comparison between PTs and their maximally overlapping 
RefSeq mRNA sequence. 
Supplementary Tables 
Table C.1 Trimming effect on the raw RNA-seq data. 
Table C.2 PTs annotated with GO terms. 
Table C.3 PTs annotated with EC codes and KEGG pathways. 
Table C.4 PTs assigned with HGNC gene symbols and Ensembl pig Gene IDs and tissue 
or cell types where their human counterparts specifically or preferentially expressed. 
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